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Abstract 
After encounter with antigen, naïve CD4 T cells proliferate and differentiate into 
effector and memory cells. Effector CD4 I cells provide help to B cells to undergo 
isotype class switching and germinal centre formation. T cells that have been activated 
in vivo in the absence of B cells are impaired as they are unable to help B cells to class 
switch in vitro. Furthermore, T cells primed in the absence of CD40 are unable to help 
normal B cells to class switch or to form germinal centres. The mechanisms underlying 
this differentiation of helper T cells are not well understood. In this study, I have 
investigated cellular and molecular interactions involved in these processes. 
B cells can directly affect CD4 T cell effector responses through antigen presentation 
and costimulation, for example via CD40-CD40L and OX40L-0X40 interactions. By 
creating bone marrow chimeric mice, we could selectively knock out MHC class-Il and 
CD40 on B cells. This allowed us to study the molecular interaction between B and T 
cells that is required for T cells to develop helper function. In the absence of B cells that 
express MHC class-Il or CD40, antigen induced differentiation of effector T cells that 
help B cells to class switch, was impaired. 
The role played by inducible costimulator (ICOS) in CD4 T cell responses was also 
examined using ICOS mice. In the absence of ICOS-ICOSL interactions, CD4 T cells 
were unable to help B cell clonal expansion and class switching to IgGi and IgG2a. Thus, 
ICOS mice have few small germinal centres, markedly reduced levels of class 
switched immunoglobulins in their serum and significantly less antibody secreting cells 
in spleen and bone marrow. Using adoptive transfer studies with ICOS-deficient 
transgenic T cells, I have shown that ICOS is important for the comprehensive 
activation, clonal expansion and differentiation of CD4 I cells. 
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1. INTRODUCTION 
1.1. Adaptive immune response: an overview 
Humoral immunity and cell-mediated immunity, the two types of adaptive immune 
responses, are mediated by different components of the immune system and function to 
eliminate different types of microbes. Antibodies, the main weapon of humoral 
immunity, are made by B lymphocytes and are the principal defense mechanism against 
extracellular microbes and their toxins. Cell-mediated immunity is mediated by T 
lymphocytes and acts to destroy intracellular microbes or kill infected cells and thus 
eliminate the reservoir of infection. There are two distinct types of T cells: cytotoxic T 
cells (CTL, CD8) and helper T cells (CD4). CTLs kill cells that produce foreign 
antigens, such as cells infected by viruses and other intracellular microbes. CD4 T cells 
recognise peptides presented by MHC-II molecules whereas C138 I cells recognise 
peptides on MHC-I molecules. MHC-II molecules (HLA-DR, -DP, and -DQ in humans 
and I-A and I-E in mice) are heterodimers formed by non-covalently associated a and 
chains. They are constitutively expressed on professional antigen presenting cells (APC) 
and are upregulated upon activation. They can also be expressed on many other cell 
types upon stimulation by inflammatory signals. CD4 T cells direct the immune 
response by regulating the proliferation and differentiation of various cells of the 
immune system and they achieve this mainly through the secretion of small soluble 
messengers called cytokines. In order to carry out these functions, the T cells must be 
activated and this occurs in the secondary lymphoid organs. 
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1.1.1. 	Secondary lymphoid organs 
Lymphoid tissues are classified as primary lymphoid organs (bone marrow and thymus), 
where lymphocytes first express receptors that recognise specific antigen and attain 
phenotypic and functional maturity, and as secondary or peripheral lymphoid organs 
(spleen, lymph nodes, Peyer's patches etc.) where lymphocyte responses to foreign 
antigens are initiated. The secondary lymphoid organs are highly organised structures 
that facilitate the encounter of antigen-specific I cells and APC that express antigen. 
The main cell types found in secondary lymphoid organs are B and T lymphocytes, 
dendritic cells (DCs), macrophages, non-haematopoietic stromal cells other than red 
blood cells. The naïve T cells continually recirculate through lymphoid organs until they 
encounter specific antigen. 
The spleen is the major site of immune responses to blood-borne antigens. It is divided 
into red pulp, containing mostly erythrocytes, and white pulp comprised of lymphocytes 
and other cel1s The T cell zones are termed periarteriolar lymphoid sheaths (PALS) 
because cuffs of T cells surround small arterioles. B cells reside in follicles, which are 
the spheroid-shaped zones located in the periphery of the PALS. A network of reticular 
cells, predominantly containing resident IgMigD B lymphocytes and marginal zone 
macrophages surrounds the white pulp, and is . called the marginal zone (MZ) [1]. 
Lymphocytes enter the spleen through the splenic artery that opens in the MZ and B and 
T cells then migrate to their respective areas in the white pulp. The spleen is also 
important for the filtration of blood and phagocytosis of the opsonised microbes. 
The adaptive immune responses to lymph-borne antigens are initiated in lymph nodes. 
These are small nodular aggregates of lymphocyte-rich tissue situated along the 
lymphatic channels throughout the body. A lymph node consists of an outermost cortex, 
the B cell area, which surrounds the I cell area called the paracortex. The medulla is the 








(mostly T cells) 
germinal center 
primary lymphoid 













Figure 1.1 Diagrammatic representation of a lymph node. T cells and B cells are 
segregated into paracortex and follicles, respectively. Adapted from lmmunobiology: 
the immune system in health and disease", Charles A. Janeway et. a!, 2005. 
EI3 
vessels (figure 1.1). Entry of the lymphocytes into the lymph nodes occurs through high 
endothelial venules (HEy). Naïve T and B cells in the lymph use specific receptors 
(CD62L and CCR7) to recognise ligands on the. specialised HEVs (peripheral lymph 
node addressin (PNAd) and SLC (secondary lymphoid-organ chemokine)) and then pass 
between these cells to enter the central part of the lymph node [2,3]. Recently, 
Matloubian et al. have found that T cell exit from lymph nodes is also an active process 
requiring the sphingosine-1-phosphate (SiP) receptor 1 [4]. Thus, naïve I cell migration 
is a controlled process, delivering T cells to the sites at which they are most likely to 
meet antigen brought by DCs or through the lymph from the periphery. 
1.2. Interaction between T and B cells 
The initial priming and activation of naïve T cells occurs on DCs [5]. Within days of the 
start of an immune response, however, the dominant APC is no longer a DC but a B cell. 
This happens because DCs have a relatively short lifespan within the lymphnode after 
entry [6]. On the other hand, the number of B cells that can act as APC increases as the 
response matures, because antigen-specific B cells undergo clonal expansion. Moreover, 
owing to their surface antigen receptor, antigen-specific B cells can present the antigen 
to T cells with very high efficiency [7]. Despite this we know very little about the 
behaviour of B cells in vivo as APC and as programmers of T cell differentiation. 
Following priming, the B cells first proliferate in T zones, the same place where T cells 
are stimulated by DCs to divide [8]. Later some of the T cells migrate into the B cell 
follicles [9]. These two migratory events are possibly an opportunity for the CD4 T cells 
to provide help to B cells. However, the interactions are cognate and have the potential 
to deliver late costimuli (e.g. via ICOS, 0X40) and/or cytokines to the T cells as well 
[10,11] 
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1.2.1. 	B cell subsets 
B-lymphocytes can be divided into B-i and B-2 cells [12]. B-i B cells are long-lived 
self-renewing B cells, which are maintained by multivalent self-antigens [13]. B-ia B 
cells are of foetal liver origin and are abundant in the peritoneal cavity. They are 
primarily involved in the generation of T-independent responses to antigens encountered 
at mucosal sites. Phenotypically, they are identified as I gMIgDI0 CD5+Maci +  B cells 
and produce natural antibodies. B-lb cells develop from bone marrow derived stem cells 
and do not express CD5. They are typically self-reactive and need cogmite self-antigens 
to be present for their development [13]. 
B-2 B cells are the major population of B cells and are further subdivided into follicular 
(FO) B cells and marginal zone (MZ) B cells. Mature FO B cells located in lymphoid 
follicles of secondary lymphoid organs are defined as IgDluIgMb0CD23+CD2 
I jnt and are 
relatively short-lived cells with a half-life of around 2-3 months [14]. They contribute to 
most I cell-dependent GC-based responses. The MZ is a distinct anatomical 
compartment that in mice is found only in spleen and surrounds the B cell follicles and 
the periarteriolar T cell areas. The MZ B cells are self-renewing cells with partially 
activated phenotype IgMIgDb0CD23CD2 liii [15]. Due to their specialised location near 
the marginal sinus and their association with various other cell types including 
endothelial cells, DCs and macrophages, MZ B cells are designated for exposure to 
blood-borne antigens [12,15]. MZ B cells are presumed to be critical for TI responses. It 
is possible that they contribute to ID responses by presenting blood-borne antigens to 
naïve T cells since they express high levels of CD80 and CD86 [16]. In addition, Pyk2 
mice lack MZ B cells and also show defective 1gM responses to protein antigens [17]. 
Recently, Notch2 and the Notch ligand Delta-like 1 have been shown to be important for 
the generation of MZ B cells at the branch point of MZ and FO B cells in the spleen 
[18,19] 
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1.2.2. 	T-independent and T-dependent antibody responses 
The production of antibodies by B cells, capable of neutralising and eliminating foreign 
organisms, is a central role of the immune system. Antibodies can block toxins from 
certain bacteria or bind them to aid the uptake of this antigen by cells of innate immune 
system. Immunity to many viruses and parasites requires the presence of specific 
antibodies: this is particularly well illustrated in .tMT mice, which lack B cells, and 
which readily succumb to infections [20-24]. There are different classes of antibodies 
that have slightly different functions. Naïve B cells express only 1gM and IgD but may 
switch to IgG, IgA or IgE once activated. 
The mechanisms by which the B cells are triggered to produce antibodies depend on the 
nature of the antigen. Congenitally athymic Nude mice, which have no I cells, are 
unable to mount antibody responses to certain antigens called T-dependent (TD) 
antigens, but they are able to produce antibodies against other T-independent (TI) 
antigens. Xid mice, which carry a mutation resulting in deficient B cell maturation, only 
generate antibodies when immunised with a subset of TI antigens - TI type 1 antigens. 
The remaining TI antigens are termed TI type 2 antigens. 
TI-i antigens are directly mitogenic to B cells. They are thus able to polyclonally 
activate large number of B cells to produce antibodies, most of which are not antigen 
specific. Most TI-i antigens are derived from components of bacterial cell walls, such as 
lipopolysaccharide (LPS). TI-2 antigens comprise of repeating polymers, which are able 
to cross-link large numbers of antigen receptors on the surface of B cells, resulting in 
production of antigen specific antibodies. The most common forms of TI-2 antigens are 
bacterial polysaccharides. 
TD antigens are much more varied but are all proteins, the most widespread type of 
antigen encountered by the immune system. They are unable toactivate B cells directly, 
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and require the help of T cells. In some cases, for example sheep red blood cells 
(SRBC), which have a limited ability to cross-link antigen receptors on B cells, soluble 
molecules produced by T cells are sufficient to allow B cell activation in vitro. On the 
other hand, soluble protein antigens require cell-cell contact between B cells and T cells 
in order for in vitro activation to occur. 
The outcome of an antibody response also depends on the type of immunising antigen: 
TI antigens elicit only low affinity antibodies of the 1gM isotype and do not generate 
lasting immunity. TD antigens, however, are able to generate high affinity antibody of 
all isotypes (1gM, IgG, IgA, IgE). Furthermore, immunisation results in long-lived 
immunity; a secondary challenge with the antigen results in a stronger and more rapid 
immune response. 
It is unclear how the antigen-specific B cells acquire antigen in the secondary lymphoid 
organs. Antigen could either enter through the blood or lymph in soluble form [25,26] or 
as unprocessed antigen on the surface of APC [27].. Once B cells take up antigen through 
their BCR, they intemalise it and present it in the context of MHC-II on their surface and 
therefore can act as APC, possibly helping T cell priming. This cognate interaction 
between B and T cells is crucial for the B cells to receive the CD40 and cytokine 
receptor signals that are required for their proliferation, antibody secretion and memory 
cell formation [28]. 
Duration of the interaction between antigen-specific T cell and APC depends on the 
number of peptide-MHC-II complexes on the surface of APC. Jenkins and colleagues 
have speculated that antigen-specific B cells produce even more peptide-MHC-II ligands 
than the tissue-derived DCs resulting in prolonged interactions between cognate B and T 
cells [29]. Thus, expression of an antigen-specific surface Ig receptor (BCR) gives a B 
cell an enormous advantage over other B cells with respect to antigen uptake and 
presentation [7]. 
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1.2.3. 	B cell trafficking 
Discovery of the chemokines and their receptors in last few years has shed light on the 
mechanisms of lymphocyte migration. Naïve follicular B cells express low amounts of 
CCR7, which binds to CCL19 (ELC, EBI-1-ligand chemokine) [30] and CCL21 (SLC, 
secondary lymphoid tissue chemokine) [31] produced by stromal cells in the I cell area, 
and high amounts of CXCR5, which binds to CXCL13 produced in the follicles possibly 
by FDCs [32-34]. This expression pattern allows naïve B cells to reside in follicles. 
Once the BCR binds the antigen, it transduces signals that change the chemokine 
receptor expression. The B cells increase the expression of CCR7 and reduce expression 
of CXCR5, as a result, movement of B cells is restricted to the outer edge of the follicle 
near the T cell area, referred to as "follicular exclusion" [35,36]. By 
immunohistochemical studies, the majority of antigen-specific B cells have been shown 
to interact with antigen-specific T cells at T-B border 48h after antigen injection [37]. 
This increases the chances of cognate interactions between T and B cells because of 
random crossing of this area by T cells, which become more numerous as time passes, 
due to prior cell division. 
By uptake of Bromo-deoxy-uridine (BrdU), Toeliner et al. have shown that B cells start 
proliferation in the T zones [38]. Following activation, antigen-specific B cells either 
migrate to the edge of I zones and form foci of proliferation, or form GCs in the centre 
of the follicles. Progeny of a single activated B cell can give rise both to extrafollicular 
foci and GCs [39]. Proliferation of B cells within foci continues until 4-8 days after 
immunisation, by which stage foci no longer contain any T cells. Proliferation then halts, 
and the B cells differentiate into plasma cells [8,38]. 
Various molecules play a role in formation of synapse between B and T cells, a critical 
event for efficient antibody responses. In addition to CD28-CD80/CD86 interactions, 
ICOS-ICOSL interactions play important role in promoting T-B cell contact (see section 
1.4). Cytokine production by T cells clearly influences B cell development, but Schultze 
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et al. have reported cytokine production by antigen experienced human tonsillar B cells 
that may create positive feedback ioop to influence helper I cell development [40]. IL-
12 and IL-6 produced by B cells in cognate contact with Thi or Th2 cells, respectively, 
could maintain or even amplif' the ongoing T cell response initiated by DCs in vivo. 
Moreover, B cell activating factor (BAFF), a member of TNF family, expressed on DC 
and activated T cells, and its counter-receptor BAFFR on activated B cells may also play 
a role in effector T cell differentiation [41,42]. 
1.3. Cell mediated immunity 
A major focus of this project has been to understand the cellular and molecular 
requirements for the activation and differentiation of the CD4 T cells. The CD4 T cell 
response is initiated with the recognition of peptide-MHC-II complexes on the APC by 
the T cell receptor (TCR). Other interactions, specifically those between costimulatory 
molecules are required for a productive T cell response. Once the T cell recognises its 
antigen, these interactions lead to the activation, proliferation and differentiation of the 
antigen-specific T cells. 
1.3.1. 	T cell priming on DCs 
DCs are heterogeneous population comprising of many subsets. The two main subsets 
being. CD1 1b myeloid DCs, which are primarily located in peripheral tissues, and the 
CD8 lymphoid DCs, which are found in the T cell areas of spleen and lymph nodes 
[43]. DCs are possibly the most efficient APCs for the naïve CD4 T cells [5]. The 
reason for this remains unclear, although it may be due to high levels of peptide-MHC-II 
complexes, adhesion and costimulatory molecules on their cell surface. Immature DCs 
constantly sample the environment around them, taking up antigen and presenting it. 
Once exposed to bacterial and viral products or inflammatory cytokines, they undergo 
maturation, increase expression of costimulatory molecules and traffic to secondary 
lymphoid organs where they interact with antigen-specific T cells. This movement to 
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secondary lymphoid tissues is the result of changes in chemokine receptor and adhesion 
molecule expression [44]. T cells then promote further maturation of the DCs through 
costimulatory molecules and cytokines. In APCs, the MHC-I and MHC-II molecules are 
present in different intracellular vesicles resulting in MHC-II molecules being loaded 
with exogenous antigens in the endocytic pathway and the MHC-I molecules being 
loaded with endogenous antigens in the endoplasmic reticulum. Recently however, this 
compartmentalisation in the DC has been shown to be somewhat lenient, giving rise to 
the phenomenon of cross-presentation [45,46]. 
It had previously been suggested that antigen-primed DCs from the periphery migrate to 
the T cell zones of the secondary lymphoid organs where they can present the antigen to 
naïve antigen-specific T cells. However, by injecting fluorescently labelled soluble 
antigen, Jenkins and colleagues visualised antigen entering the lymph node via afferent 
lymph within 15min after injection. The question of whether this antigen can be picked 
up and presented by resident DCs, was answered using antibodies specific for peptide-
MHC complexes. Itano et al. as well as Manickasingham and Reis e Sousa have shown 
peptide-MHC complexes on DCs early after s.c. injection of antigen. This timing is too 
short to be due to migration of DCs from peripheral tissues, which has been shown to 
take around 6h [47,48]. Thus, T cells first encounter antigen presented by resident DCs 
and the migrating DCs arrive later to give additional stimulation [25]. The initial 
interactions with I cells however are for shorter duration due to small number of 
peptide-MHC-II complexes displayed by resident DCs. Post-migration DCs from the 
injection site have been shown to engage T cells for around 24h due to large number of 
peptide-MHC-II complexes on their surface [29]. In, lymph nodes, migrating DCs home 
to the HEY region after capturing antigen from peripheral tissues. Since T cells also 
enter the lymph nodes via HEy, this enhances the ability of DCs to scan T cells [49]. 
Understanding of the initial interaction between T and APC has been enhanced greatly 
by the recent advent of 2-photon laser scanning microscopy. It allows 3-dimensional 
visualisation of the cells within intact lymph node and has proved invaluable to our 
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understanding of cellular interactions and migration. DCs scan at least 500 different T 
cells per hour in the absence of antigen. Antigen bearing DCs are highly efficient in 
recruiting peptide-specific T cells and can engage more than ten T cells simultaneously 
[50,51]. Several studies have found that the initial interaction between antigen-specific T 
cells and DC is transient but that more stable interactions, lasting for hours rather than 
minutes, take place between 24-48 hours after antigen recognition [52,53]. These stable 
interactions may enable the formation of an immunological synapse, a tight interaction 
between two cells that may be required for T cell activation and for the directed release 
of soluble molecules [54]. Although all naïve T cells are thought to be equally able to 
differentiate into a spectrum of effector cells, the quality of the TCR-peptidefMHC 
interaction can influence the functional commitment of T cells. 
1.3.2. 	Costimulation of T cells 
Apart from signalling through the TCR as a result of recognition of peptide/MHC on 
APCs (signal 1), additional signals in form of costimulation (signal 2) are required for 
effective T cell activation. The interplay between costimulatory pathways is only 
partially understood. In the absence of costimulation, T cells can become anergic or 
undergo apoptosis [55]. Costimulatory molecules can be divided into two main groups: 
immunoglobulin superfamily (CD28, ICOS, PD-i) and tumour-necrosis factor receptor 
(TNFR) superfamily (CD40, 0X40, 4-1BB), although it has been shown that members 
of both families can engage signalling intermediates common to each other and TCR. 
The expression of the costimulatory molecules is varied with some molecules being 
expressed on a few cell types while others widely expressed. Furthermore, some 
molecules are constitutively expressed e.g. CD28, ICOSL, whereas others are induced 
upon activation e.g. ICOS, OX40L. 
The best-characterised costimulatory pathway involves CD28, expressed by all naïve T 
cells, which binds to CD80 and CD86 upregulated on activated APCs [56,57]. CD28 can 
enhance T cell proliferation [58], transcription of IL-2 [59] and expression of anti-
apoptotic proteins such as Bcl-xL [60]. Programmed death-i (PD-i) and CTLA-4, also 
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belonging to Ig superfamily, mediate an inhibitory signal to T cells [61]. ICOS, 
expressed on T cells following activation, binds to ICOSL on B cells and other APCs. It 
has been shown to be critical for mature B cell responses (detailed in section 1.4). 
CD40 is a member of TNFR family of proteins and is expressed on APCs such as DCs, 
B cells and macrophages. Since only activated T cells express CD40L, this interaction 
may play a role in sustaining or enhancing T cell responses rather than initiating them. 
CD40 is found at low levels on resting APC, and is upregulated after activation [62,63] 
whereas CD40L is transiently induced on naïve T cells after TCR stimulation [4]. 
Splenic CD4 T cells express CD40L 4h after in vitro anti-CD3 stimulation, which peaks 
between 6-8h, and then returns to resting levels between 24-48h [64]. CD40L binding to 
CD40 results in oligomerization of CD40 molecules and this induces the association of 
cytoplasmic proteins called TNF receptor-associated factors (TRAFs) to the cytoplasmic 
domain of CD40. This recruitment initiates the enzyme cascades leading to activation 
and nuclear translocation of transcription factors, including NFKB and AP- 1. Hence, 
CD40-CD40L interaction primarily signals to the APC and sustained activation of NFKB 
transcription factor regulates the DC differentiation and cytokine production [65]. CD40 
signalling also enhances DC survival through upregulation of the survival molecule Bcl-
2 [66]. Engagement of CD40. leads to enhanced expression of CD80 and CD86 on B 
cells, causing more T cell activation. CD40 ligation on DC is a crucial trigger for IL-12 
release and priming for a Thi response [67], and CD40-CD40L interaction synergises 
with IL-12 in selectively enhancing IFNy production by I cells [68]. In the absence of 
IL-12 release, a default Th2 response is observed [69]. 
CD40-CD40L costimulation is critical for B cell help by T cells and in its absence B 
cells cannot undergo isotype class switching, somatic hypermutation, germinal centre 
formation and memory development [70,71]. Early reports suggested that CD40L T 
cells fail to prime in vivo [72], but more recently, it was shown that CD40L T cells 
become activated, but are unable to sustain a response in vivo, and are defective in Thi 
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development in viro [73]. CD40-ligation delays clonal deletion of antigen-specific T 
cells and enhanced T cell clonal expansion in response to super-antigen [74]. Recent 
reports suggest the expression of CD40 by activated T cells and CD40L by B cells 
indicating the complexity of CD40-CD40L interaction between B and T cells [75-77]. 
The 0X40-OX40L interaction is crucial for T cell activation and survival. 0X40 
expression by T cells is induced by TCR stimulation and peaks around 48 hours 
following antigen recognition [78]. Similarly, OX40L expression by APCs is inducible 
following CD40 or LPS stimulation, and peaks 2-3 days after in vitro stimulation [79-
82]. Studies using mice deficient in either 0X40 or its ligand suggest the importance of 
this interaction in T cell responses including priming, migration, differentiation, B cell 
help and memory cell development [78,80,82-85]. Furthermore, 0X40-OX40L 
interaction maintains high levels of the anti-apoptotic proteins Bcl-2 and Bcl-xL and 
suppresses apoptosis by preventing caspase activation in the absence of cell division 
[55]. 
The initial stage of antigen-specific T cell development is highly influenced by DC 
expression pattern of cytokines (IL-12, IL-6) and costimulatory molecules (CD80, 
CD86). The antigen-primed T cells can then deliver signals to the DC via cell contact 
(CD40L) and perhaps early cytokine production (TNFa). This is followed by IL-2 
dependent proliferation of the antigen-specific T cells, a process known as clonal 
expansion. Also associated with this phase is the migration of antigen-specific T cells 
towards the border of T-B areas in vivo to initiate the critical synaptic interaction 
between antigen-primed T cells and the antigen-primed B cells [37]. 
1.4. Inducible costimulator (ICOS) 
Studying the role played by ICOS in immune response was a major focus of this project, 
therefore has been introduced in detail in this section. ICOS (also known as H4 and 
AILIM) is the latest member of the family comprised of CD28 and CTLA-4. It is a 
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glycosylated disuiphide linked homodimer expressed on the cell surface of activated T 
cells. The ICOS gene maps to the CD28/CTLA-4 locus on chromosome- 1, suggesting 
that they arose from a common ancestral gene [86]. Its ligand, ICOSL, also called 137h 
[87], LICOS [88], B7RP-1 [89], B7H-2 [90] and GL-50 [91], is expressed constitutively 
on B cells, splenic and peritoneal macrophages [89] and DCs [92] and its expression is 
upregulated by TNFa and LPS [87]. ICOS-ICOSL is a distinct recéptor-ligand pair as 
interaction between them is specific and separate from that between CD28 and 
CD80/CD86 [89]. 
ICOS has an important role in enhancing T cell-dependent B cell help. Trahsgenic mice 
producing a secreted form of ICOSL-Ig develop lymphoid hyperplasia, plasmacytosis 
and high serum levels of IgG [89]. ICOS' mice exhibit profound deficits in Ig isotype 
class switching and germinal centre formation after immunisation [93-96]. However, 
McAdam et al. could restore class switching to IgGi and IgG2a in ICOS' mice by giving 
stimulatory anti-CD40 antibody [93]. This suggests that ICOS may promote the 
collaboration between T and B cell through the CD40-CD40L pathway. Using a B and T 
cell double adoptive transfer system, Smith et al. have demonstrated that T cells depend 
on ICOS-ICOSL interactions to clonally expand as well as to support B cell clonal 
expansion [97]. The authors transferred OVA-specific DO 11.10 T cells along with HEL-
specific MD4 B cells into recipient mice in the presence or absence of non-depleting 
anti-mouse ICOS mAb. After immunisation with OVA-HEL, the treated mice had half 
the number of KJ 1 .26k  T cells and 3 fold less antigen-specific B cells in comparison to 
untreated group. 
In contrast to CD28, ICOS is not expressed constitutively on naïve T cells. After 
activation, it is detected at 12h, peaks at 48h and then gradually declines. ICOS 
expression is influenced by both TCR and CD28 signals [86,98-100]. CD28 enhances 
ICOS expression, and ICOS upregulation is markedly reduced in the absence of CD80 
and CD86 [100,101] indicating that some of the functions ascribed to CD28 might be 
due in part to ICOS signalling. However, ICOS expression is not entirely dependent on 
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CD28 signals, and T cell responses have been modulated in C1328' mice with ICOS-Ig 
fusion protein [102]. Furthermore, Suh et al. generated double knockout mice lacking 
CD28 as well as ICOS and reported that partially impaired humoral responses by CD28 
" mice were abrogated when ICOS is eliminated as well [103]. ICOS is upregulated on 
both Thi and Th2 cells during the initial phase of differentiation, but levels remain high 
on Th2 and decrease on Thi cells [99,100]. The expression of ICOS on I cells in the 
GCs and surrounding T cell zones [86,98] corroborates its role in T cell help for B cells. 
	
1.4.1. 	Role of ICOS in T cell proliferation and differentiation 
A role for ICOS in T cell proliferation has not been clearly assigned. Early work showed 
that cross-linking of ICOS on human or mouse T cells in vitro can stimulate T cell 
proliferation in the presence of suboptimal concentrations of anti-CD3 antibody 
[86,89,99,100,104]. But in vitro blocking studies using ICOS-Ig fusion protein 
suggested suppression [105] or no effect at all [100] on the proliferation of naïve T cells 
in response to peptide. Studies with ICOS mice have shown only modest defects in T 
cell proliferation [93,94]. 
Although ICOS was identified initially from a subtractive library from activated Th2 
clone [99] and was considered an important costimulatory molecule for Th2 responses, 
enough evidence is now available to suggest its critical role in Thi responses (Table 
1.1). 
1.4.2. 	ICOS in Thi and Th2 effector responses 
Until recently, the prevailing hypothesis was that ICOS signalling is important in Th2 
response. This has been confirmed to some extent by in vivo findings. Mak et al. 
describe reduced allergic asthma response, a classic Th2 disease, in ICOSL' mice [106]. 
The authors suggest this resulted from the reduced production of Th2 cyfokines such as 
IL-4 and IL-13. Similarly, ICOS blockade by ICOS-Ig has been shown to ameliorate 
development of airway hyper-reactivity in a Th2 dependent model of allergic airway 
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Table 1.1 Role of ICOS-ICOSL interactions in cytokine responses 
Tools used Immune response examined Results References 
BALB/c, ICOS-Ig Bacterial superantigen Reduced TNFa and IFNy [105] 
fusion protein Staphylococcus aureus 
No effect on IL-2 and IL-4 enterotoxin B (SEB) 
DO! 1.10 mice, ICOS- 0VA323339-I-Mitomycin-C Reduced IL-2, IL-4, IL-S and IFNy from [99] 
Ig fusion protein treated splenocytes activated CD4 Cells. Reduced IL-S and IL- 
13 from effector Th2 cells, no effect on 
IFNy from ml cells  
Human peripheral CD4 SEB Reduced IFNy, IL-4, IL-S. LL-13 and IL- [109] 
T cells, ICOS-Ig fusion 10. No effect on IL-2, TNFa and GM-CSF 
protein  
BALB/c mice, B7h-Ig Anti-CD3 stimulation Upregulation of IFNy, IL-4 and IL- 10 but [100] 
fusion protein. 
DO!l.lO CD4 T cells, Cytokine production upon 
not IL-2. 
Increased IFNy and decreased IL-4 and IL- 
ICOS-Ig f'usion protein in 	tro 	
y culture w secondar 
10 
in primary culture WI 	P 
BALB/c, ICOS-Ig N. brasiliensis infection, Reduced IL-4,IL- 10, IFNy  
fusion protein cytokine production upon 
restimulation  
C57B116 mice, B7RP- Anti-CD3 stimulation Induced IFNy but not IL-2 [89] 
1-Fc fusion protein  
Human peripheral CD4 Anti-CD3 stimulation Upregulation of IL4, IL-5, IFNy, TNFa, [104] 
T cells, Anti-ICOS GM-CSF and IL-b 
mAb F44  
ICOS mice TNP-KLH-CFA, cytokine Similar levels of IL-2 and increased IFN'y [93] 
production upon in vitro production 
restimulation with KLH  
ICOS 	on 129/Ola x KLH-IFA, frequency of Low IL-4 and IL-l0 cells  
C57B1I6 background cytokine producing CD4 T High IFNy CD4 cells 
restimulation with KLH  
ICOS' on C57B116 KLH-CFA, cytokine Reduced levels of IL-4 but normal IFNy in [94] 
background production upon in vitro culture supernatants. Reduced frequency of 
restimulation with KLH IL-4 but normal IFNy cells upon ICCS  
ICOS' F6 on C57131/6 Anti-CD3 stimulation. Reduced IL-4, normal IFNy [110] 
background Real-Time PCR for 
cytokine mRNA  
ICOS 	F2 129 x Anti-CD3 stimulation Reduced IL-2 and IL4. No effect on IL-b [95] 
C57131I6 background  and IFNy  
BALB/c naïve mice Correlation between ICOS ICOSI0W CD4 cells make TNFa, IL-2, [Ill] 
cell surface density and IFNy. ICosm 	,Cd1*C cells secrete IL-4, IL-S 
cytokine secreted and IL- 13. ICOS 	cells secrete IL-I 0 
ICOSL' F2-F3 129 x KLH-CFA, cytokine Reduced IL-4, IL- 13 and IL- 10 but normal [106] 
C5713116 background production upon in vitro IFNy in culture supernatants. Reduced 
restimulation with KLH frequency of IL-4 1 , IL- 10 but normal 
LFNf cells upon ICCS  
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disease [99,107,108], although ICOS mice exhibited infiltration ofeosinophils and 
lymphocytes in bronchio-alveolar lavage fluid comparable to wildtype mice as observed 
by Dong et al. [95]. Furthermore, Miyahira et al. found that ICOS mice on the BALB/c 
background were less susceptible to Leishmania. Normally, BALB/c mice mount a Th2 
response to this parasite, preventing the protective Thl response from acting. The ICOS 
" mice made a reduced Th2 response thus allowing the Thi response to dominate [112]. 
Blocking ICOS has also been shown to prevent the development of Th2 mediated 
chronic GVHD by decreasingboth IL-4 and antibody production [113]. 
ICOS also regulates Thi effector responses. In a Thi-mediated cardiac allograft 
rejection model, ICOS blockade prolonged acute cardiac allograft survival [114]. ICOS 
has been reported to play a critical role in the protective Thi response required against 
IFNy-dependent diseases like Toxoplasmosis [115] and Leishmania mexicana [116]. 
	
1.4.3. 	ICOS in CD8 T cell responses 
ICOSL costimulation of CD8 T cells enhances IL-2 and IFNy production 
predominantly in recall responses compared with naïve responses [117]. Also, ICOSL 
expression in an immunogenic, MHC class-I tumour led to enhanced tumour rejection 
in mice [118]. On the contrary, Kopf et al. have reported that ICOSL does not enhance 
CTL effector function, nor does inhibition of ICOS pathway impair CTL responses to 
LCMV or VSV infections in mice [102]. Thus, the role of ICOS in CD8 T cell responses 
is somewhat confused and awaits clarification. 
1.4.4. 	ICOS and immune regulation 
Immune responses to foreign antigens decline with time after immunisation. This is 
mainly because of apoptosis of activated lymphocytes that are deprived of survival 
stimuli as the antigen is eliminated and innate immunity wanes. Various thechanisms of 
lymphocyte inhibition function to terminate the immune response, regulatory T cells 
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(Tregs) being one of them. Regulatory T cells can inhibit immune responses by secreting 
immunosuppressive cytokines such as IL- 10 and TGF-13. 
Of late, ICOS has been assigned a regulatory role in the immune response. Lohning et 
al. observed a tight link between high cell surface ICOS expression and IL-lO 
production by T cells [111]. Besides, the role of ICOS in T-règulatory function has been 
reported in various models. Herman et al. have recently described that 
CD4CD25CD69 Treg  cells in pancreatic tissue of BDC2.5/NOD TCR transgenic mice 
(diabetogenic, n-cell specific) express high levels of IL- 10 and ICOS alongwith GITR 
[119]. Blockade of ICOS disrupted the balance between Treg  and T effector cells 
converting insulitis to diabetes. Furthermore, Kohyama et al. demonstrated the 
development of hyporesponsive Treg  cells producing IL- 10 in DO 11.10 mice expressing 
high levels of pOVA in pancreatic 3-islet cells as self-antigen. Since blockade of ICOS. 
signalling by B71i-specific mAb reduced the IL-lO production as well as the in vitro 
suppressive function of Treg  cells, the authors suggested a critical role of ICOS in 
maintaining self-tolerance by IL-lO producing Treg  cells [120]. Similarly in a human 
study, ICOS was induced on a non-proliferating subset of T cells upon stimulation with 
CD40/80/86 deficient APCs in MLR with PBMCs. This subset when added to secondary 
MLRs did not secrete IFNy, IL-5 and IL-13, but produced IL-10 and suppressed the 
proliferative response when added to secondary MLRs [121]. 
ICOS-ICOSL pathway has been demonstrated by Akbari et al. to be critically important 
in immune regulation and respiratory tolerance in asthma [92]. The authors showed that 
ICOS costimulates the induction of Treg  cells that inhibit the function of antigen specific 
T cells via IL- 10 and thereby inhibit the development of airway hyper-reactivity (AHR). 
Interestingly, this costimulation pathway is involved in both Th2 driven inflammation 
and Treg  cell mediated tolerance in AHR. This might be due to productión of relatively 
different amounts of IL- 10 and IL-4 in these responses. Undetectable amounts of IL- 13 
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production by Treg  cells compared to large quantities secreted by Th2 cells was 
suggested for the distinct function of Treg and Th2 cells. 
1.4.5. 	ICOS and autoimmune diseases 
The severity of the Thi-mediated disease, experimental autoimmune encephalomyelitis 
(EAE, an animal model for multiple sclerosis) is exacerbated in ICOS' mice and in 
wildtype mice when ICOS is blocked during priming which correlates to decreased IL-4 
and increased IFNy production [122-124]. Such Thl polarisation of the response might 
be due to blockade of ICOS-mediated costimulation of Th2 cells and hence reduced IL-
4, IL-13 and/or IL-lO production. However, ICOS blockade after EAE induction inhibits 
the progression of the disease, indicating that ICOS has a key role in sustaining effector 
Thi cells [123,124]. 
In a murine model of collagen-induced arthritis (CIA), administration of neutralising 
anti-B7h mAb significantly ameliorated inflammatory arthritis by inhibiting I cell 
proliferative response to type-Il collagen and production of IL- 10 and IFNy. Even a 
delayed treatment after the onset of arthritis is also effective in preventing the disease 
progression [125]. ICOS' mice have been reported to be completely resistant to CIA 
along with reduced anti-collagen 1gM and IgG2a responses [122,126]. ICOS-ICOSL 
interactions are also required for the T helper cell-mediated humoral immune response 
to acetylcholine receptor leading to experimental autoimmune myasthenia gravis, as 
ICOS' mice do not develop this disease [127]. 
1.5. Delivery of T cell help to B cells 
T cell help for B cells is provided by two mechanisms: delivery of contact-dependent 
signals, and secretion of cytokines. 
Early studies showed that in vitro T cell help for B cell anti-SRBC antibody production 
could be replaced by supernatant from activated T cell cultures. Likewise, purified B 
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cells could be induced to proliferate in vitro in response to anti-Ig if T cell-derived 
supernatant is added to the culture [128,129]. However, the same effect was not seen in 
the B cell response to soluble protein antigens. In this case, B cell-T cell contact must 
occur for delivery of help. Fixed resting T cells cannot provide help to B cells, but T 
cells preactivated before fixation can. Furthermore, the help is not given if RNA or 
protein synthesis is blocked during T cell activation [130]. Hence, contact-mediated T 
cell help requires de novo gene expression. 
1.5.1. 	Contact-dependent T cell help 
CD40-CD40L interactions are crucial for the delivery of contact-dependent help by T 
cells. Antibodies against CD40L or soluble forms of CD40 which bind to CD40L, block 
contact-mediated T cell help in vitro [13 1-133]. Also, mice that lack CD40 or CD40L 
exhibit severely impaired TD antibody responses: they produce no isotype-switched 
antibodies, and they cannot form GCs [70,71]. However, they are able to produce 1gM 
antibodies to TD antigens. Moreover, human patients with hyper-IgM 
immunodeficiency, in whom CD40L expression is deficient, usually have normal or 
elevated 1gM levels [134] indicating the existence of a CD40-independent pathway of T 
cell help. Although the absence of IgG, IgA and IgE antibodies in CD40 and CD40L-
deficient mice suggest the importance of these interactions for class switching, 
signalling via CD40 is insufficient to cause B cells to isotype switch in vitro. Instead, the 
principal function of CD40-ligation appears to be to induce responsiveness to T cell-
derived cytokines, which then direct class switching and further differentiation. 
How does the immune system avoid activating 'bystander' B cells via CD40L expressed 
on activated T cells? B cells that receive a signal through CD40 are induced to express 
Fas (CD95). This surface receptor transmits a death signal to the cell when it is engaged 
by its counter-receptor, Fas ligand (FasL) expressed on activated T cells [135]. 
However, this death signal is blocked in B cells stimulated by their surface antigen 
receptor [136]. In this way, only antigen-specific B cells are able to benefit from T cell 
help through CD40; B cells that receive the CD40 signal but which do not have bound 
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antigen are susceptible to apoptosis. Also, the upregulation of CD40L is transient and is 
only directed towards the synapse with the interacting B cell. 
Another receptor-ligand known to deliver differentiative signals to B cells is 0X40-
OX40L. Cross-linking of OX40L on in vitro activated B cells has been shown to 
enhance proliferation as well as secretion of antibodies [137]. Stuber and Strober 
showed that in vivo blockade of 0X40-OX40L interactions by injection of anti-0X40 
antibodies abolished the T-dependent IgG production and prevented the formation of 
extrafollicular B cell foci in the spleen [85]. Furthermore, since this blockade did not 
affect the cytokine producing T cells, physical contact between B and T cells via 
OX40L-0X40 seems critical for the delivery of help. 
1.5.2. 	T cell cytokine production 
As discussed earlier, one of the earliest cytokines produced by I cells after activation is 
IL-2, which is required for their subsequent proliferation. A number of other cytokines 
are also produced by helper T cells, which are able to promote B cell differentiation. 
Mosmann et al. proposed the concept of helper T cell subsets nearly two decades ago 
[138]. They examined a panel of antigen-specific mouse T cell clones and found that T 
cells could be split into two categories according to the cytokines they secreted: T helper 
type 1 (Thi) and T helper type 2 (Th2) effector subsets. These two types of cells 
produce distinct profiles of cytokines and regulate different immune responses [139]. 
Thi cells produce proinflammatory cytokines such as IFNy and LTct, and mediate 
cellular immunity by activating macrophages and CD8 T cells; Th2 cells, in contrast, 
produce cytokines (IL-4, IL-5, IL-9, IL- 10 and IL- 13) that regulate B cell activation and 
plasma cell differentiation [140]. One of the principal effects of cytokines on B cells in 
vitro is to direct isotype switching and secretion of high levels of immunglobulins. For 
example, Th2 cytokines especially IL-4 mediates switching to and secretion of IgG1 and 
IgE isotypes, but this is counteracted by IFNy (Thi), which enhances production of 
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IgG2a instead [139,141]. Thus, both Thi and Th2 cells are able to provide help to B 
cells, although the nature of this help differs. In IL-4 deficient mice, production of IgGi 
is' severely impaired and 1gB is totally absent [142,143]. 
In terms of the control of parasites, Thi immune responses protect against intracellular 
protozoa e.g. Toxoplasma, Leishmania, whereas Th2 immunity is associated with 
protection against intestinal helminths. Both subsets have been implicated in 
pathological responses as well. Inappropriate Thi responses can result in autoimmune 
organ destruction, whereas atopic reactions, including asthma and allergy, are associated 
with unwarranted Th2 responses. 
Thi and Th2 populations are mutually antagonistic: IFNy, produced by Thi cells, 
inhibits the growth of Th2 cells, however, production of IFNy is blocked by the Th2 
cytokine IL-4. In primary in vitro I cell stimulations, the presence of IFNy assists in Thi 
development, and IL-4 promotes development of Th2 responses. It therefore appears that 
cytokine production early in the T cell response dictates the subsequent direction of T 
cell effector differentiation. 
There are many signals responsible for this differentiation process namely cytókines, 
costimulatory molecules, antigen dose and certain genetic modifiers, but it is still 
unknown how these signals are integrated [140,144]. DC-derived IL-12 induces Thi 
development via transcription factor Stat4, while IL-4 causes Th2 induction through 
Stat6 [140]. It is not yet clear where the initial IL-4 is produced. Two other transcription 
factors expressed selectively in Th2 cells are GATA-3 and c-maf, which primarily 
regulate IL-4 gene expression [145,146]. T-bet, a T-box factor, is a Thi restricted 
transcription factor and is expressed by Th 1 clones and differentiating T cells [147]. T-
bet and GATA-3 operate intrinsically to suppress opposing cytokines. GATA-3 is 
extinguished in Thi cells by IL-12/Stat4-mediated signalling; conversely, T-bet is 
extinguished in Th2 cells by IL-4/Stat6-mediated signalling. With the loss of one of 
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these master regulators, the capacity for downstream cytokine gene expression is lost, 
and the T cell terminally differentiates in response to the remaining regulator [1 48]. 
Among different costimulatory signals involved in T helper cell differentiation, CD28 
signal appears important for Th2 differentiation in vitro and in vivo by augmenting the 
expression of GATA-3 [149,150]. Furthermore, Th2 cytokine expression and 
differentiation requires more cell division and an increased threshold of activation [15 1]. 
ICOS, expressed on activated T cells, depends largely on CD28 for its induction [103]. 
Although ICOS has been largely implicated in Th2 induction [99,107,108], recently it 
has been shown to be important for Thi. function as well [114-116,152]. Similarly, 
0X40 has also been shown to be involved in the development of both Thl and Th2 
responses [82,153-156]. 
Antigen dose, as shown by Hosken et al., can also determine the I cell differentiation in 
vitro [157]. Using naïve I cells from TCR-transgenic mice, they found that stimulation 
on APCs pulsed with high concentrations of specific peptide favoured generation of IL-
4, while low concentrations generally favoured IFNy production. 
1.5.3. 	TFH : T cell subset specialised to help B cells 
T cell help for antibody production first occurs in T cell areas and later in B cell 
follicles. T cell help to B cells had been thought to be solely attributable to Th2 cells 
[141,158,159], first, because IL-4, a Th2 cytokine, stimulates B cell proliferation and 
class switching and induces upregulation of costimulatory molecules such as CD40; and 
secondly, Th2 cells may preferentially migrate into B cells follicles to provide help to B 
cells [160]. However, B cell help still occurs in the absence of IL-4, because IL-4- and 
Stat6-deficient mice still make antibodies [161,162]. Moreover, Smith et al. have 
recently demonstrated that in vivo generated Thi cells also enter folliclés and provide 
help to B cells [163]. This is not surprising given the production of high affinity IgG2a 
antibodies. 
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Recently, another subset of T cells "Follicular B-helper T cells" (TFH) has been 
identified through expression of the chemokine receptor CXCR5 [33,164,165]. CXCR5 
is also expressed by B cells, and is required for the development of B cell follicles in 
secondary lymphoid tissues. Mice lacking CXCR5 or its ligand CXCL13 (B lymphocyte 
chemoattractant) display major aberrations in splenic follicular architecture and reduced 
numbers of lymph nodes and Peyer's patches [166,167]. The expression of CXCR5 by 
TFH and B cells allows the co-localisation of these cells to sites of CXCL 13 production 
(i.e. B cell follicles), thus enabling productive T-B cell interactions. TFH cells are 
nonpolarized with respect to Thl/Th2 cytokine production. Despite the importance of 
TFH cells, relatively little is known about how they are generated and how they mediate 
their function. 
Expression of CXCR5 by T cells does not necessarily define T cells capable of 
providing B cell help. Kim et al. have shown in a human study that only a small subset 
of CXCR5 T cells that co-expressed CD57 and localised to GCs was capable of effector 
function [33]. However, using Affymetrix microarrays, Chtanova et al. did not observe 
any relevant difference in the pattern of gene expression in the CXCR5CD57 and 
CXCR5CD57-  subsets, suggesting the need for other markers to define the effector Th 
subset within CXCR5 T cells [159]. 
The genes differentially expressed by TFH cells were CD84 and IL-21 [159]. The 
preferential expression of CD84, a member of CD2 subgroup of Ig-superfamily 
receptors, on B and TFH  cells indicated its importance in facilitating T cell help for B 
cells. CD84 signals through SAP, an Src homology domain 2 (SH2) protein that has 
been shown to be critical for long-term humoral immunity [168]. SAP' mice generate 
strong acute IgG antibody response in response to LCMV despite 10-fold less GCs, and 
lack memory B cells and long lived plasma cells. Interestingly, by adoptive transfer 
studies, expression of SAP by CD4 T cells was found to be essential for T cells to 
provide B cell help and establish long-term humoral immunity. Presumably, signalling 
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through SAP-associating receptors expressed by T cells leads to expression of cytokines 
and cell surface molecules Important for effector function of TFH. 
The cytokine IL-2 1 is produced by activated C134 T cells and its receptor, expressed by 
T, B and NK cells, shares the common y-chain with IL-2, IL-4, IL-7, IL-9 and IL-i 5. 
Although IL-2 1 promotes Th 1 responses by enhancing IFNy production [169], Ozaki et 
al. have demonstrated markedly diminished levels of IgG1 in IL-21R 4 mice [170] and 
increased surface IgG1 B cells in the spleen of IL-21 transgenic mice [171]. IL-21 
cooperates with IL-4 in regulating the B cell function in vivo since mice lacking both IL-
21R and IL-4 exhibit dysgammagiobulinemia and severely impaired IgG and IgE 
responses [170]. Increased number of post-switch B cells and induction of plasma cell 
differentiation by IL-2 1 substantiates its expression on TFH  cells [171]. 
1.6. GCreaction 
The overall effectiveness of humoral immunity against pathogen challenges depends not 
only on the amount of antibody synthesized, but also on its affinity. It is the dynamic 
microenvironment of GC that caters to this need of the immune response. GCs are 
formed in response to protein antigens, and this process is dependent on T cell help. GCs 
do not form in B cell responses to TI antigens, and nude mice (which lack T cells) and 
MHC class-I1 deficient mice (which lack CD4 T cells) do not form GCs [172]. The GC 
is a specialised microenvironment where B cells undergo proliferation, maturation and 
selection. Cells arising from GC form either long-lived plasma cells or memory cells. 
The majority of the activated B cells become short-lived 1gM secreting plasma cells and 
may switch to other isotypes depending on the quality of interaction between B and T 
cells. Some of the expanded B and T cells migrate into the follicles where they rapidly 
expand and form the GC. Initially GC comprises of rapidly dividing Igif B cells, called 
centroblasts, but 7-10 days after initial priming, dark and light zones become evident. B 
cells proliferate and diversify their antigen receptors through somatic hypermutation 
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(SHM) in the GC dark zone [173,174]. Affinity maturation in the GC reaction is 
achieved through positive selection of centrocytes expressing high affinity variants of 
their original antigen receptor possibly via immune complexes on FDCs in the light zone 
[175]. FDCs are thought to play a key role in affinity-based selection of memory B cells 
in the GCs. They are the immune complex trapping cells and retain the antigen in its 
native form bound to antibody and complement on their surface. In addition to being a 
source of antigen long after the infection has cleared, FDC also provide contact-
dependent antigen-nonspecific costimulatory signals to B cells for their proliferation and 
chemotaxis [176]. Although GCs can form without FDC networks, they regress rapidly 
with reduced affinity maturation [42]. Members of TNF family, including TNFct, LTa 
(TNF) and LTI3 (LT(x12), have been implicated in both the development and 
maintenance of B cell follicles, FDC clustering and GC formation in mice [177-180]. 
Once GC B cells exit the cell cycle and become centrocytes, they are programmed to 
undergo apoptosis unless they recognise the antigen on FDCs. 
Class switch recombination (CSR) is another phenomenon supported by GCs in which 
the rearranged VDJ gene segment recombines with a downstream C (constant) region 
gene and the intervening DNA is deleted. This results in switching of 1gM antibodies to 
other isotypes namely IgG, IgA and IgE, adding diverse effector functions to Ig with a 
given antigen specificity. However, Toellner et al. have demonstrated that the peak of 
production of yl -switch transcripts in the spleen, a marker for actively class switching B 
cells, happens before GC formation had begun. This suggested that the major site of 
class switching is in the I zones [38]. 
Recently, an activated B cell-specific enzyme, activation-induced cytidine deaminase 
(AID), has been shown to be essential for CSR as well as SHM [181]. AID is a single-
stranded DNA deaminase that converts deoxycytidine residues to deoxyuridine on target 
DNA followed by DNA cleavage by base excision repair enzymes. For CSR, AID is 
required for DNA cleavage of S (switch) regions of the CH locus. AID-deficient mice 
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exhibit complete loss of class switching and accumulation, of 1gM in sera and faeces. 
Human patients with an autosomal recessive hereditary disease called hyper-IgM 
syndrome type 2 (HIGM2) have severe defects in class switching, and absence of SHM 
due to mutations in AID gene [182].. 
Molecules that are known to support GC development include CD40-CD40L [183], 
CD28 [184], CD86 [185], çD19 [186] and ICOS [93,94,96]. In support of the 
importance of TCR-peptidefMHC interactions, nearly complete absence of GC has been 
reported in the absence of Cathepsin-S, which blocks invariant chain degradation and 
delays peptide loading into class-IT MHC molecules [187]. Various cytokines and 
chemokines have also been implicated in controlling GC formation. Signalling via the B 
cell homing chemokine CXCR5 seems to direct GC founder cells into follicles 
[166,167]. Although CXCR5 mice have unimpaired primary antibody production, and 
contain many PNA B cells, GCs are lacking (PNA recognises a sialic acid modification 
upregulated only by GC B cells). Furthermore, CXCR5' B cells adoptively transferred 
into CXCR5 mice were unable to enter follicles, and remained in the T zones [166]. 
1.7. B cell differentiation into antibody secreting cells (ASC) 
T cell cytokines and CD40-mediated signals enhance the transcription of Ig genes and 
therefore antibody synthesis in response to protein antigens by B cells. Cytokines such 
as IL-2, IL-4 and IL-6 have been shown to stimulate antibody synthesis and secretion by 
activated B lymphocytes [188]. The differentiation of B cells from antigen-recognising 
cells that express membrane Ig receptors for antigens into effector cells that actively 
secrete antibodies involves a change in Ig expression from the membrane to secreted 
form, which lacks the hydrophobic amino acids required for anchor in the cell 
membrane. As differentiation proceeds, more of the Ig mRNA is of the form encoding 
secreted 1g. Numerous B cell-specific surface proteins are downregulated upon plasma 
cell differentiation, including MHC-II, B220, CD 19, CD21 and CD22. The proteoglycan 
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syndecan-1 (CD138), which recognises extracellular matrix and growth factors, is 
induced on ASCs and is often used as marker of plasma cells [189]. 
Within lymphoid organs, ASC are found mainly in extrafollicular sites, such as red pulp 
of the spleen and the medulla of the lymph nodes. Many of the antibody-secreting B 
cells change into morphologically distinct plasma cells committed to abundant antibody 
production. Decreased expression of CXCR5 and CCR7 on ASCs reduces 
responsiveness to B and T cell zone chernokines CXCL13, CCL19 and CCL21. In 
contrast, expression of chemokine receptor CXCR4, which recognises CXCL12 present 
in splenic red pulp, lymph node medullary cords and in bone marrow remains high 
[190]. These changes mediate the movement of plasma cells from the follicles to other 
locations, including the bone marrow. At 2-3 weeks after immunisation, bone marrow 
may be the major site of antibody production. The longevity of the plasma cells 
however, is unclear, with reports suggesting weeks to even years available [191,192]. 
Secreted antibodies enter the circulation and mucosal secretions, but antibody-producing 
cells do not circulate actively. 
1.8. Role of B cells in regulation of T cell responses 
Interacting B and T cells are involved in a vibrant "conversation" in response to a 
protein antigen [130]. But, how much influence B cells can have in regulating I cell 
responses has been a contentious issue. B cells can modulate T cell responses by 
affecting priming via MHC-II-TCR interactions, provision of costimulation and by 
secreting antibodies; they can regulate differentiation of T cells by cytokines and other B 
cell derived factors; and by maintaining the organisation of the secondary lymphoid 
organs. 
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1.8.1. 	T cell Priming 
The earliest studies to assess the role of B cells in T cell activation were done in mice 
rendered B cell-deficient by injecting anti-jL antibodies from birth. T cell priming in 
these anti-FL suppressed mice (.tsm) was defective in response to protein antigens [193-
195]. Later, B cell deficient mice were- created by disrupting the gene encoding the 
membrane spanning exon of the p. heavy chain (p.MT mice) or by disrupting the JH 
variable region of the 1gM locus (JHD mice) [196,197]. Both types of mice do not have 
peripheral B cells. Various groups reported conflicting results, varying from complete 
deficiency to near normal T cell responses in these mice [198-205]. However, 
differences in genetic backgrounds of mice used, immunisation regimes including 
antigen dose and route of immunisation, and in vitro readouts might account for these 
results. Although many questions remain, a role of B cells in T cell responses has been 
generally accepted. 
Transfer of wildtype B cells in the p.MT mice could restore T cell priming 
[193,199,203], however, whether these B cells were required to present the antigen to T 
cells is unclear. Kurt-Jones et al. and Rivera et al. found that the transferred B cells have 
to be antigen-specific in order to restore the T cell priming [193,199]. On the other hand, 
Bradley et al. could successfully prime T cells in p.MT mice after adoptive transfer of 
splenic DCs, suggesting an APC deficit rather than a unique role of B cells [203]. 
Furthermore, in relB mice which are deficient in myeloid and functional lymphoid 
DCs, CD4 T cells can be primed in response to soluble protein antigen, suggesting that 
B cells play a role in T cell priming in the absence of DC functions [206]. 
That B cells can affect T cell responses by providing costimulatory molecules, was 
demonstrated by Linton et al. [82]. They showed restoration of expansion of transgenic 
CD4 T cells in p.MT mice by transferred activated OX40L B cells and not OX40U' B 
cells. Furthermore, Th2 cytokine response was restored in OX40L' mice that received 
wildtype B cells. 
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1.8.2. 	Effector T cell differentiation 
Although several studies have identified a link between B cell antigen presentation and 
the induction of IL-4 secretion by CD4 T cells [207-209], this may not always be 
required. Epstein et al. observed similar levels of IL-4 secretion in tMT and wildtype 
mice in response to KLH as well as the Th2 inducing soluble egg antigen from 
Schistosoma mansoni (SEA) [205]. A role for B cell-derived OX40L for in vivo IL-4 
production by CD4 I cells has been shown by Linton et al. [82]. B cells from C57BL/6 
mice could reconstitute IL-4 production by OT-Il T cells in pMT mice but 0X40L' B 
cells could not. Harris et al. demonstrated for the first time that B cells are able to 
regulate polarisation of T cells through differential expression of cytokines [210]. They 
proposed subsets of B cells, Bel and Be2, which could support the differentiation of 
naïve T cells into effectorThi and Th2 cells, respectively. B cell modulation of immune 
response through cytokine secretion has been described as context-dependent in humans 
by Duddy et al. [211]. They proposed that B cells when activated appropriately through 
the BCR and CD40, produce high levels of IL-6, TNFa and lymphotoxin (LT), a 
combination that promotes GC development and amplifies T cell responses. In contrast, 
bystander B cells activated through CD40 without antigen-BCR engagement produce 
negligible amounts of proinflammatory cytokines, but secrete significant levels of IL-b, 
which would act to suppress the local inflammatory response. 
Skok et al. have shown that B cells are able to secrete cytokines such as IL-b, IL-6, 
TGF1, TNFa and IFNy. They found that DC-derived IL-12 was required for induction 
of Th2 response by a negative feedback loop involving IL- 10 secreted by B cells [11]. B 
cell-derived IL-6 can direct the differentiation of Th2 cells by inducing IL-4 
transcription [11,212]. These reports indicate that B cells can inflyence T cell 
differentiation either directly (IL-6) or by modulating DC function (IL-b). 
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It has long been realised that delivery of help by T cells require cognate recognition of 
antigen presented by B cells, however the mechanisms by which this is achieved are 
unclear. Although initial activation of naïve cells occurs on DCs, it seems unlikely that T 
cells primed in this way should immediately express all the functions of a competent 
helper cell, as this would allow help to be given to all the B cells, regardless of the 
antigen specificity. Instead, there may be further signals which are required for the T 
cells to mature as helper cells, or which trigger delivery of help. This could be delivered 
during secondary interactions between recently primed T cells and B cells. 
Whether T cells primed in B cell deficient mice can deliver help to B cells for antibody 
production is also unclear. Several groups have reported provision of little or no help to 
B cells by primed JHD T cells for antibody production [202,204]. Macaulay et al. 
suggested reduced upregulation of IL-4 synthesis by JHD T cells as the probable reason 
[204]. In support, Rivera et al. observed greatly reduced DTH response in j.iMT.B6 as 
well as tMT.BALB/c in comparison to control mice [199]. In contrast, they found that I 
cells from these mice were equally capable of helping B cells in an in vivo adoptive 
transfer system when primed with a high dose of SRBC. They argued that efficient B 
cell antigen presentation is restricted to antigen-specific B cells and hence dependence 
on B cells when low antigen dose is used. 
B cells may regulate their own help by directly influencing TFH cell phenotype, 
proliferation and function. In vivo studies in mice demonstrate that effective help for Ig 
production requires T-B interactions [204,208]. Ebert et al. in a human study showed 
that CXCR5 TFH cells when cultured with B cells, express CD70, which interacts with 
CD27 and allows efficient differentiation of the expanded B cells to Ig-secreting plasma 
cells [134,213,214]. The authors have also shown that these B cells promoted ICOS-
dependent IL- 10 secretion by TFH allowing their own differentiation to plasma cells 
[213]. 
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B cells have been shown to play a critical role in the development of respiratory 
tolerance. Effective induction of T cell unresponsiveness to aeroallergen in BCR-
transgenic but not JHD mice, was observed by Tsitoura et al. [215]. Moreover, T cell 
tolerance developed in JHD mice reconstituted with B cells. Filiatreau et al. 
demonstrated a key role of B cells in the recovery from EAE, a Thi -driven autoimmune 
disease [216]. The authors showed that .xMT mice failed to resolve EAE and that IL-b 
produced by B cells is required for the recovery from the disease. Also, NOD-j.tMT mice 
do not develop diabetes [217]. 
Impaired CD4 T cell memory in the absence of B cells has been shown by van Essen et 
al. [218]. Intennittent stimulation by persisting antigen has been shown to be necessary 
for the survival of memory cells, and this may happen in form of immune complexes on 
the surface of FDCs [219]. Given the mice which lack B cells can form neither immune 
complexes nor support the development of FDCs, this is not surprising [220,221]. 
B cells have been implicated in CD8 T cell responses as well, although contradictory 
literature is available. Christensen et al. have shown that CD8 T cell response to LCMV 
initially is qualitatively similar in wildtype and B mice but CD8 I cells loose 
functional capacity in the absence of B cells [198]. Increased contraction of antigen-
specific CD8 T cells has been witnessed in B cell deficient mice despite normal 
activation and antigen-driven expansion following Listeria monocytogenes infection 
[222]. On the contrary, normal CD8 responses have been reported in mice lacking B 
cells in response to acute infections with LCMV or Influenza virus [222,223]. 
Last but not the least, B cells have been implicated in maintaining the architecture of 
secondary lymphoid organs [224]. B cell-derived LTP has been reported to be critical 
for splenic microarchitecture but not for lymph nodes and Peyer's patches [177]. Mice 
with gene deletion for LTP from B cells had significantly reduced populations of MZ B 
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cells, metallophilic and MZ macrophages, and FDC networks [177]. B cell-derived LT 
was demonstrated by Gonzalez et al. to be playing critical role in FDC maturation and 
organisation of B cell follicles [178]. The authors showed that FDCs are lacking in SCID 
mice, but are induced when reconstituted with spleen cells. However, this induction was 
dependent on LT-R signalling by B cells since LTa B cells were incapable of 
inducing FDC development in SCID mice, even upon LTa" T cell co-transfer. 
1.9. Tools to study immune responses 
1.9.1. 	T cell help for antibody responses 
Much of our knowledge of T-dependent antibody responses comes from the studies of 
"hapten-carrier" antigens. Haptens are small organic molecules, to which antibodies are 
able to bind, but which are unable to elicit specific antibody production when used alone 
to immunise an animal. This inability may be overcome if the hapten is covalently 
attached to a larger molecule, called the carrier, which is immunogenic in its own right. 
When immunised with the conjugated hapten-carrier, not only antibodies specific for 
carrier, but also antibodies specific for the hapten alone are generated [225]. If the 
carrier is a TD antigen, production of antibodies against the hapten is also T-dependent. 
Mitchison [226] demonstrated that different cells are specific for the hapten and for the 
carrier. They immunised mice with a hapten-carrier conjugate, and showed that 
splenocytes from these mice could produce hapten specific antibodies in vitro when 
stimulated by same hapten-carrier conjugate. In contrast, no antibody production was 
seen if the same hapten conjugated to another carrier was used for the in vitro 
stimulation. However, antibody production could be restored if splenocytes from a 
second, syngeneic mouse, immunised with the other carrier, were added at the same 
time. Thus, carrier-specific cells from one mouse were able to help the hapten-specific B 
cells from the other. 
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Figure 1.2 Hapten-carrier system. Hapten-specific B cells bind antigen and present the carrier on 
MHC class-Il molecules. Carrier-specific T cells recognise this, and provide help to the B cells. 
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The identity of the helper cells as T cells was revealed by Raff and co-workers by 
showing that the carrier-specific help was lost when T cells were depleted in vitro using 
an anti-Thy-i antibody and complement [227,228]. Furthermore, the ability of T cells to 
help B cells is restricted by the M1HC expression of the B cells [229-231]. Hence, T cells 
help B cells only when the latter present specific antigen in association with MHC 
molecules recognised as self by the T cells. The ability of B cells to present antigen to T 
cells was shown by Chestnut and Grey [232]. They immunised mice with rabbit IgG, 
and then measured the proliferation of T cells from these mice in vitro, using B cells or 
macrophages to present the antigen. Macrophages were able to stimulate T cells using 
either normal rabbit y-globulins or rabbit anti-mouse IgG as antigen, but B cells could 
elicit T cell responses only when rabbit anti-mouse IgG was used. Thus, B cells can act 
as APC, only when they are able to bind the antigen with their surface antigen receptor. 
Together, these findings provide an elegant explanation of the hapten-carrier effect: B 
cells specific for the hapten are able to bind it and present the attached carrier to carrier-
specific T cells. These T cells then deliver the help required for antibody production 
(figure 1.2). 
1.9.2. 	Tracking antigen-specific T cells 
The frequency of antigen-specific CD4 T cell in a naive individual can be as low as 1 in 
100,000 and can go up to 1 in 10,000 after immunisation [233]. Such low frequencies 
are below the detection limits of the usual detection methods of flow cytometry and 
immunohistology, and difficult to be assessed accurately by techniques like limiting 
dilution assay (LDA) which rely on functional capacity of the cells. Moreover, the only 
way to distinguish between antigen-specific and non-specific T cells is by virtue of their 
TCRs. 
The production of TCR transgenic mice revolutionised the study of antigen-specific T 
cells. Most of the T cells in such mice are specific for a defined peptide-MI-IC complex. 
Clonal competition between the inordinately abundant TCR transgenic I cells for 
peptide/MHC bearing APCs results in inefficient T cell activation in these mice. An 
elegant solution to this problem developed by Marc Jenkin's group was to transfer a 
small cohort of TCR transgenic T cells into syngeneic recipient mice, which was small 
enough to behave in a physiological manner following immunisation. The antigen-
specific transgenic T cells can be tracked by flow cytometry following staining with 
anti-clonotypic antibody or antibody specific for congenic markers like Ly5 and Thy etc 
[233]. The DO 11.10 transgenic mice have TCR specific for chicken ovalbumin peptide 
323-339 bound to IA" MHC class-Il molecule that can be detected with KJ1 .26 mAb. 
The OT-Il transgenic mice are on I-A" background and also recognise chicken 
ovalbumin peptide 323-339, but they do not have a clonotypic antibody. Instead, they 
can be detected by antibodies specific for Vet and V13 chains of their TCR (Vet2, V35). 
Another technique that has been recently developed to track antigen-specific CD4 T 
cells is MHC-II tetramers [234]. This allows detection of antigen-specific T cells in an 
un-manipulated mouse in more physiological settings. Due to exceedingly small number 
of antigen-specific cells, however, they have to undergo clonal expansion for detection 
by tetramers. This limits the use of this technique to track T cells following the initial 
phase of expansion. 
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1.10. Aims 
Despite the rarity of antigen-specific T and B lymphocytes and the random movement 
they undergo in the secondary lymphoid organs, amazingly, they are able to find each 
other [29]. My PhD has focussed on studying the importance of T-B cell interactions not 
just for the B cells but for the T cell responses as well. 
Despite the plethora of costimulatory molecules and the intriguing mass of conflicting 
knowledge available, there still are questions to answer. In an attempt to address the 
issue of "costimulation" in T-B interactions, I have tried to answer the following 
questions: 
Is CD40 dispensable for T cell proliferation? 
(Chapter 3) 
• How the ICOS-ICOSL interaction affects the immune response? 
(Chapter 4) 
• How can B cells affect the T cell acquisition of helper function? 
(Chapter 5) 
This thesis presents some novel insight into the collaboration between various cells of 
the immune system via costimulatory molecules. 
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2. Materials and Methods 
2.1. Animals 
All the mice were maintained under specific pathogen free conditions in the animal 
facilities of the Faculty of Science and Engineering at the University of Edinburgh. 
Strains of mice used in this study were: BALB/c, C5 7B116, CD40(H2d & H2b) [71], 
pMT [196], DO! 1.10 [235], DO! 1.10 CD40', OT-lI [236], OT-Il CD40', OT-Il 
Ly5.1, (BALB/c x C57B1/6) Fl, 0X40L' [154], I-A' [172], ICOS (section 2.1.1), 
OT-Il ICOS'. 
Mice were used at 6-12 weeks of age, and were sex and age matched within experiments 
as closely as possible. All strains of mice were bred in house. All experiments were 
performed under guidance from the appropriate Home Office personal and project 
licenses. 
2.1.1. 	Generation of lCOS mice 
The ICOS' mice used in this study were generated by gene targeting in this lab by Dr. 
Ma Cervera, in collaboration with Dr. Andrew Smith (ICSR, Edinburgh). The targeting 
vector replaced the exons 3, 4 and parts of exons 2 and 5 of the ICOS locus with the 
(IRES-lacZ-MClneo-polyA) neomycin resistance gene (fig 2.1). The germ-line 
transmission of the ICOS disruption was confirmed by Southern blotting, figure 2.2 (by 
Dr. Ana Cervera and Stephen Meek). ICOS mice were generated by inter-crossing 
heterozygous offsprings. Since the knockout mice were generated on 129/Sv 
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Exon 2 	IRES-IacZ-MClneo-polyA 
4.7kb 
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gure 2.1 Gene targeting for the generation of ICOS' mice. The targeting vector replaced the exons 3, 4 and 
uts of exons 2 and 5 of the ICOS locus with the (IRES-IacZ-MCIneo-polyA) neomycin resistance gene. 
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generations. Unless otherwise stated, the experiments were done while the backcrossing 
was being carried out, in which case the control group in experiments were either 
icos' or ICOS' littermates. It was not feasible to differentiate between the ICOS' 
and ICOS' mice due to some problems arising with the optimisation of the Neo PCR 
used for the screening of these mice, during the period of study. Wherever backcrossed 
mice (F7) were used in experiments, the control group comprised of C57B1/6 mice. 
+1+ 	+1- 	-I- 
9.7 kb 
	
. 	 9.7 kb 
4.7 kb 
	 4.4 kb 
5' Probe 	 3' Probe 
Figure 2.2 Confirmation of ICOS' genotype. The gerniline transmission of the ICOS 
disruption was confirnd by Southern blotting (by Dr. Ana Cervera and Stepin Meek). 
ICOS mice were generated by inter-crossing heterozygous offsprings. 
2.2. Reagents 
2.2.1. 	Media 
Unless otherwise stated, medium was Iscove's Modified Dulbecco's Medium (IMDM) 
(Gibco BRL, Life Technologies, Paisley, UK) supplemented with 5% foetal calf serum 
(FCS) (Labtech International, Andover, MA, USA), 2mM L-Glutamine (Gibco), 50p.M 
3-mercaptoethano1 (2-ME) (BDH Merck, Poole, UK), 50U/ml Penicillin and 50p.g/ml 
Streptomycin (Gibco). 
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Tetramer staining was done in IMDM with 10% FCS and supplements as above. During 
MACS purifications, cells were prepared and washed in Hanks Balanced Salt Solution 
(HBSS) (Sigma-Aldrich, Poole, UK) with 2% FCS. Dendritic cells were grown in RPMI 
1640 (Sigma) supplemented with 2mM L-Glutamine and antibiotics as above. For 
acquisition by FACS, cells were stained in FACS buffer (PBS containing 2% FCS). 
For injections into mice, cells were resuspended in Dulbecco's PBS (Sigma). For all 
other purposes, PBS was made in house by dissolving 137mM NaCl, 8.2mM 
NaH2PO4.2H20, 2.7mM KC1 and 1.5mM KH2PO4 in Millipore water. PBS was 
autoclaved to sterilise. 
2.2.2. 	Antigens 
Phycoerythrin (PE, Prozyme, CA, USA), Ovalbumin (Sigma), keyhole limpet 
haemocyanin (KLH, Calbiochem, La Jolla, CA, USA) were used a protein antigens. 
Ovalbumin and KLH were coupled to dinitrophenyl (DNP) by reacting with 32p1 and 
14.tl, respectively, of dinitrofluorobenzene (DNFB, Sigma) solution (in oil) in 0.1M 
Borate buffer, pH 8.4, per mg of protein. Conjugated proteins were extensively dialysed 
against PBS to remove free hapten. 
To study clonal expansion of T and B cells, ovalbumin and PE were alum precipitated 
by mixing equal volumes of antigen and 9% aluminium potassium sulfate dodecahydrate 
(Sigma). The precipitated antigens were washed extensively after the pH was adjusted to 
7.0 using 5M NaOH (Sigma). Ovalbumin was also emulsified in Freund's complete 
adjuvant (CFA; Sigma). Wherever stated, killed Bordetella pertussis (LEE laboratories, 
Grayson, USA) bacteria were used as adjuvant, 10 9/mouse. 
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For tetramer experiments, the peptide H19env (EPLTSLTPRCNTAWNRLKL; ABC, 
Imperial College, London, UK), the epitope of moloney murine leukaemia virus, was 
emulsified in CFA. Ovalbumin peptide OVA323..339 (ISQAVHAAHAE[NEAGR; ABC, 
Imperial College, London, UK) was used in in vitro proliferation assays. 
Schistosoma mansoni eggs were injected subcutaneously into the footpad of the hindlegs 
of mice, 1500 eggs/footpad. Soluble egg antigen (SEA) prepared from isolated 
Schistosoma mansoni eggs, was used to restimulate lymph node cells in vitro. Heat-
killed Propionebacterium acnes (Pa), 50tg/footpad, was given s.c. in the hind footpads. 
Schistosoma mansoni eggs, SEA and Pa were all kindly provided by Dr. Andrew S. 
MacDonald. 
2.3. In vivo antigen administration 
	
2.3.1. 	Intraperitoneal immunisations 
For help assays, mice were injected either with 200ig alum-precipitated DNP-KLH 
along with 109 killed Bordetella pertussis bacteria or 1 5O.tg alum-precipitated 
ovalbumin with 10 9 pertussis bacteria. Studies for clonal expansion of T and B cells 
involved injections with 200 j..tg ovalbumin-alum and lOOjig PE-alum, respectively. 
2.3.2. 	Subcutaneous immunisations 
ICOS' and ICOS mice were challenged in vivo with Moloney Virus peptide Hi 9env 
emulsified in CFA for tetramer studies. img/ml peptide was combined with an equal 
volume of çFA containing heat killed Mycobacterium tuberculosis H37RA (Sigma), 
vortexed and sonicated. 50pil was injected subcutaneously (s.c.) into each hind leg. 
Ovalbumin 50jig emulsified in CFA was injected s.c. in each hind leg of ICOS' and 
wildtype mice 24h after adoptive transfer of OVA-specific transgenic cells for clonal 
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expansion studies. Schistosoma mansoni eggs (1500 eggs/footpad) or P. acnes 
50.tgIfootpad were injected s.c. in the hind footpads of ICOS and wildtype mice to 
study the differentiation of effector CD4 T cells in ICOS mice. 
2.4. Cell purification 
2.4.1. 	DC preparation 
Splenic DCs by plastic adherence 
BALB/c and CD40' (H-2') spleens were removed and a single cell sUspension 
prepared. Cells were resuspended in 1 Omi medium per spleen and distributed into 
60mm, tissue culture grade petridishes (Nalge Nunc International, Roskilde, Denmark) 
using Sml cell suspension per plate. These were incubated at 37°C for 90min to enable 
macrophages and DCs to adhere. The plates were rinsed, using pre-warmed medium and 
gentle pipetting, until it could be seen that the majority of the non-adherent contaminants 
had been removed; The plates were given Sml fresh culture medium, without GM-CSF, 
and returned to the incubator overnight. This long incubation allowed transiently 
adherent DCs to detach and they were harvested the following morning by more 
vigorous washing. Strongly adherent macrophages were left on the plates. Yields at this 
stage averaged 2-3x 106  cells per spleen and were 30-40% CD1 1c1v1HC-II DCs, as 
assessed by flow cytometry. The majority of the contaminants were CD19 B cells. 
To further enrich the DCs, cells collected after overnight adherence, were depleted of B 
cells and T cells using Dynabead technology (Dynal, Oslo, Norway). Cells were 
resuspended at 2x10 7/ml and incubated with unconjugated antibodies against CD19 
(lOpg/ml) and Thyl .1 (5.tg/ml) (all from Pharmingen, San Diego, CA, USA) for 30mm 
at 4°C on a rotating mixer. Excess antibody was removed by washing in cold culture 
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medium. Dynabeads were prepared for use by washing to remove the azide preservative 
and finally resuspended at 1x10 7 beads/mi. Antibody-labelled cells were added to the 
bead susIension to give 6 beads per labelled cell and 4x10 8 beads/ml, and the mixture 
incubated, rotating, for 30min at 4°C. Beads were then removed using a strong magnet 
(Dynal) and the unbound cells collected from the supernatant. 
Bone marrow-derived DCs 
DCs were grown from early bone marrow progenitors under the influence of GM-CSF, 
using a protocol based on that of Inaba et al. [237]. flone marrow was flushed from the 
femurs and tibias of C57B1/6, BALB/c, CD40' (both H-2' 1 and H-2 1') and 
(C57B1/6xBALB/c) Fl mice using medium and gentle pressure from a 2.5m1 syringe 
and a 25G needle. Cell clusters were dispersed by passage through a second 25G needle. 
Red blood cells were removed using lysis buffer (Sigma) and the remaining cells seeded 
into 24 well tissue culture plates at 3.75x10 5 cells/ml and lml per well. The culture 
medium was as normal, but using 10% FCS and without 2-ME. GM-CSF was added in 
the form of 5% supernatant from the transfected cell line X63-gmcsf [208], providing 
10-15ng/ml GM-CSF. Cultures were washed at day 3 and day 6 to remove non-adherent 
granulocytes and lymphocytes. This involved swirling the plates before removing 1 ml 
from each well and replacing it with fresh medium. On day 7, loosely adherent DCs 
were harvested by more vigorous washing, leaving firmly adherent macrophages 
attached to the plate. Preparations were 85-90% CD1 lc,' MHC-If' DCs. 
2.4.2. 	CD4 T cell purification 
Positive selection 
Cells from spleens and lymph nodes were incubated with L3T4 microbeads (Miltenyi 
Biotech, Bergisch Gladbach, Germany), logl/107 cells for 20min on ice, followed by 
washing in large volume of MACS buffer. Cells were loaded onto LS positive selection 
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column in a quadroMACS magnet (Miltenyi). Cells were routinely >90% CD4 and 
yield was typically about 10-15% 
Negative Selection 
Cells from spleens and lymph nodes were depleted of B cells,, other MHC-I[ cells and 
CD8 I cells to purify CD4 T cells. Following red blood lysis, cell preparations were 
incubated with biotin-conjugated antibodies against MHC-II (clone M5 114; I-A specific; 
grown in house and used at 1:100), K-light chain (187.1; 1:100), anti-IgM (Southern 
Biotechnology Associates, AL, USA) and CD8 (53-6.72; 1:100) for 15 min on ice. The 
cells were washed and incubated with streptavidin-conjugated microbeads (Miltenyi) 
10tl/107  cells, for 20min on ice, before being loaded onto a CS MACS column in a 
varioMACS magnet (Miltenyi). A singk column was used for up to 2x10 8 total cells. 
The column was washed and unbound cells collected. They were routinely >80% CD4, 
and yield' was typically about 5-10%. 
	
2.4.3. 	B cells 
B cells were purified from the spleens of naïve C57B1/6 mice for transfer into MHC 
class-TI or C1340-deficient B cell chimeras. This was done by depletion of CD43 cells 
from splenocytes. Single cell suspension of splenocytes were treated with red blood cell 
lysis buffer (Sigma) to get rid of RBCs and after washing twice with MACS buffer, cells 
were incubated with anti-CD43 microbeads (Miltenyi), 5p.11l0 7 cells for 20min on ice. 
Following a wash in large volume of MACS buffer, unbound B cells were collected 
using CS depletion columns and varioMACS magnet (Miltenyi). Cells were routinely 
>90% B220. 
2.4.4. 	Blood mononuclear cells 
To confirm reconstitution of irradiated bone marrow chimaeras (section 2.12), peripheral 
blood mononuclear cells were harvested and stained for analysis by flow cytometry. 
5091 of tail blood was collected into an equal volume of heparin (1000U/ml; CP 
Pharmaceuticals, Wrexham, UK) and layered over 500p.l Lympholyte TM (Cedarlane 
Laboratories Ltd, Homby, Ontario, Canada). After centrifugation at 2000rpm for 20mm 
at zero deceleration, mononuclear cells were harvested from the interface and washed 
before use. 
2.5. Adoptive transfer of cells 
OT-Il (CD40', ICOS', Ly5. or wildtype) and DO 11.10 (CD40 or wildtype) lymph 
nodes (popliteal, inguinal, brachial, axillary, superficial cervical, periaortic, iliac and 
mesenteric) were mashed using nytex mesh (Wm Ritchie, London, UK) in IMDM. Cells 
were then washed in serum free IMDM, a viable cell count performed in 0.05% trypan 
blue (Sigma) and resuspended in PBS (Sigma). They were then filtered through 
parachute silk (Wm Ritchie, London, UK) to remove any clumps before being injected 
i.v. into recipient mice, 4-5x10 6 cells/mouse in 200pi PBS. The lymph nodes from one 
donor mouse usually yielded sufficient cells to transfer into 5-6 hosts. Purified CD4 T 
cells from transgenic mice were adoptively transferred into chimeras during help assays. 
CD4 T cells were purified as described in 2.4.2. B cells were purified as described in 
2.4.3 before transfer into chimeras. 
2.6. CFSE labelling 
Wherever stated, transgenic T cells were labelled with CFSE (5, 6-carboxyfluoroscein 
diacetate succinimidyl ester; Molecular Probes, Leiden, The Netherlands) before either 
transfer into recipient mice or culture in vitro. CFSE is a membrane permanent dye that 
binds covalently to cytoplasmic proteins and is distributed equally to each daughter cell 
upon division, thus the mean fluorescence halves progressively as the cells divide [238]. 
Purified T cells were resuspended at lx i0 7 cells per ml in serum-free HANKS (Sigma) 
containing 5j.tM CFSE. After 8min incubation at 37°C, the CFSE was quenched with an 
equal volume of FCS, and cells washed 2-3 times with serum positive medium before in 
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vitro cultures. If cells were to be transferred in vivo, further washes with PBS were done. 
Background fluorescence was determined for each sample 16-1 8h later, using flow 
cytometry. 
2.7. Flow cytometry 
Samples were acquired with a FACScalibur flow cytometer and CellQuest software 
(Becton Dickinson, Mountain View, CA, USA), using a live cell gate set by forward and 
side scatter characteristics (see fig 3.13, for example). The analysis was done by FlowJo 
software (TreeStar, California, USA). 
2.7.1. 	Surface staining 
Cells were taken from culture or directly after isolation and placed in a 96-well, V-
bottomed plate for staining. 1-2x10 5 cells were used routinely to collect 10 000 events 
on the flow cytometer. When the target population was small, as in the OT-Il adoptive 
transfer experiments, lxi 6  cells were stained and 200 000 events collected. The cells 
were washed and resuspended in lOOj.il of antibody diluted In PBS supplemented with 
2% FCS. Details of the specific antibodies and dilutions are listed in table 2.1. The cells 
were stained for 20min on ice in the dark, washed and, if necessary, stained with a 
secondary antibody. Cells were resuspended in 200p1 PBS/2% FCS and analysed 
immediately. 
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Table 2.1 Antibodies used in flow cytometry. 
Antibody Clone Source Dilution Isotype 
T-cell markers CD4-FITC GK1.5 In house 1:100 rIgG2b 
CD4-APC RM4-5 Pharmingen 1:400 
DOl 1.10 TCR-FITC KJ1 .26 In house :400 mIgG. 
DO1I.IOTCR-biotin KJI.26 Inhouse 1:100 mIgG2.  
CD69-PE H1.2F3 Pharmingen 1:100 HsIgG 1 
1gM 
CD25-PE 7134 Pharmingen 1:100 
rIgG2 
CD62L-PE MeI-14 In house 1:100 
CD44-PE 1M7 Pharmingen 1:100 
CD44-biotin 142.5 Inhouse 1:100 
Ly5. I -biotin A20 Pharmingen 1:200 
rIgG2b 
ICOS-biotin 7E. I 7G9 Pharmingen 1:100 
rIgG2. 
Va2-R-PE B20.1 Pharmingen 1:200 
rIgG) 
V 3 -FITC/biotin MR94 Pharmingen 1:100 
rlgGi 
0X40-biotin OX-86 Pharmingen 1:10 
MHC-II Tetramer-PE  Schumaker lab  
Othercells CD8-biotin 53.6.72 Inhouse 1:100 rIgG2.  
CD19-FITC 1D3 In house 1:100 rIgG2.  
CD40-PE 3/23 Pharmingen 1:100 rIgG2.  
GrI-PE RB6-8C5 Pharrningen 1:100 rIgG 
B220-PerCP RA3-6132 Pharmingen 1:300 rIgG2.  
B220-PE RA3-6132 Pharmingen 1:400 rIgGs 
CDI1c-APC HL3 Pharmingen 1:200 HsIgG 1 
MHC-II-biotin/FITC MS 114 In house 1:100/200 
F4/80-RPE-Cy5 CI-A3-1 Serotec 1:400 rIgG2b 
B7-1-PE 16-IOA1 Pharmingen 1:100 HsIgG2 
B7-2-PE GLI Pharmingen 1:100 rIgG2.  
Cytokines IFNy-FITC XMG1.2 Pharmingen 1:100 rIgG t 
IL-2-PE JES6-51-14 Pharmingen 1:100 rlgGm 
IL4-PE BVD6-24G2 Pharmingen 1:100 rigG i 
IL-lO-PE JES5-2A5 Pharmingen 1:100 rlgG i 
Secondary Streptavidin-PE Calbiochem 1:1500 
Reagents 
Streptavidin-PerCP/Quantum Red  Pharmingen/ Sigma 1:200/100  
Miscellaneous Propidium Iodide Pharmingen 1:400 
Annexin-V-FITCIPE Pharmingen 1:20 
7-AAD  Pharmingen 1:40  
Monoclonal primary antibodies were supplied by Pharmingen, Serotec or grown and conjugated in house (section 2.9). Isotype 
controls from Phamiingen were used at the same concentration as the test antibody, and in house antibodies were matched with an 
irrelevant antibody of the same isotype at the same concentration. Abbreviations in isotype column: r, rat; Hs, hamster; m, mouse. 
63 
	
2.7.2. 	Intracellular cytokine staining 
CD4 T cells cultured in vitro with DCs or ex vivo splenocytes from mice were stimulated 
in the presence of 50ng/ml phorbol 12-myristate 13-acetate (PMA) and 500ng/ml 
ionomycin (both from Sigma) for 5h at 37 °C. GolgiStopTM (Pharmingen) was included at 
a dilution of 1:1500, as recommended by the manufacturer. Cells were stained with 
CD4-APC to detect surface CD4 expression, washed and then fixed and permeabilised 
by resuspending in CytofixlCytopermTM reagent (Pharmingen) for 20min on ice. Cells 
were washed in permeabilisation buffer (provided in the CytofixlCytopermTM kit) and 
stained with PB-labelled antibodies against IL-2, IL-4, IFNy and IL-10 for 30min on ice. 
Subsequent washes were again performed in permeabilisation buffer and the cells finally 
resuspended in PBS/2% FCS for analysis by flow cytometry. 
2.7.3. 	Assessing cell division by CFSE staining 
T cell proliferation was visualised using CFSE. CD4 T cells from spleens or lymph 
nodes taken from mice transferred with CFSE labelled OT-Il or OT-Il ICOS' cells and 
immunised with ovalbumin were assessed for CFSE expression at various day points. 
DO 11.10 and OT-Il T cells from in vitro cultures with DCs were also examined for 
CFSE expression at various days. 
2.7.4. 	Dead cell analysis 
To quantify cell death, Annexin-V and 7-amino-actinomycin D (7-AAD) staining of the 
CD4 T cells was undertaken. One of the earliest signs of apoptosis is the translocation of 
membrane phospholipid phophatidylserine (PS) from inner membrane to outer plasma 
membrane. Annexin-V binds to the PS and therefore is a sensitive tool to detect early 
apoptotic cells. 7-AAD is a nucleic acid dye that stains the nonviable cells. 
Cells from in vitro cultures or lymph nodes of mice were surface stained for CD4 and 
the markers for transgenic TCRs (KJ 1.26 for DO 11.10; V(X2  and V5 for 01-1I). After 
washing with cold PBS, cells were resuspended in 100p1 Annexin-V binding buffer 
(supplied as lOx with apoptosis detection kit, Pharmingen). FITC or PE labelled 
Annexin-V (Pharmingen) was added at a dilution of 1:20, as recommended by the 
manufacturer and incubated at room temperature in dark for 1 5mm. Additional 400tl 
binding buffer was added to the samples followed by immediate acquisition by FACS. 
7-AAD was added to surface stained cells 10min before acquisition, 5.tII10 6 cells. It is 
detected on FL3. 
2.7.5. 	Tetramer staining 
For detection of polyclonal cell populations, MHC-II tetramers were used. Erythrocytes 
were lysed in the single cell suspensions prepared from spleens and lymph nodes. 
Approximately 1-2 x106 cells were plated in round bottom 96-well plates (Corning Inc, 
Costar, \'WR International Ltd, Poole, UK), washed in 10% IMDM (Sigma), before the 
addition of PE-labelled class II tétramers diluted in 10% IMDM. Tetramers were made 
as described in chapter 4 and figure 4.9 [239]. The cells were incubated at 37°C for 3 
hours with gentle agitation every 20-30 minutes to prevent clumping of cells. APC-
labelled anti-CD4 (Pharmingen), R Phycoerythrin (RPE)-Cy5-labelled anti-F4/80 
(Serotec, Kidlington, Oxford, UK) and FITC-labelled anti-CD44 (142.5, in house) were 
added and incubated for 10-15 minutes at room temperature. Cells were washed 3 times 
in FACS buffer. Propidium iodide (Pharmingen) was added prior to acquisition. 200 
000 live events were collected on FACS. Tetramer-positive cells were identified by 
gating on CD4 and live lymphocytes, excluding macrophages (see figure 4.10). The 




Spleens were frozen in OCT-embedding medium (BDH, Dorset, UK) in cryomoulds 
(BDH, Dorset, England) on top of dry ice and stored at -80°C. Tissue sections (5pm 
thick) were cut onto multi-well glass slides (Hendley-Essex, London, UK) using a 
cryo stat (model CM 1510, Leica) and left overnight to dry before fixation in acetone for 
10min at 4°C. Sections were stained with texas-red labelled polyclonalgoat anti-mouse 
1gM (SouthernBiotech) and FITC-conjugated peanut agglutinin (PNA). Stained tissue 
sections were mounted with the embedding medium moviol (Hoechst, Frankfurt, 
Germany) and analysed using an Olympus BX50 microsope. Images were captured with 
a Hamamatsu digital camera and Openlab imaging software (Improvision, Coventry, 
UK). 
2.9. Antibody production, biotinylation and FITC conjugation 
Hybridomas were grown in culture flasks in 5% IMDM until transferred to roller bottles 
where they were cultured in 2% IMDM and bubbled with 5% CO2. The contents of the 
roller bottles were filtered to remove cells and the immunoglobulin was precipitated 
with ammonium sulfate (Sigma) using 291g per litre of supernatant. Precipitates were 
dissolved in PBS and extensively dialysed against PBS. Antibodies were purified by 
binding to a 1 or 5m1 Hitrap protein G column (Amersham Bioscience, Bucks, UK) at 
pH 7 and eluted at pH2'.8 using an AKTAprime (Amersham Bioscience). The antibody 
was dialysed with PBS until the pH was neutral. Antibody concentration was estimated 
by measuring absorbance at 280nm. 
GM-CSF supernatant was prepared by growing the cell line X63-gmcsf in tissue culture 
flask in 5% IMDM with Geneticin (G418 sulfate; Gibco) at a final concentration of 
1mg/mi to select for the GM-CSF producing cells. Before transfer into roller bottles, the 
cells were washed twice in 5% IMDM to remove the G418. The cells were grown in 
500m1 of medium in roller bottles for 4-5 days. The cells were then transferred into 50m1 
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Falcon tubes and the cells separated from the supernatant by centrifugation. The 
supernatant was pooled and titrated each time a new batch was made. 
Purified antibodies were conjugated to biotin by reacting each 1mg of protein with 75.tg 
of succinimidyl-6 (biotinamido) hexanoate (EZ-LinkTM NHS-LC-Biotin; Pierce, 
Rockford, IL, USA) in dimethyl formamide (Sigma). FITC conjugation was performed 
by reacting each 1mg of antibody with 50ng FITC Isomer I (Sigma) in 0.05M carbonate-
bicarbonate buffer at pH9. Conjugated antibodies were then dialysed extensively against 
PBS to remove excess label. Antibodies were filter sterilised and stored frozen at -20°C. 
2.10. In vitro assessment of T cell function 
2.10.1. In vitro proliferation assays 
Single cell suspensions from spleens of immunised mice were plated at 5-8x10 5 
cells/well of a 96-well, flat-bottom plate in 200.t1 final volume. Graded doses of 
pOVA323..339 or KLH were added. Proliferation was measured by the addition of 0.5pCi 
of 35Ci/mmol [240]-thymidine (ICN, Basingstoke, UK) to each well, 16h before the end 
of culture. Plates were harvested onto filter mats (Printed Filtennat A; Wallac, Turku, 
Finland) using a 96-well MachiliM Tomtec harvester (Wallac). The mats were dried on 
a hot plate and a solid scintillation wax melted into them (MeltilexTM A; Wallac). When 
the wax had re-solidified, the mats were read using a Trilux 1450 Microbeta liquid 
scintillatioh and luminescence counter and software (Trilux, Arnsberg, Germany). 
Wherever stated, irradiated splenocytes were used as APCs in T cell proliferation asays. 
Before single cell suspension was prepared, spleen was placed in a bijou in a small 
volume of medium and irradiated with a y-source for 100 seconds. 
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2.10.2. Help Assay 
B cells were purified from the spleens of C57B1/6 mice immunised intraperitoneally 
with alum-precipitated DNP-KLH and killed B. pertussis. CD4 T cells were purified 
from spleens of wildtype C57B1/6 or knockout mice or bone marrow chimeras with 
defective B cell compartment, immunised with ovalbumin-alum and killed B. pertussis. 
A minimum of three mice constituted a group and T cells were purified from the pooled 
splenocyte population. Purified B and T cells were cultured in vitro in the presence of 
soluble DNP-ovalbumin. After 2 days, the medium containing the antigen was removed 
and replaced with fresh medium. The culture supernatant was harvested after 5 days and 
DNP-specific immunoglobulin isotypes measured by ELISA. The reciprocal dilution 
required for half-maximal OD was measured and plotted. The experimental protocol is 
outlined in figure 5.1. 
2.10.3. Measuring cytokines by cell-based ELISA 
Splenoctyes were plated at 8x10 5 cells per well in 96-well flat-bottom plate and 
incubated at 37 °C in the presence of OVA323339 titrated in log-fold dilutions starting at 
100.tM. After 48 hours, lOOxl of cells was transferred to maxisorb plates coated with 
antibodies against IL-2, IL-4, IL-lO and IFNy (all from Pharmingen). Double dilutions 
of recombinant cytokines (Pharmingen; Peprotech EC Ltd., London, UK) were done for 
standard curve. The following day, plates were washed and incubated with cytokine-
specific biotinylated antibodies. Extravidin-AP was used as secondary antibody 
followed by addition of p-nitrophenyl phosphate (PNPP) substrate. Amount of cytokine 
secreted was measured by interpolation of absorbance from the, standard curve. 
2.10.4. Measurement of cytokine in supernatant by ELISA 
Maxisorb plates were coated overnight with antibodies against IL-2, IL-4, IL-5, IL-b, 
TNFa and IFNy in 0. 1M carbonate/bicarbonate buffer (Sigma) pH9.6 at 4 °C. After 
blocking with 10% FCS-PBS, culture supernatant and standards were added and 
incubated at 4 °C overnight. After washing, cytokine-specific biotin-conjugated 
antibodies were added (Pharmingen) for lh at room temperature. Peroxidase-conjugated 
streptavidin was then added followed by substrate TMB. Absorbance was measured at 
450nm and amount of cytokine measured by interpolation from standard curve. For 
measuring TNFa, TNFa DuoSet kit (R&D) containing all the reagents including coating 
antibody, standards and detection antibody was used. 
2.11. Assessment of B cell function 
2.11.1. B cell clonal expansion 
Mice were immunised intraperitoneally with 1 00kg alum-precipitated Phycoerythrin 
(PE). Spleens were harvested 2 weeks following the immunisation and cells stained with 
1 Op.gIml PE and FITC-labelled anti-CD 19 mAb 1D3. By the addition of PE, we can 
detect the PE-binding B cells when analysed by flow cytometry (see figure 4.4A). PE 
cells were compared between groups either as percentage of ID3 cells or total number 
of ID3PE cells per spleen. Background PE staining in un-immunised mice was 
minimal. 
2.11.2. Measurement of antigen-specific immunoglobulins by ELISA 
ELISA was performed on either serum from DNP-KLH immunised animals or the 
culture supernatants from the help assays. Blood collected from the tail veins of the mice 
was allowed to clot at 4 °C before centrifuging twice at 15000 rpm for 20min and serum 
was collected. Culture supernatants were harvested after centrifugation of 96-well plates 
at 1500rpm for 1mm, and frozen at -20 °C until analysed. 
Bovine serum albumin (BSA, Sigma) was conjugated to DNP using DNFB as done for 
ovalbumin (section 2.2.2). 96-well PVC microtitre plates (Dynex Technologies Inc.) 
were coated with 50p.g/ml DNP-BSA in 0.1M carbonate/bicarbonate buffer, pH 9.4, 
overnight at 4 °C. Plates were washed in PBS and sera added in two fold dilutions in PBS 
starting from 1/20. The culture supernatants were added without further dilution to the 
top rows. Plates were incubated for 2h at room temperature. Following washing in PBS 
0.05% Tween-20, plates were incubated with alanine phosphatase (AP) conjugated 
polyclonal goat anti-mouse 1gM, IgG, IgGi, IgG2 and IgG2 a (all from Southern 
Biotechnology Associates, Inc., USA) in PBS 0.05% Tween-20 for lh at room 
temperature. Antibody binding was detected by addition of PNPP substrate 
(SouthernBiotech) dissolved in 0.5M magnesium chloride in 9.8% diethanolamine, 
buffered at pH9.8 and the optical density (OD) at 405 nm was measured on ELISA 
reader (Labsystems). Comparative titres were calculated by plotting serum concentratiOn 
against OD, and reading the dilution at the half-maximal OD, compared with a positive 
control. 
2.11.3. Enumeration of antigen-specific antibody secreting cells (ASC) 
by ELISPOT 
96-well nitrocçllulose plates (Millipore) were coated with 10pg/ml DNP-BSA in 0.1M 
carbonate/bicarbonate buffer, pH 9.4, overnight at 4 °C. Plates were washed in PBS and 
blocked with 10% FCS-PBS for 2 hours at room temperature. Following 3 washes with 
PBS, 10- or 2-fold dilutions of spleen and bone marrow cell suspensions were added in 
tripliate, over the range of 1 0- 106  total cells per well. Plates were incubated overnight 
at 37°C, 5% CO2 in humid atmosphere. Plates were washed thoroughly: thrice with PBS, 
thrice with PBS 0.05% Tween-20, then thrice again with PBS. The secondary antibody, 
AP-conjugated goat anti-mouse 1gM, IgG, IgGi or IgG2a were added in PBS-5% BSA, 
4h at room temperature, then washed thoroughly as before. Spots were developed by 
incubation with lmg/ml of 5-Bromo 4-Chlorophosphate (BCIP, Sigma) in 0. 1M Tris 
(Sigma) pH9 plus 5mM MgC1 (Sigma) and 0. 1M NaC1 (Sigma). Spots were scored by 
eye using a dissection microscope and the average number of spots per well was used to 
calculate the frequency of DNP-specific ASCs. Spleen and bone marrow from 
Kill 
unimmunised control mice consistently gave no spots for IgG, although in one 
experiment 1gM spots were noticed in control mice. 
2.12. Generation of bone marrow chimeras 
Recipient C57B1I6 mice were lethally irradiated by exposure to 11 50rad over 47-50mm, 
using a caesium source irradiator ( 137Cs source). 24h later they were reconstituted with 
pooled bone marrow cells from j.tMT (80%) and C57B1/6 /CD40/A7OX40L' (20%) 
mice. A single cell suspension of each bone marrow population was prepared and 
depleted of Thy! + T cells by incubating with CD90 microbeads and subsequent removal 
on a MACS depletion column (Miltenyi). This aimed to prevent graft-versus-host 
disease in the recipient mice. T-depleted bone marrow cells were then combined at a 
ratio of 80:20, filtered through parachute silk and 3.5x10 6 injected i.v. into each 
irradiated host. The chimeras were left 8 weeks before use, to allow reconstitution of the 
immune system. This was confirmed by a normal ratio of B to T cells in the peripheral 
blood, measured by flow cytometry. The FACS plots showing the reconstitution are 
shown in figure 5.7B. 
2.13. Statistics 
Statistics were calculated using GraphPad Prism®  (version 3.0, GraphPad software, San 
Diego, CA, USA, www.graphpad.com), following the recommendations made by this 
programme. Results were considered significant if P<0.05. 
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3. Is CD40 dispensable for CD4 T cell proliferation? 
Introduction 
There has been a great interest in the roles of costimulatory interactions in T cell 
responses, largely because of the potential for targeting these receptor-ligand pairs for 
the prevention of graft rejection and the treatment of various immunological diseases 
[73]. A detailed understanding of the relative contribution of various costimulatory 
pathways in T cell responses to antigen is critical to optimise clinical protocols that 
employ costimulator-blocking agents in an effort to modulate immune responses. 
CD40 is widely expressed in vivo and is detectable on APCs such as DC, B cells and 
monocyte/macrophages and also on other cells like endothelial cells, epithelial cells, 
mast cells, fibroblasts and even smooth muscle cells [75,241]. Its ligand, CD40L 
(CD154), is also widely expressed, notably on T cells, NK, basophils, mast cells, 
eosinophils, platelets and even B cells [75,241]. Given this broad pattern of distribution 
of both receptor and ligand, it is not surprising that CD40-CD40L interactions are 
thought to play a key role in a diverse array of in vivo activities during immune 
response. CD40 ligation on the APCs leads to various responses including proliferation, 
maturation, increased survival, increased expression of cell surface proteins (CD80, 
CD86, CD54 etc.), and production of cytokines (IL-i, IL-6, IL-12, IL-lO and TNF(x) 
[75]. 
The absence of CD40-CD40L interactions during the initiation of T-dependent immune 
responses in vivo has marked effects on these responses. Various studies in CD40 and 
CD40L knockout mice have provided insights into the importance of these interactions 
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in T cell priming. While several studies have shown reduced CD4 and CD8 T cell 
priming, others have found a defect only in the CD4 response or no defect at all [72,242-
244]. These variations perhaps reflect the various immunisation strategies used and 
inherent differences between viral and protein based immunisations. Given the complex 
in vivo interactions between cells bearing CD40-CD40L along with plethora of other 
costimulatory molecules, it is difficult to definitely associate defective T cell priming 
and survival with CD40-CD40L interactions. To simplify the analysis of T cell-APC 
interactions to gain additional insight into the role of CD40 in inducing CD4 T cell 
proliferative responses, I examined the in vitro responses of naïve CD4 cells from 
transgenic mice (DO 11.10 and OT-Il) to antigens presented by CD40-sufficient or - 
deficient APCs. 
To address the issue of 1CR-affinity for peptide-MHC-II complex, I have used altered 
peptide ligands in this study. The term "altered peptide ligand" (APL) was coined to 
describe analogues of immunogenic peptides in which the TCR contact sites have been 
manipulated. The first description of APLs, more than a decade ago, marked an 
important turning point in the understanding of the immune response. The notion of 
single ligand specificity for any particular T cell was challenged by many studies using 
analogues of immunogenic peptides demonstrating flexibility in this recognition [245]. 
In response to antigenic stimulation, I cells mount a continuum of responses, the 
individual components of which may be effectively uncoupled by introducing subtle 
changes in the ICR contact sites of their cognate ligand. Interactions with such APLs 
can result in dramatically different phenotypes of the T cells, ranging from inducing 
selective stimulatory functions to completely turning off their functional capacities. 
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Results 
3.1. C1340-deficient bone marrow derived DCs (BMDC) stimulate strong 
primary CD4 T cell proliferative response 
To examine the CD40 dependence of CD4 T cell proliferative responses in vitro, 
BMDCs from BALB/c (CD40') mice versus CD40' mice were used. CD4 T cells 
were purified (by negative selection) from spleens and pooled lymph nodes of TCR 
transgenic DO 11.10 mice bred onto CD40' background (IAd).  A total of 10 5  CD4 T 
cells were cultured with a titration of BMDCs in the presence of 0.5p.gIml of peptide 
OVA323..339 in 96-well plates. T cell proliferation was measured by thymidine 
incorporation at d3 and d6 of culture. As shown in figure 3.1, CD40' DCs induced 
strong primary proliferative responses that were equivalent to or slightly higher than 
. ri responses to CD40+1+ 	i DCs n various expements. These findings are representative of 5 
experiments and applied regardless of the number of DCs added (fig 11A) or 
concentration of antigen used (fig 3.1B). CD40' DCs are thus not intrinsically defective 
in stimulating naïve CD4 T cells. 
To quantitate the dynamics of T cell proliferative responses in the presence or absence 
of CD40, DO 11.10 T cells were labelled with CFSE before culturing with the BMDCs 
and pOVA. The division of the T cells was followed over various days by examining the 
loss ÔfCFSE. The rate of division of the transgenic T cells was similar at days 3, 5 and 7 
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Figure 3.1 In vit,v proliferation of 13011.10 CD4 T cells in the presence of pOVA 3339 
and BALB/c or CD40 BMDC. DCs were grown from bone marrow precursors in the 
presence ofGM-CSFand harvested at d7 of culture (section 2.4.1). CD4T cells were purified 
from spleens and lymph nodes of naïve DOl 1.10 CD40' mice. (A) 10 T cells were cultured 
with a titration of DCs in the presence of 0.5i.g/ml pOVA in 96-wdl plates at 37°C. (B) W 5  T 
cells were cultured with 10 DCs in the presence of titration of pOVA. Proliferation was 
measured by 311-thymidine incorporation during the last 16h of 3 or 6 day culture. Data is 
shown as the mean of triplicate wells ± SEM and is representatative of three independent 
experiments. 
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3.2. CD40 does not affect T cell apoptosis 
That I cell priming and proliferation in vitro can occur in the absence of CD40 on the 
APCs, was an unexpected finding given that defective T cell priming in vivo has been 
reported in the absence of CD40-CD40L interactions (reviewed in [75]). I next asked the 
question if there were more T cells in CD40' cultures undergoing apoptosis because 
perhaps the activation was not sustained in the absence of CD40-CD40L interactions. 
Annexin-V is a sensitive tool to detect early apoptotic cells and 7-amino-actinomycin D 
(7-AAD), a nucleic acid dye, stains the non-viable cells. 
Cultures of 106  DO 11.10 T cells and 105  BMDCs were set up in 24-well plates in the 
presence of 0.5p.g/ml of pOVA323339. At days 3, 5, 7 and 10 of cultures, the cells were 
harvested and counted using haemocytometer. Cells were stained with anti-CD4, KJ1 .26 
(clonotypic antibody specific for TCR of DOl 1.10) and Annexin-V or 7-AAD and 
analysed for apoptotic cells by flow cytometry. 
There was no apparent difference in the cell counts and the number of apoptotic 
DOl 1.10 T cells when cultured with either BALB/c or CD40T' BMDCs (fig 3.3A). 
Figure 3 .3B depicts the histogram overlays of Annexin-V and 7-AAD positive 
transgenic T cells at different days in culture. 
Thus, T cells activated by CD40-deficient APC were not more likely to undergo 
apoptosis than T cells activated by wildtype APC. Therefore, T cell activation was not 





















Figure 3.2 Loss of CFSE by DO 11.10 CD4 T cells cultured 
in vitro with BALB/c or CD40 BMDCs in the presence of 
pOVA3339. Purified DO! 1.10 CD4 T cells were labelled 
with CFSE before culure with DCs. The histogram overlay 
shows the dilution of CFSE bv T cells in culture with BALB/c 
(blue line) or CD40' (red tinted) DCs at d3. Cells gated on 



























d3 	 d5 	 d7 	 dlO 
Figure 3.3 CD4() does not affect 13011.10 CD4 T cell apoptosis in vitro. 106  DO! 1.10 T cells 
were cultured with 105  BMDCs in the presence of 0.5tg/m1 pOVA in 24-well plates at 37°C. At 
3, 5, 7 and 10 days of culture, cells were harvested and counted using haemocytometer (A, left). 
Cells were stained with anti-CD4, KJ1.26 and Annexin-V or 7-AAD, and number of apoptotic 
cells assessed by flow cytometry. The % of DO! 1.10 T cells positive for Annexin-V and 7-AAD 
are shown in A, middle and right plots, respectively. (B) Histogram overlay of Annexin-V and 7-
AAD positive DOt 1.10 T cells cultured with BALB/c (blue line) and CD40' (red tinted) DCs at 
indicated days of culture. Data shown is representatative of three independent experiments. 
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3.3. D011.10 T cells proliferate in the absence of CD40 on splenic DC 
There are a growing number of reports that have demonstrated that there are different 
subsets of DCs specialised for priming T cell responses [246]. BMDCs are primarily 
CD8cC and DEC-205 (myeloid DC5) in comparison to DCs freshly isolated from the 
spleen, which contain both myeloid as well as lymphoid DCs (CD8a and DEC-205). 
In vivo CD40 plays important role, for example, DC expression of CD40 has been 
implicated in Th2 responses against schistosome egg antigen [247]. 
To examine whether expression of CD40 by splenic DCs affect T cell priming and 
proliferation in vitro, 105 DO 11.10 CD4 T cells were cultured with a titration of splenic 
DCs purified from the spleens of either BALB/c or CD40' mice in the presence of 
0.5.tg/ml of peptide OVA323..339. The DO 11.10 CD4 T cells proliferated equally in the 
presence of CD40-sufficient or -deficient DCs at d3. At d6 however, there was slightly 
less proliferation in the absence of CD40, although the kinetics of the response was 
similar in both groups (fig 3.4A). 
When analysed by Annexin-V and 7-AAD staining, the number of viable and apoptotic 
DO 11.10 CD4 T cells were similar in the presence or absence of CD40 on antigen 
presenting splenic DCs (fig 3.4B). 
CFSE-labelled DO11.10 T cells were cultured with wildtype and CD40' splenic DCs 
and pOVA and their division followed over time by examining the loss of CFSE. The 
rate of division of the transgenic T cells was similar at days 3, 5 and 7 whether CD40 
was present on the DCs or not. Figure 3.5 depicts the CFSE overlays at d3 and d5. Thus, 
the priming, proliferation and survival of DOl 1.10 T.cells in vitro are not dependent on 
CD40-CD40L interactions with the APC. 
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Figure 3.4 In vitro proliferation and apoptosis of 1)011.10 C134 T cells in the presence of BALB/c or 
C1340' splenic DCs. DCs were purified from mouse spleen using plastic adherence and depletion of 
contaminating lymphocytes (section 2.4.1). CD4 T cells were purified from spleens and lymph nodes of 
naive 1)011.10 CD40 -' mice. (A) io T cells were cultured with a titration of DCs in the presence of 
0.5g/ml pOVA in 96-well plates at 37°C. Proliferation was measured by 31-1-thymidine incorporalion 
during the last 16h of 3 or 6 day culture. Data is shown as the mean of triplicate wells ± SEM and is 
representatative of two independent experiments. (B) 1()1 DOl 1.10 T cells were cultured with lO splenic 
[X's in the presence of 0.5ig/ml pOVA in 24-well plates at 37°C. At 3,7, 10 and 14 days of culture, cells 
were harvested and counted using haemocytometer (left). Cells were stained with anti-C[)4, KJl.26 and 
Annexin-V or 7-AAD, and number of apoptotic cells assessed by flow cytometty. The % of 1)011.10 T 










Figure 3.5 Loss of CFSE by DO! 1.10 CD4 T cells cultured in vitro in the presence of p0VA 3 , and 
BALB/c or CD40 splenic DCs. Purified D0I 1.10 CD4 T cells were labelled with CFSE before culure 
with splenic DCs. The histogram overlay shows the dilution of CFSE by T cells in culture with BALB/c 
(blue line) or CD40' (red tinted) DCs at d3 and d5. Cells gated on CD41KJI.26+ cells. Data shown is 
representatative of two independent experiments. 
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3.4. OT-lI T cells are dependent on CD40 activation of APC for 
proliferation and survival in vitro 
To investigate whether T cell independence of CD40-CD40L interactions for 
proliferation and survival was a phenomenon specific to DO 11.10 TCR transgenic mice, 
similar studies were conducted on OT-Il mice. OT-Il mice are TCR transgenic mice that 
recognise the same 0VA323339 ipeptide as DO 11.10 mice but they are I-A" MHC 
restricted. 
CD4 I cells purified from spleens and pooled lymph nodes of OT-Il CD40 mice were 
cultured with BMDCs from C57B1/6 and CD40' (I-A") mice. T cell proliferation was 
measured at days 3 and 5 by thymidine incorporation. T cell proliferation at d3 in CD40 
" cultures was slightly lower compared to C57B116 DCs, when the number of DCs or the 
amount of pOVA was titrated in the cultures (fig 3.6A & B). This difference, however, 
became much more evident at d5. At all titrations of DCs except maximal 1DC/5 T cells, 
the T cells proliferated much less in the absence of CD40 (fig 3.6A). When T cells were 
stimulated with serial dilutions of pOVA, less proliferation was observed if DCs lacked 
CD40. At higher concentrations of the peptide, however, T cells in C57B1/6 cultures 
started dying due to overgrowth at d5 (fig 3.613). 
3.5. OT-Il cells undergo apoptosis in the absence of CD40-CD40L 
interactions in vitro 
Cultures of 106  01-Il CD40' I cells and 10 5 BMDCs were set up in 24-well plates in 
the presence of 0.5g/ml of pOVA323.339. At days 3, 5, 7 and 10 of cultures, the cells 
were harvested and counted using haemocytometer. Cells were stained with antibodies 
against CD4, Va2 and V135  along with Annexin-V or 7-AAD and analysed for apoptotic 
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Figure 3.6 In vitro proliferation of OT-il CD4 T cells in the presence of pOVA 3 , 
and C57B116 or CD4O BMDC. DCs were grown from lxne marrow precursors in the 
presence of GM-CSF and harvested at d7 of culture. CD4 I cells were purified from 
spleens and lymph nodes of naïve OT-Il C1340' mice. (A) UP T cells were cultured with 
a titration of DC's in the presence of 0.5.tg/ml pOVA in 96-well plates at 37°C. (B) lO T 
cells were cultured with 10 4  DCs in the presence of titration of pOVA. Proliferation was 
measured by 31-l-thymidine incorporation during the last 16h of 3 and 5 day culture. Data 
is shown as the mean of triplicate wells ± SEM and is representatative of two independent 
experiments. 
F:" 
underwent apoptosis. The CD40 cultures had higher proportion of cells positive for 
Annexin-V and 7-AAD in comparison to wildtype cultures from d5 onwards (fig 33A). 
Figure 3.7B depicts the histogram overlays of Annexin-V and 7-AAD positive OT-Il 
cells in culture with CD40 4 or C5713116 DCs. 
3.6. CFSE dilution 
01-I1 CD40' CD4 T cells were labelled with CFSE before culture with BMDCs from 
C57B1/6 and CD40' mice and their division followed over time. The division of the T 
cells was equivalent in both cultures on dl, d3 and d5, but at d7 and dl 0, no further 
division was noted in CD40' cultures, whereas the T cells in C57B1/6 cultures 
underwent additional divisions (fig 3.8). This happened because T cells in CD40' 
cultures started to undergo apoptosis. 
Thus, 01-I1 T cells are more dependent on CD40-CD40L interactions than DO 11.10 T 
cells for proliferation and survival in vitro. 
3.7. DOl 1.10 versus OT-Il 
Robertson et al. have shown that DO 11.10 T cells respond to lower amounts of 0VA323 
339 than OT-Il T cells [248]. Various studies have reported that the DOl 1.10 cells 
proliferate extensively following transfer into T cell-deficient or irradiated hosts, the 
phenomenon referred to as homeostatic proliferation [249]. In contrast, the OT-Il- cells 
do not divide much after transfer into immunodeficient hosts [250,251]. Since in this 
system, recognition of self-peptide on MHC molecules is thought to induce the 
proliferation, it is suggested that DO 11.10 cells have greater affinity for self-MIHIC than 
































Figure 3.7 RoLe of CD40 in OT-1 I CD4 T cell apoptosis in vitro. 106  OT-lI T cells were cultured with 105  
BMDCs in the presence of 0.5tgJml pOVA in 24-well plates at 37°C. At 3, 5, 7 and 10 days of culture, cells 
were harvested and counted using haemocytometer (A, left). Cells were stained with antibodies against 
CD4, Va2 & VO,  , and Annexin-V or 7-AAD, and number of apoptotic cells assessed by flow cytometry. The 
% of OT-il T cells positive for Annexin-V and 7-AAD are shown in A, middle and right plots, respectively. 
(B) Histogram overlay of Annexin-V and 7-AAD positive OT-Il T cells cultured with C5713I/6 (blue line) 
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Figure 3.8 Loss of CFSE by OT-lI CD4 T cdls cultured in vitro in the presence of pOVA331, and 
C57111/6 or CD40 BMDCS. Purified OT-Il CD4T cells were labelled with CFSE before culure with DCs. 
The histogram overlay shows the dilution of CFSE by T cells in culture with C5713116 (blue line) or CD40 
(red tinted) DCs at d3, dS and V. Cells gated on CD4' Va2Vf 5 ' cells. Data shown is representatative of two 
independent experiments. 
Requirement for CD40 interactions for T cell proliferation depends on the type of APC 
used, ligand density and the avidity of interactions among TCR, antigen and MHC 
molecules [254]. I hypothesized that due to lower affinity for the MHC-peptide, OT-Il T 
cells are dependent on .CD4O costimulation more than the DO 11.10 T cells for 
proliferation. Conversely, stimulation of DO 1 1.10 T cells with an altered peptide ligand 
(APL) might increase their dependence on costimulation for proliferation. To test this 
hypothesis, the following in vitro experiments with APLs were carried out. 
3.7.1. 	APLs 
Initial experiments were done to repeat the published results that D011.10 I cells 
respond to lower amounts of OVA32339 than OT-Il T cells [248]. 5x104 purified CD4 T 
cells from DOl 1.10 and OT-Il mice were cultured with 5x10 5 irradiated splenocytes 
from BALB/c and C57131/6 mice as APC. Proliferation was measured by thymidine 
incorporation during the last 16h of 3d culture. As shown in figure 3.9, proliferation of 
DO 11.10 T cells was much higher when antigen was presented on I-A" APC as 
compared to I-A" APC. In contrast to the findings of Robertson et al. [248,249], 
however, I did not observe any proliferation of OT-Il T cells when stimulated with 
BALB/c APC. 
Robertson etal. have shown that amino acid (aa) 333 of the OVA peptide is the primary 
contact residue for both DO 11.10 and OT-Il TCR transgenic T cells, and the core 9-aa 
epitope 329-337 recognised by both the cell types is presented by I-A' as well as IAb 
MHC molecules [248]. Amino acid 331 is an important TCR contact residue for both 
cell types and substitutions at this residue may yield partial agonist peptides. Based on 
this report, two APLs were chosen: 33 1M and 3 3 1 Q corresponding to methionine and 
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Figure 3.9 In vitro proliferation of D011.10 and 0TH cells. CD4 
T cells purified from spleens of naive DOl 1.10 or OT-lI mice were 
cultured with titration of pOVA for 3 days with either irradiated 
BALB/c or C57131/6 splenocytes. Proliferation was measured by 3 1-1-
thymidine incorporation during the last 16h of culture. Data is shown 
as the mean of triplicate wells ± SEM. 
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3.7.2. 	Proliferation of CD4 T cells in response to pOVA and APL5 
The proliferation of DO 11.10 and OT-Il T cells in response to pOVA and the APLs - 
331 M and 331Q was assessed. Since this was a direct comparison between DO 11.10 and 
01-11 T cells, BMDCs derived from (BALB/c x C5713116) F 1 mice were used as APCs. 
10 CD4 T cells were cultured with 10 4 DCs in the presence of titration of all three 
peptides. By thymidine incorporation at d3 of culture, figure 3.10A, OT-Il T cells 
proliferated much less than the maximal proliferation exhibited by DO 11.10 T cells. 
Moreover, OT-Il I cells required 4000 times more pOVA (4pgIml) in comparison to 
DO 11.10 T (0.001tgIml) cells to achieve half-maximal proliferation (105  cpm). The 
DO 11.10 T cells responded to all the peptides in a dose dependent manner, but used 
lOOx more 33 1Q and 1000x more 33 1M than pOVA to proliferate to the same level. 
Thus, for equal proliferation, DO 11.10 T cells need higher concentrations of 33 1M and 
331Q in comparison to pOVA owing to their lower affinity for MHC-APL complex. 
Surprisingly, I did not observe any proliferation of OT-Il T cells in response to the APLs 
presented on I-A""' (F 1), thus OT-Il cells could only respond to APLs presented by I-A" 
at homozygous levels (see section 3.7.4). It is possible that all or most of the peptide was 
bound to I-A' MHC molecules, so the OT-Il cells could not be activated properly. The 
CFSE labelling experiments yielded similar data. DO1 1.10 and OT-Il T cells were 
CFSE labelled before culture with DCs at fixed peptide concentration of 0.5tg/ml for all 
the antigens. DO 11.10 T cells exhibited similar dilution of CFSE at d3 and d5 of culture 
in the presence of p0 VA, 3 3 1 Q and 33 1M. On the other hand, OT-Il T cells divided and 
lost CFSE only in response to pOVA (fig 3.1 OB). 
The background proliferation of DO 11.10 T cells in response to all the antigens 
presented by F! BMDCs was high (fig 3.10A). This may probably be due to allo-
response to H2b component on the APCs, however, this was not the case when 
irradiated splenocytes from Fl mice were used as APCs (data not shown). Since the 

























Figure 3.10 In vitm proliferation of D011.10 and OT-LI cells in the prence of pOVA 
and APLs. BMDCs were grown from (BALE/c x C57B1/6)F1 mice. (A) 10 5 C[)4 T cells 
purified from spleens of naive DOl 1.10 or OT-Il mice were cultured with 1 04  DCs in the 
presence of a titration of pOVA and APLs 331Q and 331M. Proliferation was measured by 3 1-1-
thymidine incorporation during the last 16h of 3d culture. Data is shown as the mean of 
triplicate wells ± SEM. (B) 106 CFSE labelled CD4 T cells were cultured with 10 DCs in the 
presence of pOVA (red tint.ed), 331M (green line) and 331Q(blue line). The histogram overlay 
shows the dilution of CFSE of T cells at d3. Cells are gated on CI)4 4 KJ 1.261 for DO 11.10 cells 
(left plot) and CD4Va2V 5 for UT-Il cells (right plot). 
and APLs, which were all presented by same DCs, I felt it was appropriate to use this 
system to study the role of CD40 in further experiments. 
	
3.7.3. 	Proliferation of DOl 1.10 T cells in response to APL5 is 
unaffected in the absence of CD40 
5x104 DOl 1.10 T cells were cultured with 5x10 3 BMDCs from BALB/c and CD40' 
mice in. the presence of varying concentrations of pOVA and 33 1M. At d3, proliferation 
of the T cells was measured by thymidine incorporation. Figure 3.11 shows that in 
response to either pOVA or 33 1M, DOl 1.10 T cells proliferated equally in the presence 
or absence of CD40 on the APCs. 
Thus, lower affinity of the DO 11.10 T cells for the APLs in the culture did not increase 
their requirement for costimulation in terms of CD40. 
3.7.4. 	Proliferation of OT-Il T cells in response to APL5 presented on I- 
AbMHC 
5x105  irradiated splenocytes from C57131/6 and CD40' mice were used as APCs to 
stimulate 5x104  OT-Il CD40' T cells in the presence of varying concentrations of 
pOVA, 331Q and 33 1M. 01-I1 cells responded to all the peptide antigens when 
presented on IA" MHC class-Il. Slightly but not significantly lower proliferations were 
observôd to all the antigens in absence of CD40 on APCs (fig 3.12). 
3.8.. In vivo studies: adoptive transfer experiments 
As introduced in section 1.9.2, adoptive transfer technique involving transfer of TCR-
transgenic cells into the mice followed by immunisation is an elegant way to study the 
clonal expansion of I cells ex vivo [233]. I took advantage of this system to study the 
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Figure 3.11 In vitro proliferation of D011.10 cells in the presence of pOVA and 331M. 
BMDCs were grown from BALB/c and CD40' mice. 5x10 4 CD4 I cells purified from 
spleens of naive DO 11.10 mice were cultured with 5xI0 3 DCs in the presence of a titration of 
pOVA and 331 M at 37°C. Proliferation was measured by 31-1-thymidine incorporation during 
the last 16h of 3d culture. Data is shown as the mean of triplicate wells ± SEM. Data 
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Figure 3.12 In vitro proliferation of OT-Il cells in the presence of pOVA, 331Q and 331M. 
5x105 irradiated splenocytes from C57131/6 and CD40 4  mice were used as APC to stimulate 
5x104  CD4 T cells purified from spleens of naive OT-Il mice in the presence of a titration of 
pOVA. 331Q and 331M at 37°C. Pn)liferation was measured by 3 H-thymidine incorporation 
during the last 16h of 3d culture. Data is shown as the mean of triplicate wells ± SEM. Data 
represents two independent experiments. Proliferation was minimal in the absence of antigen. 
	
3.8.1. 	Expansion of D011.10 T cells 
Lymph node cells from DO11.10 CD40' mice were injected i.v. in the tail vein of 
BALB/c and CD404 mice, 5x106/mouse, followed 24h later by i.p. immunisation with 
alum-precipitated ovalbumin and s.c. immunisation with ovalbumin-CFA in both thighs. 
The expansion of the DO 11.10 T cells in the spleens and draining inguinal lymph nodes 
of the recipient mice was measured ex vivo at d3 and d6 after immunisation by flow 
cytometry. Cells were stained with anti-CD4 and KJ1 .26 and the double positive cells 
indicated the extent of T cell-clonal expansion (fig 3.13). 
As shown in figure 3.13, at d3 after immunisation, the percent of KJ1.26 CD4 T cells 
was similar in CD40' and wildtype groups, both in spleen as well as lymph nodes. At 
d6 however, the expansion in CD40' mice was reduced compared to BALB/c mice, 
although the difference was not significant. From this experiment, I felt that 
immunisation by single route i.e. either i.p. or s.c., would be a cleaner experimental 
protocol with results easier to analyse. When this experiment was repeated and mice 
immunised only i.p., I did not observe any defect in CD4 T cell expansion in the spleens 
of CD40' mice. Rather, the percent of DO 11.10 k CD4 T cells was higher in CD40' 
mice compared to the wildtype mice (not shown). 
Thus, DOl1.10 T cells can get activated and undergo proliferation in the absence of 
CD40-CD40L interactions, but may need these signals to sustain the response, although 
these results await confirmation. 
3.8.2. 	Expansion of OT-lI cells 
To see whether 01-I1 cells are dependent on CD40 for clonal expansion in vivo, OT-Il 
CD40' lymph node cells were transferred into C57B1/6 and CD40' syngeneic recipient 
mice followed 24h later by i.p. immunisation with ovalbumin-alum. At d3 and d6, the 
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Figure 3.13 Role of CD40 in clonal expansion of DO11.1O T celLs in p1w: adoptive transfer system. 5x106 
lymph node cells from D011.lO CD4O mice were transferred into BALB/c and CD40' mice followed 24h 
later by i.p. immunisation with alum-precipitated ovalbumin and s.c. immunisation with ovalbumin-CFA in 
thighs. The expansion of the D011.1OT cells in the spleens and draining inguinal lymph nodes of the recipient 
mice was measured at d3 and d6 after immunisation by flow cytometry. Cells were stained with anti-CD4 and 
KJI.26 and the double positive cells indicated the extent of T cell clonal expansion. Graph shows the KJl.26 
cells as percent of CD4 T cells. Each point represents an individnal mouse. PBS controls harvested as 0 and 
d6 are shown together. This experiment was done twice. 
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expansion of transgenic cells was measured by staining the splenocytes with antibodies 
against CD4, Va2 and V35 and analysis by flow cytometry. At d3, OT-Il T cells 
expanded to similar extent in wildtype and CD40-deficient hosts, however, at d6, the 
percent of Va2V 5 T cells was significantly reduced in CD40 4 hosts in comparison to 
the wildtype mice (fig 3.14). The data shown suggests that the initial activation and 
proliferation of 01-11 T cells is independent of CD40-CD40L interactions, but it is 
critical to sustain the proliferative response. 
3.9. Discussion 
In addition to the confirmed role of CD40-CD40L interaction in B cell responses [183], 
it has also been suggested that it is critical for T cell responses as well. Impaired T cell 
expansion of adoptively transferred CD40L-deficient CD4 T cells was demonstrated 
nearly a decade ago by Grewal et al. [72]. The importance of CD40-CD40L interactions 
in T cell responses was further confirmed in several other reports. Various in vivo 
studies have shown normal initial expansion of T cells in the absence of CD40-CD40L 
interactions, although this expansion was not sustained resulting in loss of antigen-
reactive T cells [73,255,256]. Howland et al. found similar proliferation of CD40L and 
wildtype DO 11.10 T cells when cultured in vitro in the p.resence of high antigen 
concentration and high APC:T cell ratios, although at low concentrations of antigen or 
APC, CD40L T cells proliferated less than wildtype T cells [73]. Miga et al. further 
argued that lack of CD40 on the DCs impaired their capacity to persist in vivo, and 
hence reduced T cell expansion [256]. In addition, in response to viral infections LCMV 
and vesicular stomatitis virus (VSV), Oxenius et al. observed efficient induction of CD4 
T cells as well as T-effector function generation in CD40' and CD40U' mice [242]. 
Therefore, the precise role for CD40 costimulation in T cell responses including priming 
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Figure 3.14 Role of CD40 in clonal expansion of OT-It T cells in vivo: adoptive transfer system. 
5x106  OT-Il C.O' lymph node cells were transferred i.v. into C57131/6 and CD40' mice followed by 
i.p. immunisation with alum-precipitated ovalbumin 24h later. At 0 and d6, spleens were harvested and 
cells stained with antibodies against C134, Va 2 and V 5, and anslysed by flow cytometry. CD4 cells 
expressing both Va2 and V 5  indicate the expansion of transgenic cells. (A) shows the gating procedure to 
measure the expansion and the numbers show the pementage of cells in the gated box. (B) The Va. 2V35 
cells expressed as percent of CD4 T cells. The data represents two independent experiments, each using 
3-4 mice per group. PBS controls harvested as 0 and d6 are shown together. The groups were compared 
statistically using unpaired Student's t-test. 
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In the experiments described here, CD40-deficient DCs on the H2d  background were 
not inherently defective in their ability to induce strong CD4 T cell responses. Indeed, 
responses of DO11.1O T cells to pOVA323..339 or the APL 3 3 1 M were similar when 
presented by either BALB/c or CD40' DCs. Responses induced by CD40' BMDCs 
were higher than those induced by wildtype DCs in approximately half the experiments. 
Although, I have no explanation for this variability, the key point is that proliferation 
was never reduced in the absence of CD40 expression on APCs. Similar observations 
have been reported by Ozaki et al. [254]. They found that CD40' splenic APCs induced 
higher proliferative response of DO1l.1O T cells in comparison to CD40' APCs, 
however, they could not explain this finding either. By contrast, prominent differences 
were observed in the proliferation of OT-Il T cells. Confirming an important role for 
CD40-costimulation, CD4 T cells from OT-Il mice underwent less peptide-specific 
proliferation when CD40 4  DCs were used as APC, especially at d5. CD40' DCs 
induced similar proliferation of OT-Il cells as C57B116 DCs only when the APC to T cell 
ratio was high. 
UT-TI T cells underwent apoptosis in the absence of CD40 on APCs in vitro, perhaps, 
because the activation of APCs is not sustained in the absence of CD40-CD40L 
interactions. Miga et al. found that in addition to the physical persistence of the DC, 
CD40 triggering of DC also greatly increases the period for which they can productively 
present antigen to T cells [256]. In addition, the induction of OX40L on the APC is 
dependent on CD40 crosslinking [9]. The ligation of OX40L with 0X40 on I cells 
promotes the expression of Bcl-xL and Bcl-2 thus prolonging the T cell survival [55]. 
The in vivo adoptive transfer experiments showed that the initial expansion of OT-Il T 
cells was similar in wildtype and CD40' mice, but at d6 after immunisation, there were 
significantly lower numbers of transgenic T cells in CD40' mice as compared to the 
wildtype mice. Similar experiments done with DOl 1.10 T cells, although await 
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confirmation, suggest that they may require CD40-CD40L interactions to sustain the 
response. Howland et al. have reported similar observations [73]. Considering that 
CD40L is upregulated on T cells only after activation, it is not surprising that T cells 
undergo initial expansion in the absence of CD40. The CD28-CD80/CD86 interactions 
are possibly more critical at the priming stage since CD28 T cells show greatly reduced 
proliferative responses in vitro and fail to expand in vivo as well [73]. Moreover, CD28 
signalling induces the expression of other costimulatory molecules on T cells as well 
[57]. CD86 is constitutively expressed at low levels on DCs and B cells and is markedly 
upregulated on activated mature APCs [118]. After immunisation, T cell expansion may 
be maintained by continuous stimulation by antigen released from its depot. As the 
quantity of available antigen decreases and, the innate immune response to the adjuvant 
subsides, CD40L-mediated stimulation of APCs becomes increasingly important. 
The importance of CD40 on APC in T cell responses is two-fold. Its interaction with 
CD40L primarily signals to the APC, resulting in sustained activation of NFKB 
transcription factor, which regulate DC differentiation and cytokine production [65]. 
Bjorck et al. have shown that as a consequence of CD40 ligation, DCs become resistant 
to Fas-induced apoptosis, possibly as a result of upregulation of bcl-2 protein expression 
[66]. Furthermore, CD40-CD40L interaction results ,in signalling to the T cell through 
various TNF receptor associated factor (TRAF) family molecules eventually activating 
NFxB [257,258]. Although various studies have shown that CD40L enhances the T cell 
responses and the likely mechanism is by DC upregulation of costimulatory molecules, 
chemokines and cytokines [62,259], we and others have observed similar levels of 
MHC-H, CD8O and CD86 on splenic DCs from either wildtype or CD40' mice [255]. 
Furthermore, Ozaki et al. showed that purified B cells but not splenic APC from CD40' 
mice were deficient in inducing T cell proliferation in vitro. Although CD40-CD40L 
interactions upregulate important costimulatory molecules like CD80, CD86, CD44 and 
ICAM- 1 on B cells making them efficient APC, prior upregulation of these molecules 
by LPS pre-treatment did not increase their efficacy as APCs [254]. 
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Although I have not addressed the role of CD40 on effector T cell differentiation, the 
literature suggests that this interaction is crucial for induction of Thi responses. 
Howland et al. found that DO 11.10 CD40L T cells had a selective dàfect in IFNy 
production in vitro [73]. Moreover, StUber et al. found an increase in IL-4 production 
following the administration of a blocking anti-CD40L antibody to mice in a murine 
colitis model [260]. The inability to differentiate into Thi cells may be due to the fact 
that in the absence of CD40-CD40L interactions, T cells fail to activate APCs to produce 
the essential Thi-inducing cytokine, IL-12, since exogenous IL-12 could restore the 
IFNy response of CD40L' T cells [67,73]. 
Recent findings that CD4 as well as CD8 T cells can express CD40 [77] and APCs like 
B cells and monocytes can express CD40L [75,76] have blurred the otherwise sharp 
demarcations of the expression of these molecules. However, use of T cells from 
DO 11.10 or OT-Il mice bred onto CD40' background excludes the possibility of any 
CD40L binding on the T cells in our assays. Moreover, this ensured that any 
contaminating CD4 DC in the purified T cell preparations would be CD40. 
Using (C57131/6 x BALB/c) F 1 DCs in in vitro proliferation assays, we showed that 
DO 11.10 1 cells respond to lower doses of antigen as compared to OT-Il cells. 
Moreover, DO 11.10 T cells exhibited much bigger proliferative response to pOVA 
presented by F 1 DCs. This confirms the previous reports that DO 11.10 T cells may have 
higher affinity receptor for the peptide-MHC complex and for self-MHC [248,249]. 
Moreover, experiments done in the lab by M. MacLeod showed that the two transgenic 
cells proliferate differently in vivo. CFSE labelled OT-Il and DO 11.10 transgenic cells 
were transferred into (C57131/6 x BALB/c) Fl mice that were immunised the following 
day with alum-precipitated pOVA323-339. After 5 days, DO11.10 cells were found to 
proliferate more than OT-Il cells. 
041 
It was hypothesized that the lower affinity of DO 11.10 T cells for analogue peptides 
331M and 331Q, might correspondingly increase the requirement of these cells for 
costimulatory signals to proliferate. However, the proliferation of DO 11.10 T cells in 
response to pOVA or 33 1M was similar, whether or not CD40 was present on the APCs. 
Thus, this study did not shed any light on why DO1 1.10 T cells are independent of 
CD40 costimulation. Nevertheless, it does suggest that study of one type of TCR 
transgenic T cells does not do justice to the complex physiology of I cells in vivo. 
Although such T cells provide invaluable models to study T cell responses, it may be 
inappropriate to draw conclusions based on them, because of variation among different 
cells in terms of affinity for peptide and/or MIHC and other activation or differentiation 
requirements. 
In terms of the affinity for MHC-peptide complex, OT-Il T cells may represent the 
majority of T cells whereas the DO 11.10 T cells may lie at the far end of the bell shaped 
curve with very high affinity. Considering the fact that DO 11.10 mice were made using 
the T cell hybridoma generated in response to chicken ovalbumin [261], these I cells do 
represent a subset of high affinity T cells that might naturally exist. This illustrates the 
importance of examining more than one clone of T cells before assigning definitive roles 
to particular molecular interactions in T cell mediated immune responses. 
Collectively, these findings suggest that requirement for CD40 is much more stringent 
for low affinity TCR-peptide-MfIC interactions of OT-Il T cells than for high affinity 
DOI1.10 T cells. 
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4. Role of ICOS-ICOSL interaction in immune responses 
Background 
For an effective T cell response, recognition of antigen and additional signals from 
costimulatory receptors are required. Costimulation can promote more efficient 
engagement of TCR molecules to enhance the initial activation and can also provide 
additional signals to promote cell division, augment cell survival or induce effector 
functions. Many receptors have recently been described to be costimulatory, ICOS, a 
CD28 homologue, being one of them. 
It has previously been suggested that ICOS interactions are not involved in the initial 
response of naïve T cells to antigen, as ICOS is not expressed on resting T cells [104]. 
This conclusion is supported by in vitro studies where naïve transgenic T cell responses 
to peptide remained intact despite ICOS-ICOSL interactions being blocked by an ICOS-
Ig fusion protein [100]. The issue of ICOS involvement in T cell activation and 
proliferation has been addressed mainly by in vitro studies. Among the few in vivo 
studies, although Mak et al. did not find reduced T cell proliferation in the absence of 
ICOS signalling, Smith et al. found that adoptively transferred DO 11.10 cells 
proliferated less in the presence of a blocking ICOS fusion protein, in both Thi and Th2 
inducing environments [97,106]. Therefore, the precise role for ICOS costimulation in T 
cell responses including priming has not been clearly assigned. The different results 
described probably reflect the varying protocols used: ICOS fusion protein, antibodies 
and different knockout mouse strains examined. In this chapter I have stu qied the role of 
ICOS in the clonal expansion of T cells by in vivo adoptive transfer studies using OT-Il 
TCR transgenic T cells. I have also addressed effector T cell differentiation in the 
context of this interaction. 
W. 
The phenotype of both ICOS and ICOSL knockout mice has demonstrated the 
importance of this interaction in the B cell response in both the generation of germinal 
centres and class switching [93,94]. However, its role in direct T-B collaboration has 
received limited attention. The B cell responses in 1COS mice have been examined in 
this chapter by quantitating the clonal expansion in primary and secondary responses. 
Also, the class switching in terms of serum antibody levels as well as number of 
antibody secreting cells has been assessed. 
Results 
While the ICOS mice were being made in our lab, several reports were published 
characterising such mice made in other labs. The initial experiments were done to 
confirm the phenotype of the mice generated in this lab. To confirm that gene targeting 
has abolished ICOS expression, T cells from mice immunised with alum-precipitated 
ovalbumin, were stained with anti-ICOS antibody and analysed by flow cytometry. 
ICOS was expressed on the surface of CD4 ICOS T cells, but was undetectable from 










Figure 41 Expression of ICOS on the surface of CD4' T cells. 1COS and ICOS' 
mice were immunised Ip. with alum-precipitated ovalbumin. 48h later, spleens were 
harvested, splenocytes stained with antibodies against CD4 and ICOS and analysed by 
flow cytometry. The histogram overlay depicts the expression of ICOS on CD4 cells in 
the splenocytes of ICOS and ICOS' mice. Data is representative of two separate 
experiments. 
4.1. Role of ICOS in humoral immune responses 
	
4.1.1. 	Antigen-specific serum lmmunoglobulins 
Since ICOS has been implicated in T-B cell collaboration, initially we investigated the 
role of ICOS in humoral immune responses. The role of ICOS in generation of antigen 
specific antibody response was examined. ICOS and ICOS mice were immunised 
with haptenated protein DNP-KLH intraperitoneally. The amount of DNP-specific 
immunoglobulin isotypes in the sera was measured at days 0, 7 and 13 post-
immunisation by ELISA (fig 4.2). DNP-specific 1gM was modestly reduced in ICOS 
mice at d7 although the difference was not as pronounced at dl 3. A marked defect was 
observed in the class switched isotypes in the ICOS' mice. The anti-DNP IgG response 
was around 2.5-fold lower in ICOS' mice at d7 with a further reduction at dl 3 when it 
was around 5-fold lower. Similar reduction in titres of DNP-specific IgGi was noticed in 
the sera of ICOS mice. ICOS' mice elicited markedly reduced IgG2a response both at 
d7 (10-fold lower) and d13 (20-fold lower). Reduction in the titres of IgG3 and IgG2b 
was notable but less marked than the other isotypes. Hence, interaction between T and B 
cells via ICOS-ICOSL is critical for B cells to undergo class switching of antibodies. 
4.1.2. 	Germinal centre reaction 
We next evaluated the GC formation in the spleens of ICOS' and ICOS mice after 
immunisation with DNP-KLH in alum. This was done by staining spleen sections with 
peanut agglutinin (PNA)-FITC and 1gM-Texas Red (see section 2.8). PNA selectively 
binds to B cells in GCs. At d13 after immunisation, ICOS mice had fewer and smaller 
GCs than ICOS mice (fig 4.3). 
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Figure 4.2 Antigen-specific immunoglobulins in the sera of ICOS and ICOS' mice. 
Mice were immunised with lOOg alum-precipitated DNP-KLH i.p. once dO serum samples 
were taken. Mice were bled 7 and 13 days post- i mmunisation and serum was separated from 
blood and stored at -20°C until used. The amount of DNP-specific antibodies of various 
isotypes was measured by ELISA (section 2.11.2). Comparative titres were calculated by 
plotting serum concentration against OD, and reading the dilution at the half-maximal OD, 
compared with a positive control. The class switched antibodies were below the detection 
limits at dO, hence not shown. Both ICOS and 1C0S 4 groups consisted of 2 mice each. Data 
is representative of two independent experiments. The error bars indicate the standard error 





Figure 4.3 Germinal centre formation in the spleens of ICOS knockout and wildtype mice. 
wildtype (A) and ICOS' (B) mice were immunised i.p. with lOOig alum-precipitated DNP-KLH. 
Two weeks after immunisation, mice were killed and sections from their spleens were examined for 
the presence of germinal centres (section 2.8). Sections depided here are stained with FITC-
conjugated peanut agglutinin (PNA) and anti-lgM-Texas Red. PNA selectively binds to B cells in 
germinal centres and 1gM is B cell marker. (A) Large PNA GC in a wildtype mouse. (B) Small 
PNA4  GC in the spleen of ICOS -' mouse. PNA also stains the stromal elements that surround the B 
cell follicle. Original magnification 200x. 
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4.1.3. 	B cell clonal expansion 
Given that ICOS mice, have few small GCs, I next investigated whether interaction 
with T cells in the absence of ICOS affects the B cell priming and clonal expansion. 
Primary response 
ICOS and ICOS mice were immunised intraperitoneally with alum-precipitated 
Phycoerythrin (PB). Since strong 'adjuvants can bypass the requirement of costimulation, 
killed Pertussis bacteria were not used in the immunisation protocol. Spleens were 
harvested 2 weeks following the immunisation, cells stained with PE and FITC-labelled 
anti-CD 19 mAb 1D3 and analysed by flow cytometry. By the addition of PE, we can 
detect the PE-binding B cells. Background PE staining in un-immunised mice was 
minimal. As seen in figure 4.4A, a small population of ID3PE cells is clearly visible at 
this time point. At this early time point, these are probably mostly PE-specific, affinity 
matured, GC B cells, although there will also be some memory cells and antibody 
secreting cells in the spleen. The percent of PE-specific B cells was markedly reduced in 
the ICOS mice as compared to the C57B1/6 mice. When PE cells/spleen were 
compared, there was a significant reduction in the number of PE B cells in the ICOS 
mice than C57B116 mice (fig 4.4B). 
Secondary response 
Mice primed with PE were re-challenged 5 weeks later to evaluate if this interaction is 
required for the B cell secondary response. Spleens were harvested 5 days after the boost 
and PE B cells enumerated by FACS. There was a significant reduction-in the percent 
103 
4.3e-3 	 0.13 	10- 
1 03 
























p00119 	 a 
75 






























ICOS4- 	C57Bl 	 COS4- 	C57BU6 
Figure 4.4 B cell clonal expansion during primary and secondary response in ICOS and ICO&' 
mice. Mice were immunised i.p. with lOOg alum-precipitated PE. Two weeks later, spleens were 
harvested and splenocytes stained with anti-CD 19 and PE For secondary response, mice were boosted 
5 weeks later with 50ig alum-precipitated PE and spleens harvested 5 days later. (A) FACS plots 
showing the expansion of antigen-specific B cells. Upper iight quadrant of the FACS plots indicate the 
PE+ B cells. (B) PE+ cells plotted as % of CD19 B cells in the top graphs. Total PE B cells per spleen 
shown in the bottom graphs. The background staining in the non-immunised mice was minimal. Data is 
representative of three independent experiments, each using three mice per group. The two gmups were 
compared statistically by unpaired Student's t-test. 
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of PE B cells in ICOS' mice as compared to C57B116 mice (fig 4.413). However, when 
the total number of PE specific B cells in the spleen was compared between the two 
groups, the difference was not significant. This was probably due to the variation among 
C5713116 mice. Thus, ICOS-ICOSL interaction is necessary for the B cells to undergo 
maximal clonal expansion both during primary and secondary responses. 
4.1.4. 	Enumeration of the Antibody Secreting Cells (ASC) 
Given that B cell clonal expansion as well as isotype class switching is defective in the 
absence of ICOS, we expected the number of antibody secreting cells in ICOS-deficient 
mice to be affected as well. This was confirmed by ELISPOT assay. 
Pnmary response 
ICOS and control mice were immunised i.p. with alum-precipitated DNP-KLH 
(200j.tg/mouse). Frequency of DNP-specific antibody secreting cells in the spleen and 
the bone marrow was measured 3 weeks after immunisation by ELISPOT assay. Figure 
4.5 shows that the number of ASCs producing class switched antibodies (IgG and IgG i ) 
was lower in the ICOS mice in comparison to ICOS mice. However, the number of 
IgIv1T ASCs in the spleen was higher in ICOS as compared to control mice. Similar 
trend was noticed in the bone marrow. Splenocytes from un-immunised ICOS as well 
as ICOS mice were also plated as controls. Negligible number of class switched ASCs 
were detected, if any, in wells from these mice. However, some variability in the 
background levels of anti-DNP IgM ASCs in unimmunised mice was noticed, with one 
mouse having fairly high numbers in the bone marrow. This may be due to cross-
reactivity between DNP and a ubiquitous environmental antigen. 
105 
Spleen 






























I. 	• •s -5- 
- — 	S 



























Ill-S -lI -;.- 




























Figure 4.5 Number of antibody secreting cells during primary and secondary response in 
ICOS' and ICOS mice. Mice were immunised with 200.&g alum-precipitated DNP-KLH i.p. 
and three weeks later, spleen and bone marrow (from femurs) were harvested. EUSPOT was 
peiformed to eneumerate the ASC (section 2.11.3). The spots were counted manually using a 
dissection microscope. The class switched ASC in non-immunised contml mice were minimal, 
Some variability was observed in 1gM ASC in control mice. Both ICOSI and ICOS groups 
consisted of 3-4 mice each. Each point in the graph represents an individual mouse. Data is 
representative of two independent experiments except 16 weeks time point which was done 
once. The two groups were compared statistically by unpaired Student's t-test. 
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Secondary response 
5 weeks after the primary immunisation, mice were boosted with 1 OOj.tg DNP-KLH-
alum, and spleens and bone marrow harvested 5 days later. The number of ASCs was 
higher in the spleens as expected for B cell recall responses, however, this was not the 
case for bone marrow cells. Probably a 5-day period after the boost was not long enough 
for the ASC to expand in the bone marrow. 
Effect of the absence of ICOS was much more pronounced in the secondary response, as 
there was significant reduction in the number of ASC producing the class switched 
antibodies (IgG, IgGi and IgG2a) in the spleen. A similar trend was noticed in the bone 
marrow, although the difference was not significant in terms of IgGi and IgG2 a, which 
was probably due to the variation among mice within ICOS group. 1gM producing 
ASCs in the spleen of ICOS mice were notably reduced as well (fig 4.5). 
On the whole, DNP-specific ASCs especially IgG2a, were fewer in the bone marrow in 
the secondary response at 5 weeks. Probably this time was not long enough for maximal 
plasma cells migration into the bone marrow. To address this issue, mice were 
immunised and re-challenged 16 weeks later. 5 days after the boost, spleen and bone 
marrow were harvested and ASCs enumerated. The number of ASCs in the bone 
marrow was higher compared to the 5-week time point. Generally, the number of isotype 
switched ASCs was same as at 5 weeks with the exception of one mouse in the ICOS 
group that gave an unusual very high 1gM response both in the spleen and the bone 
marrow (fig 4.5); 
From the data shown so far, ICOS-ICOSL interactions play a crucial role in B cell 
responses. The secondary B cell responses are particularly deficient in the absence of 
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these interactions suggesting a role of ICOS in the generation or reactivation of antigen-
specific memory B cells. 
4.1.5. 	Help Assay 
From the results so far, it is clear that ICOS-ICOSL interaction is involved in the T cell 
help for B cells to produce class switched antibodies. We wanted to validate this 
hypothesis using carrier-hapten based in vitro help assay. 
To investigate whether ICOS-deficient T cells can help primed wildtype B cells to class 
switch, we set up an in vitro culture with DNP-primed purified C57131/6 B cells and 
ovalbumin-primed ICOS deficient or sufficient, purified CD4 T cells in the presence of 
soluble DNP-OVA (refer materials and methods, section 2.10.2). The medium 
containing the antigen was removed after 2 days and replaced by fresh medium. Culture 
supernatants were harvested 5 days later and DNP-specific 1gM, IgG, IgG i and IgG2a 
measured by ELISA. As shown in figure 4.6, the 1gM response was unaffected by the 
absence of ICOS. However, T cells lacking ICOS were unable to help primed B cells to 
class switch. The amounts of IgG, IgGi and IgG2 a were significantly lower in the 
supernatañts of cultures with ICOS' T cells as compared to the ICOS T cells. 
Reduced serum levels of DNP-specific IgGi and IgG2 a in ICOS' mice and inability to 
help DNP-primed B cells to produce IgG i and IgG2a by ICOS T cells strongly suggest 
that it is not just Th2 response that is reduced in ICOS 4 mice; these T.cells were equally 
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Figure 4.6 ICOS' T cells are unable to help wildtype B cells to class switch in vitm. B 
cells were purified from the spleens of C5713116 mice immunised i.p. with alum-precipitated 
DNP-KLH 200pg/mouse two weeks before the assay. T cells were purified from the spleens 
of lCOS and ICOS' mice that were immunised i.p. with alum-precipitated ovalbumin 
150tg/mouse a week before the assay. Purified B and T cells were cultured in the presence of 
soluble DNP-ovalbumifl at 37°C. Medium containing the antigen was replaced by fresh 
medium after 2 days. The culture supematant was harvested 5 days later and the amount of 
DNP-specific antibodies measured by ELISA. Comparative titres were calculated by plotting 
the concentration against OD, and rending the dilution at the half-maximal OD, compared 
with a positive contml. Data is representative of three independent experiments, each using 3 
mice per group. The error bars indicate the SEM. The two groups were compared statistically 
by unpaired Student's t-test. 
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4.2. Role of ICOS in T cell responses 
	
4.2.1. 	Role of ICOS in T cell proliferation in vitro 
To examine if ICOS is required for the proliferation of CD4 T cells in vitro, ICOS' and 
ICOS' mice were immunised with alum-precipitated DNP-KLH intraperitoneally. 
After 7 and 13 days, in vitro proliferation assays were set up with splenocytes in the 
presence of varying concentrations of KLH. Tritiated-thymidine was added 48h after the 
culture, and proliferation measured 1 6h later. 
Similar proliferation was noted irrespective of the presence or absence of ICOS on T 
cells from mice immunised either 7 or 13 days earlier (fig 4.7). 
4.2.2. 	Role of ICOS in T cell activation: activation markers 
Activated T cells are often identified by the expression of newly synthesized surface 
proteins, called activation markers. CD44 is expressed on variety of cell types including 
mature T cells, thymocytes, B cells and macrophages. Recently activated and memory T 
cells express higher levels of CD44 than do naïve T cells. Its ability to bind hyaluronate, 
a matrix molecule, is responsible for the retention of antigen-stimulated T cell in 
lymphoid organs and at peripheral sites of infection and antigen persistence. CD62L, or 
L-selectin, expressed on lymphocytes and other leucocytes, serves as homing receptor to 
lymph node high endothelial venules. It is expressed at high levels on naïve T cells; 
activated T cells downregulate CD62L and upregulate carbohydrate ligands for CD62P 
and CD62E. These two selectins are expressed on inflamed endothelial cells and enable 
the activated T cell to transmigrate into the inflamed tissue [262]. CD69 isnot expressed 
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Figure 4.7 Role of ICOS in T cell proliferation in vitro. ICOS4  and ICOS' mice were 
immunised i.p. with 1OO.tg alum-precipitated DNP-KLH. 7 and 13 days later, spleens 
were harvested and in vitro proliferation assays were set up with splenocytes in the 
presence of titration of KLH. Proliferation was measured by 3H-thymidine incorporation 
during the last 16h of a 3d culture. Data is shown as the mean of triplicate wells ± SEM 
and is representatatiVe of three independent experiments. Proliferation was less than 
2500cpm in the absence of antigen. 
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Figure 4.8 Activation markers on CD4 T cells. 1COS and ICOS' mice were 
immunised i.p. with 200,.tg alum-precipitated ovalbumin. Ten days later, splenocytes 
were staired with antibodies against CD4 and various activation markers and analysed 
by flow cytometry. Data is shown as the percentage of CD4 T cells expressing the 
indicated marker. Both groups consisted of three mice each, represented by individual 
points in the graph. Unpaired Student's (-test was used to compare the groups 
statistically. 
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CD25 is the a-chain for IL-2 receptor and is upregulated on lymphocytes upon 
activation. CD43 is present on most of the cells except resting B cells. It has been 
suggested to have a positive regulatory role in costimulation and negative regulatory role 
in down-modulation of the immune response [263]. 
To see if ICOS has a role in activation of T cells, ICOS sufficient or deficient mice were 
immunised i.p. with alum-precipitated ovalbumin and splenocytes examined for various 
activation markers on the CD4 I cells 10 days post-immunisation. As depicted in figure 
4.8, fewer ICOS CD4 T cells exhibited activated phenotype in terms of CD44 high 
(18.93±3.3) and CD62L low (21.1±3.72) in comparison to ICOS mice (28.3±3.0, CD44 
high; 31.47±2.54, CD62L low). This indicates that fewer CD4 cells get activated in the 
absence of ICOS. 
Cells expressing CD69 were significantly reduced in ICOS' mice (13.68±0.49) in 
comparison to ICOS 1 mice (18.64±1.02). Even though CD69 is an early activation 
marker, since alum was used as adjuvant during immunisation, antigen persistence lead 
to longer T cell activation period. Significant difference was noticed in the number of 
CD4 T cells expressing CD25 with 10.28±0.89ICOS and 13.9±0.82 ICOS T cells 
expressing the marker. CD43 was expressed by lower number of CD4 T cells in ICOS 
mice (89.42±1.07) as compared to ICOS mice (93.44±1.43). Number of cells 
expressing costimulatory molecules like CD40L and 0X40 did not differ between the 
ICOS and ICOS' mice (fig 4.8). Thus, ICOS seems to be important for comprehensive 
activation of the C134 I cells. 
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4.2.3. 	Role of ICOS in antigen-specific T cell priming and clonal 
expansion in vivo 
The role of ICOS in antigen-specific CD4 T cell priming and clonal expansion in vivo 
was studied by two different techniques: MHC-II tetramers and adoptive transfer of 
TCR transgenic cells. Since for adoptive transfer technique, the 01-Il mice needed to be 
crossed onto IC0ST1 background, we initially addressed this issue by MIHC-II tetramer 
technique. 
4.2.4. 	MHC class-Il Tetramers 
"MI'HC-II tetramers" are a recently developed tool for tracking antigen-specific CD4 T 
cells in vivo [234]. We used MIHC-II tetramers in ICOS and ICOS mice to determine 
whether there is a role of ICOS in primary T cell activation and expansion during a 
polyclonal T cell response. 
The MHC class II tetramers were obtained from Ton Schumacher's research lab at the 
Netherlands Cancer Institute in Amsterdam [239]. The tetramer constructs, as shown in 
figure 4.9, were designed to enhance the production of the tetramers: the T cell epitope 
(Hi 9env) was covalently attached to the extracellular domain of the beta chain (antigen 
link in figure); heterodimerization in the insect cells was promoted by the addition of 
leucine zippers to the COOH-terminus of both chains; a His-tag was attached to. the 
alpha chain to aid purification of the tetramers and a biotin-tag added, to the beta chain to 
allow tetramer formation. The tetramers were finally generated by the addition of 
streptavidin-PE, which has 4 binding sites for biotin. Monomers were removed by gel 
filtration chromatography, and the tetramers stored at -20°C in glycerol. 
The tetramers are specific for Hi 9env, a peptide from an envelope protein of Moloney 
Murine Leukaemia virus, so the mice were immunised with Hi 9env peptide emulsified 
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Figure 4.10 Gating analysis for teframer positive cells: To analyse tetramer positive 
cells, first a broad lymphocyte gate was drawn. FL3 positive cells (macrophages and dead 
cells) were gated out. Of the remaining cells, only Cl)4 positive cells were analysed for 
tetramer staining in conjuncture with CD44 expression. The number shows the percentage 
of cells in the gated box. 114 
in CFA, a potent adjuvant, which forms an antigen depot at the injection site [264]. Mice 
were immunised subcutaneously in the hind leg, which primarily drains to the inguinal 
lymph nodes. The draining lymph nodes and spleens were taken at various time points 
after immunisation and stained with class II tetramers. The tetramer staining in response 
to H19env was characterised by Megan MacLeod in the lab. 
To identify tetramer positive cells, a live lymphocyte gate was drawn from which 
macrophages and dead cells were excluded by gating out cells, positive for F4/80 and 
propidium iodide. This is essential to remove the background staining since the antigen-
specific tetramer positive population is so small. The CD4 cells were then gated and the 
proportion of cells positive for tetramers and expressing high levels of CD44 was 
measured. Figure 4.10 shows the gating procedure. Cells from mice immunised with 
pOVA323339, an irrelevant peptide for the tetramers, were used as background staining 
control. 
As shown in figure 4.11, the percent of tetramer positive CD4 T cells in the spleen as 
well as the draining lymph node at day 8 was equivalent in ICOS and wildtype mice. 
At day 15 however, fewer tetramer positive I cells were observed in the lymph node 'of 
ICOS' mice, although this difference was not significant. Using this method, T cell 
priming was not reduced in the absence of ICOS signalling. 
4.2.5. 	Adoptive transfer system 
The adoptive transfer system involves transferring T cells from OT-Il OVA-specific 
TCR transgenic mice into syngeneic host mice. Immunisation with ovalbumin 24h after 
adoptive transfer induces proliferation of transgenic OVA-specific T ceUs. The T cell 
expansion can be measured ex vivo by staining for variable chains Va2 and V135  of the 
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Figure 4.11 T cell priming is unaffected in the absence of ICOS. Tetramer positive 
cells expressed as percent of CD-P T cells in the spleens and draining lymph nodes of 
ICOS and ICOS' mice 8 and 15 days alter s.c. immunisation with HI 9env-CFA. Each 
point repisenLs an individual mouse and the lire shows the mean of the group. There 
was no significant difference between both groups at d8 or d15 by unpaired Student's t-
test. Data is representative of two independent experiments. 
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CD4 I cells that are double positive for Va2 and V135 as enumerated by flow cytometry, 
indicate the extent of clonal expansion (fig 4.12). 
T cell expansion following intra-peritoneal immunisation with ovalbumin-alum 
Since I wanted to ascertain the role of ICOS in T cell clonal expansion, ICOS' mice 
expressing the OT-Il transgenic TCR were generated so that peptide-specific I cell 
proliferation could be examined directly in adoptive transfer experiments. A cohort of 
either ICOS-deficient or ICOS-sufficient transgenic OT-Il lymph node cells were 
transferred into naïve C57131/6 mice followed by i.p. immunisation with alum-
precipitated ovalbumin 24h later. The expansion of CD4 T cells in these mice was 
followed over a time course between 3-8 days post-immunisation (fig 4.12). 
In this adoptive transfer system, the peak of the clonal expansion is at day 4. My results 
show that T cell priming in the spleen is significantly reduced in the absence of ICOS-
ICOSL interaction. The percent of VcV35 positive CD4 T cells was significantly 
lower in the clonal expansion phase when transferred transgenic T cells lacked ICOS 
(fig 4. 13C). The reduction in the number of OT-Il ICOS' T cells was also significant in 
comparison to OT-Il ICOS at the later time point of d8, which corresponds to the 
contraction, activation-induced cell death (AICD) phase. The kinetics of the response 
was similar in both groups except that expansion of ICOS-deficient T cells did not peak 
at d4 (fig 4.1 3D). Unlike wildtype OT-Il T cells, ICOS transgenic T cells did not 
proliferate further after initial expansion at 0 and entered the clonal deletion phase. 
Since the in vitro proliferation of the 01-Il splenocytes was unaffected in the absence of 
ICOS, these results highlight the importance of studying cellular interactions in the more 
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Figure 4.12 Adoptive transfer system. A cohort of OT-il TCR transgenic lymph node cells on 
ICOSI or ICOS' background was transferred into C57131/6 mice followed by i.p. immunisation 
with alum-precipitated oval bumin 24h later. At various time points, spleens were harvested and 
cells stained with antibodies against CD4, Va 2 and V, and analysed by flow cytometry. CD4 
cells expressing both Va.2  and V135 indicate the expansion of transgenic cells. The lower parel 
shows the gating procedure to measure the expansion and the numbers show the percentage of 
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Figure 4.13 Role of ICOS in T cell clonal expansion. C5713116 mice received OT-il !COS or OT-il 
ICOS4  lymph node cells befoie immunisation with ovalbumin-alum i.p., and the expansion of Vcz2V 5 ' 
cells measured at days 3,4, 6 and 8 in the spleen and inguinal lymph nodes. The data is representative of 
three independent experiments, each using 3-4 mice per group per time point. (A) In vitro proliferation of 
splenocytes from OT-il ICOS' and OT-Il ICOS" donor mice, measured by 3H-thymidine incorporation at 
d3. (B) FACS plots depicting similar proportion of Va 2V 5 ' cells in the lymph node suspension used for 
adoptive transfer. Cells are gated on live lymphocytes. (C) Va 2Vf' cells as % of CD4 cells in the spleen 
of recipient mice at indicated time points. Both grciips were statistically compared using unpaired 
student's t-test. The % of OT-lI cells in spleens of control mice was invariably between 0.5-1%. (D) Time 
course of the T cell proliferative response in spleen. (E) Time course of T cell response in inguinal lymph 
node 
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The expansion of VcL2VI35 positive CD4 T cells was observed in the inguinal lymph 
nodes as well, though to a much lesser extent than in spleen which is the draining 
lymphoid organ. The peak expansion of OT-Il cells in these lymph nodes was around 
7% of the CD4 I cells at d4, compared to around 15% in the spleen (fig 4. 13E). The 
difference in the percent of Va2V135 cells in the lymph nodes between 01-11 and 01-Il 
IC0S groups was significant at the peak of response (d4) as well as in the deletion 
phase (d8). Thus, ICOS has a critical and non-dispensable role in T cell activation. 
CFSE 
To assess quantitatively the dynamics of I cell proliferative response, OT-Il and OT-Il 
ICOS' T cells were CFSE labelled before transfer into syngeneic C57B1/6 hosts and 
their division followed. Figure 4.14 shows that at d3 after immunisation, although ICOS 
deficient transgenic T cells underwent similar number of divisions as their ICOS 
sufficient counterparts, the mean percentage of ICOS' OT-Il cells that had undergone 
more than four divisions was 41.23% compared to 54.21% ICOS OT-Il T cells. This 
suggests that although T cells can enter the proliferative phase in the absence of ICOS, 
ICOS' cells undergo less proliferation in comparison to IC0S cells. 
Activation status ofT cells 
The CD44 and CD62L expression on Va2VI35 cells was measured to assess their 
activation status. The OT-Il T cells that lacked ICOS had fewer cells with high  
CD62L IOW  phenotype compared to the wildtype I cells (fig 4.15). This difference was 
significant at the peak of the response on d4 suggesting that ICOS is important for the 





















Figure 4.14 Dynamics of T cell proliferative response illustrated by the loss of CFSE. lCOS 
or lCOS' OT-Il T cells were labelled with CFSE before transfer into recipient C57B116 mice. At 
0 after i.p. immunisation with ovalbumin-alum, the division of T cells between both groups was 
compared by the loss of CFSE. The histograms show the CFSE staining of Va2V' CD4 T cells 
in spleen. The left panel is a histogram overlay of CFSE staining one mouse from each group 
immunised with ovalbumin-alum, while the right panel depicts the PBS controls from each group. 
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Figure 4.15 T cell activation status. At d3, 44 and d6, splenocytes of the recipient mice were 
stained with antibodies against CD4, Va 2, V 5 and CD44 or CD62L and aualysed by flow 
cytometry. Data shown indicates the percent of Va 2Vf 5 CD4 T cells with CD44 (A) and 
CD62LIOw phenotype (B) from separate experiments. Each point represents an individual mouse. 
Unpaired Student's t-test was applied to compare both groups. 
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In vitro restimulation 
OT-Il IC0S and OT-Il cells recovered from the spleens of C57B1/6 recipients at 
different time points after immunisation were restimulated in vitro with varying 
concentrations of p0 VA. OT-Il cells proliferated around 3-fold higher than OT-Il ICOS 
cells at the maximal antigen concentration when the number of transgenic cells was 
different in both populations (fig 4.16A). However, when the number of transgenic cells 
were equalised between IC0S' and wildtype groups in a separate experiment, there was 
no difference in their proliferation in vitro (fig 4.1 6B). 
Role of ICOS in Tcell differentiation: cytokine profile 
T cell clonal expansion after priming is only one component of the immune response. To 
establish whether the reduced T cell proliferation in the absence of ICOS was 
accompanied by any defect in the cytokine response, cell-based cytokine ELISA was 
done for IL-2, IL-4, IL- 10 and IFNy. 
At all concentrations of the pOVA, the OT-Il ICOS cells produced less IL- 10 and IL-4 
as compared to OT-Il cells. The difference in the levels of IL-2 and IFNy was even more 
pronounced with OT-Il cells secreting more of these cytokines except at lowest 
concentration of pOVA (0.01 riM) (fig 4.17). However, since the proportion of OVA-
specific T cells was not equal in 01-Il ICOS +  and OT-Il ICOS -I.  cultures to start with, it 
is difficult to definitely state anything about the role of ICOS in effector T cell 
differentiation from these results. Hence, the data was transformed and the cytokine 
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Figure 4.16 In vitro restiniulation of OT-il cells. The splenocytes from the recipient mice 
of ICOS or ICOS' OT-Il cells were restimulated at 0 in vitro in the presence of titration of 
pOVA. Proliferation was measured by 3H-thymidine incorporation during the last 16h of a 3d 
culture. Data is shown as the mean of triplicate wells ± SEM. The propottion of OT-il cells 
was different (A) or equalised between groups (B) in separate experiments. Proliferation was 
less than 2500cpm in the absence of antigen. 
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Figure 4.17 Cytokine secretion by OT-Il cells in the presence or absence of ICOS. 
Following adoptive transfer of lCOS or ICOS' OT-Il cells and i.p. immunisation with 
ovalbumin, the splenocytes from the recipient C57131/6 mice were assessed for cytokine 
secretion by cell-based ELISA at d4 (section 2.10.3). Splenocytes, 8x10 5/well were cultured in 
vitro for 3 days in 96-well plate and the cytokine secreted during the last 20h of culture 
measured by ELISA. Amount of cytokine secreted was measured by interpolation of 
absorbance from the standard curve. 
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At 1 0O.tM pOVA, the calculated amount of cytokines produced by 103  Va2V05 
depicted in the following table: 
Table 4.1 Cytokine production by OT-Il ICOS' and OT-il ICOS cells. 
Cytokine 
per 103 Va2V135 cells  
OT-Il ICOS OT-Il ICOS 
IL-2 (pg/mi) 111.0 76.0 
IL-4 (pg/ml) 1.06 0.432 
IL-lO (pg/mi) 33.0 26.7 
IFNy(pg/ml) 352.0 614.0 
However, it is important to note that in order to normalise the data, a linear relation 
between the number of Va2V135 cells per well and the cytokine secreted, was assumed, 
which may not actually be the case. In a separate experiment, cultures for cell-based 
cytokine ELISA were set up with equal number of Vcz2Vf35 cells from both groups, in 
which case the OT-Il ICOS' group had around 3 times more cells than the OT-Il ICOS 
group. ICOS-deficient OT-Il cells secreted similar or slightly higher amounts of IL-2, 
IL-4 and IL-10 in comparison to wiidtype OT-Il cells in this experiment. The amount of 
IFNy secreted by OT-Il ICOS' cells, however, was higher than 01-11 cells at all 
titrations of the antigen. This was probably due to additional number of T cells (added to 
equalise thenumber of Va2V135 cells between both groups) in ICOS-deficient cultures 
responding to the pOVA. 
Thus, from these experiments, it can be summarised that ICOS-deficient T cells are 
defective in the production of IFNy, but not other cytokines. 
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T cell expansion following subcutaneous immunisation with ovalbumin-CFA 
In contrast to above adoptive transfer experiment, I had not found any defect in CD4 T 
cell priming in the absence of ICOS using tetramers. The reason for different outcomes 
might be that the two approaches used different immunisation protocols; antigen 
emulsified in CFA given subcutaneously in tetramer studies, and alum-precipitated 
antigen given intraperitoneally in the adoptive transfer system. CFA is a strong ml 
inducing adjuvant while alum is a Th2 inducing adjuvant. To investigate if this might be 
the reason for difference in results, an adoptive transfer experiment was undertaken with 
immunisation regime used in tetramer studies. Either OT-Il or OT-H ICOS lymph node 
cells were transferred into C57B1/6 mice followed 24h later by s.c. immunisation with 
ovalbumin emulsified in CFA in both the thighs. The expansion of the OVA-specific 
transgenic CD4 T cells in the inguinal lymph nodes was examined at different days after 
immunisation by staining with antibodies against Va2 and V1 35. 
The expansion of OT-Il cells was equivalent in the both groups in the priming and 
expansion phase (d3 and d4), however, significant difference in the number of Va2 V5 
cells was noticed during the clonal deletion phase. Significantly lower number of OT-Il 
cells were found in the draining inguinal lymph nodes in the absence of ICOS (fig 4.1 8A 
& B). Similar trend was  observed in the spleen at all the day points (fig 4.1 8C). 
CFSE 
To determine whether the difference in the Va2Vf5 cell numbers in both groups was 
due to less T cells entering division or T cells undergoing fewer divisions, OT-Il and 
OT-Il ICOS' T cells were CFSE labelled before transferring into C57B1/6 hosts and 
their division followed after immunisation. The overlay of CFSE histograms at d4 shows 
that ICOS-deficient OT-Il cells in the lymph nodes had undergone fewer divisions in 
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Figure 4.18 Role of ICOS in T cell donal expansion. C57B116 mice received OT-il lCOS or 
OT-il ICOS4  lymph node cells before immunisation with ovalbumin-CFA s.c., and the 
expansion of Vo2V( 5' cells measured at days 3, 4, 6 and 9 in the draining and spleen. This 
experiment is done once using 4 mice per group per time point. (A) VaV cells as % of C134 
cells in the inguinal lymph nodes of recipient mice at indicated time points. Both groups were 
statistically compared using unpaired Student's t-test. The % of OT-Il cells in LN of control 
mice was invariably between 0.5-1% of C134 T cells. (B) Time course of T cell proliferative 
response in inguinal lymph nodes. (C) Time course of the T cell response in spleen. 
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comparison to ICOS-sufficient UT-Il T cells (fig 4.19). Thus, in the absence of ICOS,,T 
cells are slower to divide. 
Role of ICOS in T cell apoptosis 
Once a I cell response is generated, clonal expansion is followed by clonal deletion 
phase where in majority of the activated T cells undergo apoptosis. It is difficult to 
detect the apoptotic cells as the phagocytic and scavenger cells of the body are very 
efficient at phagocytosing them quickly. One of the earliest signs of apoptosis is the 
translocation of membrane phospholipid phosphatidylserine (PS) from inner membrane 
to outer plasma membrane. Annexin-V binds to the PS and therefore is a sensitive tool 
to detect early apoptotic cells. The 01-I1 cells in the inguinal lymph nodes were 
examined for Annexin-V binding at various days after immunisation. At d4 post-
immunisation, the ICOS-deficient 01-1I cells had slightly higher proportion of apoptotic 
cells as compared to ICOS OT-Il group, but this difference was not significant (fig 
4.20). At d6 and d9 after immunisation, however, there was not much difference in the 
number of apoptotic cells in both the groups. Thus, ICOS does not seem to play a role in 
regulating the apoptosis of T cells. 
From the results described so far, it can be concluded that the difference in the number 
of Va2V15 cells between ICO S-sufficient and -deficient groups is due to fewer ICOS' 
T cells undergoing proliferation, since proportion of Va2V135 cells undergoing apoptosis 








Figure 4.19 T cell proliferative response illustrated by the loss of CFSE. lCOS or 
1COS' or-Il T cells were labelled with CFSE before transfer into recipient C57B1/6 
mice. At d4 after s.c. immunisation with ovalbumin-CFA, the division of T cells in the 
LN between both groups was compazed by the loss of CFSE. The histogram shows the 
CFSE staining of cells gated on Va2VE35 CD4 T cells. The histogram overlay depicts 
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Figure 4.20 Role of ICOS in T cell apoptos&s. The inguirl LNs of the recipient mice in a 
group were pooled and OT-il cells undergoing apoptosis assessed at days 4, 6 and 9 post-
immunisation. The cells were stained with CD4, Va 2, V35 and Annexin-V and analysed by 
flow cytometry. Data represented show Annexin-V cells as the percentage of Va.2Vf 5 ' 
CLW T cells. This experiment was done once. 
128 
4.2.6. 	Role of ICOS in CDC effector T cell generation 
Antigen presentation in combination with costimulation drives T cells to enter cell cycle 
and to produce IL-2 [5]. Proliferating CD4 T cells initially express a spectrum of 
cytokine genes, but within a short period, a population of cells, each producing a broadly 
similar array of cytokine, emerges as a dominant type. These T cells have a stable, 
inheritable phenotype characterised by the production of signature effector cytokines 
that define the immune response. ICOS has been implicated in Th2 responses, though it 
also plays critical role in Thi responses as shown recently in in vivo infectious Th 1 
models [1 14-1 16]. 
I aimed to elucidate the role of ICOS in T cell differentiation in vivo by using polarising 
antigens: heat killed Propionebacterium acnes (Pa, Thi) and Schistosoma mansoni eggs 
(Th2). Schistosome eggs release proteins into the tissues surrounding their site of 
deposition during infection [265]. Soluble Egg Antigen (SEA) contains these released 
antigens, and is widely used to assess CD4 T responses during infection [266]. 
Similarly, infection with Pa involves exposure of the host to the whole bacteria. These 
polar opposite CD4 T responses mimic the dominant responses seen during infection 
with these bacterial and helminth pathogens. 
As outlined in figure 4.21, ICOS and ICOS mice were immunised s.c. in the footpad 
with either Pa (50p.g/footpad) or S. mansoni eggs (lSOOeggs/footpad) or PBS. The 
popliteal lymph nodes were harvested a week after the immunisation. 7.5x10 5 cells/well 
from the lymph nodes were restimulated in vitro in the presence of Pa (Sji.g/ml) or SEA 
(25p.tg/ml) or medium for 3 days before supernatants were harvested. The amount of 
different cytokines such as IL-2, IL-4, IL-5, IL-lO, TNFa and IFNy, secreted by the cells 
in the culture supematant was measured by cytokine specific ELISA. 
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Day 0 	Subcutaneous immunisation of ICOS -' and ICOS mice with Pa, 
S. mansoni eggs or PBS in the footpad 
¶4, 
Day 7 	 Popliteal lymph nodes harvested 
4! 
In vitro restimulation of lymph node cells with Pa, SEA and medium 
¶4, 
Day 10 	 Culture supematant harvested 
4! 
Amount of cytokines lL-2, IL-4, IL-5, lL-10, TNFa and lFNy measured by ELISA 
Figure 4.21 Flow diagram of the experimental outline. Role of ICOS in effector T cell 
differentiation was assessed using polarising antigens, P - Thi and SEA - Th2. 
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Upon in vitro restimulation with Pa, T cells from ICOS' mice immunised with Pa 
secreted less IFNy and TNFa as compared to ICOS mice (fig 4.22). Reduced levels of 
IL-2 in the ICOS4 culture supernatants were noted as compared to ICOS cultures. I did 
not find any defect in Th2 differentiation in terms of IL-4 and IL-5. The amount of IL-4 
in the supernatants of lymph node cells from the mice that were immunised with 
Schistosome eggs and further cultured with SEA was similar in both groups. Though 
surprisingly, the levels of IL-5 in the ICOS supematants were higher compared to the 
ICOS supernatants. Although ICOS has been reported to be a superinducer for IL-lO 
[104], this experimental protocol did not yield similar observations. No difference in the 
levels of IL- 10 in both culture supernatants was observed (fig 4.22). This experiment, 
although done only once, suggests that costimulation via ICOS is required for the 
induction ofThl responses. 
4.3. Discussion - 
ICOS is a CD28 homologue implicated in regulating T cell differentiation. 
Costimulatory signals are critical for regulating T cell activation, and thus an 
understanding of these signals may enable the design of rational therapies for immune 
mediated diseases. In this chapter, I have characterised the ICOS' mice and using them, 
I have shown that interaction between ICOS and ICOSL is critical for activation and 
clonal expansion of both T and B lymphocytes. Moreover, this interaction is crucial for 
the provision of T cell help for B cells to produce class switched antibodies and form 
GC. 
4.3.1. 	T cell activation 
The role of ICOS in T cell activation has been a contentious issue due to differing 
reports published since its identification five years ago. Initial studies reported that 
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Figure 4.22 Role of ICOS in effeetor T cell diffenliation. As per the expenment 
outlined in fig. 4.21, ICOSI and ICOS' mice were immunised s.c. in the footpad with Thi 
inducing Pa (50i.g/footpad), Th2 inducing S. mansoni eggs (1500 eggs/footpad) or PBS. 
Popliteal LNs were harvested a week later and 7.5x 10 5  cells/well restimulated in vitro in the 
presence of Pa (5.tg/ml) or SEA (25p.g/ml) or medium for 3 days before the supematants 
were harvested. The immunisations are labelled on x-axis and colour of the bars depict the 
culture conditions. The amount of cytokines in the supernatants was measured by cytokine-
specific EUSA (section 2.10.4). This experiment was done once with 3 mice per group. 
The error bars represent the SEM. 
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even in CD28 mice, showing that it can regulate T cell function independent of CD28 
[89,100]. However, Gonzalo et al. observed that ICOS-Ig fusion protein markedly 
reduced the expansion of CD4 and CD8 cells in vivo as well as in vitro [105] while 
McAdam et al. did not find any difference in T cell proliferation in the presence of 
blocking ICOS-Ig fusion protein [100]. Later reports using ICOS knockout and ICOSL 
knockout mice did not make the issue any clearer. McAdam et al. noticed equal 
proliferation of T cells from either ICOS' or wildtype mice in the presence of wildtype 
APCs [93], while profoundly defective proliferation was reported when ICOS' T cells 
were stimulated by anti-CD3 alone [95] or in presence of B7RP-l-Fc [94]. Nurieva etal. 
observed reduced T cell proliferation when activated by B7h APCs [267]. 
This issue has been mostly addressed either by in vitro studies or in vivo experiments 
involving blocking of ICOS-ICOSL interactions by antibodies or fusion proteins. I 
studied the role of ICOS in T cell activation by an adoptive transfer system, whereby we 
could track the expansion of the transgenic T cells directly ex vivo. My finding that 
clonal expansion of OT-Il cells lacking ICOS was significantly deficient compared to 
ICOS OT-Il cells came as a surprise, since ICOS splenocytes restimulated in vitro 
proliferated similarly to ICOS cells (fig 4.7). One possible explanation may be that a 
minor defect in the ICOS T cell priming from normal (non-transgenic) mice gets 
accentuated in transgenic mice where most of the T cells are antigen-specific. But given 
that even OT-Il and OT-Il ICOS' splenocytes proliferated similarly in vitro (figs 4.13A 
and 4.1 6B), this does not seem to be the reason. It also indicates the unlikelihood of an 
intrinsic qualitative defect in naïve CD4 I cells in ICOS" mice. 
Possible explanations for reduced expansion of transgenic T cells when ICOS was 
lacking are: decreased migration of transgenic T cells to spleen; increased death of 
transgenic T cells; or decreased division of transgenic T cells. We addressed the division 
issue by injecting CFSE labelled CD4 T cells into recipient mice. Although both types 
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of cells underwent a similar number of divisions, fewer ICOS transgenic T cells 
compared to ICOS, divided at d3. Similar observations have been reported by Smith et 
al. in a double adoptive transfer system [97]. They transferred HEL-specific B cells and 
DO 11.10 1 cells into BALB/c mice followed by immunisation with HEL-OVA and 
treatment with anti-ICOS mAb. Although treatment with anti-ICOS mAb did not 
prevent transgenic T cells from dividing, T cell expansion was nearly half than that 
found in the non-treated group at d3 post-immunisation. Although ICOS may not be 
involved in the initial interactions between T cell and APC, it seems important in the 
generation of primary T cell responses. Since OT-Il cells were unaffected in the absence 
of ICOS in vitro, these results highlight the importance of studying responses in the 
more complex environment of in vivo models. 
I did not find much difference in the Annexin-V binding of ICOS and ICOS' CD4 T 
cells during the clonal expansion and deletion phases. Mak et al. observed similar 
staining for Annexin-V and 7-AAD by CD4CD25 T cells from wildtype and ICOSL4 
mice [106]. Therefore, the reason for the reduced number of Va2VI35 cells in the 
recipients of ICOS-deficient OT-Il cells might be that ICOS' T cells underwent less 
proliferation and not because of more cells dying. 
Fewer CD4 T cells with activated phenotype in terms of CD44"", CD62L' °'', CD69 
and CD43 expression were observed in ICOS mice in comparison to the wildtype 
mice. Conflicting reports are available regarding the effect of ICOS on upregulation of 
activation markers on T cells. Tafuri et al. observed reduced levels of CD40L, CD25 and 
CD69 on ICOS' CD4 T cells 24h after in vitro stimulation with anti-CD3IB7RP1-Fc 
[94]. On the other hand, Hutloff et al. observed upregulation of CD69, CD25 and CD7 1 
on human T cells to be normal when stimulated in vitro in the presence of anti-ICOS 
mAb [104]. Probably, this is due to technical differences, ICOS 4 mice versus blocking 
anti-ICOS mAb, and mouse versus human study. In my study, similar number of cells 
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expressed CD40L and 0X40 in both groups. Normal upregulation of CD4OL has been 
observed in ICOS mice in vivo [93,96] as well as on human T cells treated with anti 
ICOS mAb in vitro [104]. Recently, Suh et al. have reported similar levels of CD40L 
induction on T cells from wildtype, ICOS', CD28' and ICOS/CD28 doUble knockout 
mice [103]. This is in line with existing literature that CD40L induction is largely 
independent of costimulatory signals [96,268,269]. 
Using MHC-tetramer binding assays, there was not significant difference in the number 
of antigen-specific cells in ICOS' and wildtype mice at d8 and dl 5 after immunisation. 
However, while studying the role of ICOS in the reactivation of CD4 memory T cells, 
Megan MacLeod in the lab, observed significantly reduced number of tetramer positive 
cells in the draining lymph nodes of ICOS' mice compared to C57B116 mice at 10 
weeks after immunisation. These mice were initially immunised with BMDCs pulsed 
with Hl9env peptide and boosted with peptide-CFA subcutaneously after 10 weeks. The 
tetramer positive cells were measured 5 days after the boost. Thus, using this method, 
ICOS seems to be required for generation or reactivation of the memory CD4 T cells. 
Although the adoptive transfer system has been invaluable in understanding T cell 
activation in vivo, it is far from physiological as it results in an artificially higher 
proportion of antigen-specific T cells. Moreover, different TCR-transgenic T cells can 
have different characteristics such as affinity for MHC and costimulatory requirements 
as discussed in chapter 3. The OT-Il transgenic I cells have low affinity for the MHC 
class-lI [252,253], which might increase their requirement for costimulation in 
comparison to the polyclonal population in non-transgenic mice. On the other hand, 
tetramer staining allows detection of antigen-specific T cells in more physiological 
settings, but due to exceedingly small number of antigen-specific cells, they have to 
undergo clonal expansion before they can be detected by tetramers. Hence, soon after 
the initiation of the immune response, the number of antigen-specific cells is too low to 
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analyse reliably. Thus, transgenic cells provide more useful information at early times of 
T cell activation. Both techniques demonstrated that T cell activation could occur in the 
absence of ICOS-ICOSL interactions, however, the defects in the transgenic system 
were greater than those in the polyclonal system and this illustrates the importance of 
examining more than one system of T cell activation before assigning definitive roles to 
particular molecular interactions. 
4.3.2. 	Effector T cell differentiation 
Earlier work using anti-ICOS antibodies and fusion proteins suggested that ICOS 
signalling induces the secretion of IFNy but not IL-2 [89,99,102,104,105]. Later, studies 
with ICOS' mice have reported both normal [94], and even increased production of 
IFNy in the in vitro culture supernatants of ICOS T cells, as compared to ICOS' I 
cells [93]. It was reasoned that ICOS enhances Th2 response, so its absence might 
increase generation of Thi cells. As both these groups have used similar immunisation 
protocols, the reason for different findings is unclear. Dong et al. observed that in vitro 
differentiated ICOS CD4 I cells could produce IFNy and IL-10 but failed to secrete 
IL-4 and IL-2 [95]. Also, ICOS has also been implicated for the production of IL-4, IL-
5, GM-CSF and TNFa [102,104,105]. ICOS costimulation has been reported to induce 
several fold higher secretion of IL- 10 as compared to modest stimulatory capacity of 
CD28, hence called a superinducer for IL-b [104,111]. Hence, the role of ICOS in 
cytokine induction remains slightly confused. 
I tried to clarify whether ICOS is instrumental in both Thi and Th2 effector cell 
generation by immunising ICOS and wildtype mice with polarising antigens. Heat 
killed Pa induces strong Thi response while Schistosoma mansoni eggs elicit Th2 
response. Using this protocol, I did not observe reduction in any of the Th2 cytokines, 
but levels of IFNy, TNFa and IL-2 were reduced in the ICOS' culture supernatants. 
This suggests that ICOS is important for the Thi differentiation. As this experiment has 
only been done once, these results await further validation. Also, considering that 
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schistosome eggs are very strong Th2 inducing antigen, it can possibly overcome the 
need for ICOS costimulation. Since from other experiments, it appears that ICOS is 
more important in the secondary responses, the ideal way to do this experiment would be 
to measure the cytokines in the in vitro restimulated culture supematants after boosting 
the immunised mice with the antigen. Also, Pa-specific and SEA-specific antibody 
response in the sera of ICOS-deficient or -sufficient mice would be informative 
regarding the helper T cells generated. Another way to address the role of ICOS-ligation 
in effector T cell generation would be to inject ICOSL' or wildtype DCs pulsed with Pa 
or S. mansoni eggs into wildtype mice. This protocol would take care of any differences 
in the APCs, if any, in mice lacking ICOS. 
My results correlate with Dong et al. in terms of IL-2, IL-5 and IL-b. They immunised 
ICOS' and wildtype mice s.c. with KLH in alum or CFA. In vitro restimulation of the 
draining lymph node cells with peptide revealed reduced IL-2, IL-5 and IL-4 with no 
difference in IL-i 0 response. They also observed similar amounts of IL-5 and IL- 10 and 
reduced IL-4 and IL-13 by in vitro restimulated lung lymph node cells from OVA-
sensitised ICOS mice followed by airway boost with antigen [95]. 
Recently Lohning et al. reported a tight link between ICOS and IL-b, as cells 
expressing high levels of ICOS were the main secretors of IL- 10 [lii]. They observed a 
relation between low expression of ICOS and early cytokine secretion and medium-high 
ICOS expression corresponded to late cytokine production. The authors argued that 
ICOS is gradually upregulated in the course of progressing T cell differentiation. So, 
first T cells would utilise ICOS to release Th2 cytokines, and later a population of T 
cells would differentiate to produce IL-iO and would utilise high ICOS expression for an 
effective downregulation of the immune response. Though the observation that T cells 
from ICOS' mice are fully capable of secreting IL- 10 upon CD3 stimulation in vitro 
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seems to indicate that ICOS is not directly involved in the differentiation of T cells to 
IL- 10 secreting cells, but rather controls the release of this cytokine [95]. 
Using CD80-CD86 double knockout mice, Schweiter and Sharpe have shown that CD28 
is required by naïve T cells for IL-2 production and clonal expansion but recently 
activated T cells do not need these signals for secretion of IL-4 or IFNy [149]. 
Furthermore, ICOS has been shown to function as an important costimulatory molecule 
for effector cytokine production by recently activated T cells in CD28-B7 independent 
response [99]. Low levels of ICOSL are expressed constitutively on peripheral tissues, 
for example, endothelial cells and its expression increases upon inflammation [270]. 
Under these conditions, ICOS-ICOSL is the main pathway for cytokine release by I 
cells upon antigen presentation by endothelial cells, since the inflamed endothelial cells 
remain negative for CD80/CD86 [111,270]. 
In the adoptive transfer experiments, I studied the role of ICOS on effector T cell 
differentiation and cytokine secretion by cell based ELISAs. Difficulty in analysing 
these results arose from the unequal number of OT-Il cells in the starting populations in 
both ICOS and ICOS' groups. When equal number of OT-Il cells were cultured in both 
groups, the ICOS cultures had 3 times more cells as compared to ICOS cultures, 
which might have accounted for the increased secretion of IFNY. An ideal way would be 
to measure the amount of cytokine secreted by same number of OT-Il and OT-Il ICOS' 
T cells. This can be done by sorting these cells from spleens of the adoptive transfer 
recipients and the amount of cytokine measured by quantitative real time PCR. 
4.3.3. 	T cell-B cell collaboration 
ICOS-ICOSL costimulation is a key interaction in humoral responses to T-dependent 
antigens. Our findings that ICOS' mice have reduced levels of DNP-specific class 
switched antibodies in their sera as compared to ICOS mice confirm the earlier reports. 
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ICOS mice have been shown to mount normal levels of 1gM and markedly reduced 
IgGi and IgG2a antibodies [93,94,103]. Furthermore, class switching is highly dependent 
on ICOS-mediated T cell help when CD28 is not present. A recent study using 
CD28IICOS double knockout mice has shown that in the absence of CD28, ICOS plays 
a critical role in promoting switching to IgGi. Basal IgG1 levels in CD28' mice was 
10% of the wildtype mice, while in double knockout mice, it was 1.2%. Also, GCs are 
totally absent in CD28/ICOS double knockout niice [103]. 
I observed slightly reduced 1gM response at d7 in ICOS mice. Nurieva et al. observed 
significantly reduced 1gM responses in B7h' mice [267] as well as in ICOS' mice 
[126]. They suggested that ICOS-ICOSL interactions might have a role in the initial B 
cell response before Ig class switching occurs. DNP-specific 1gM response at dO may be 
due to cross-reactivity between DNP and a ubiquitous environmental antigen. 
Interestingly, the defect in Ig isotype switch could be overcome when CFA was used in 
the immunisation regime, suggesting that given enough inflammation and CD80, CD86 
upregulation, CD28-mediated costimulation provides enough T cell help for B cells to 
undergo class switching [93]. This is consistent with previous observations 
demonstrating a role for CD28 in providing B cell help [61]. 
I found B cell clonal expansion to be markedly reduced in ICOS' mice immunised with 
PE as compared to ICOS mice. This finding validates a previous study by Smith et al. 
using ICOS-Ig fusion protein in a double adoptive transfer system [97]. The authors 
showed that antigen-specific B cell clonal expansion was reduced approximately 3-fold 
in mice treated with ICOS-Ig fusion protein in comparison to untreated mice. Moreover, 
these mice had lower HEL-specific serum 1gM levels at dlO post-immunisation. Since B 
cell expansion is dependent on T cell help, these findings further validate the crucial role 
of ICOS-ICOSL interactions T-B cell collaboration. 
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Indeed, following immunisation with T-dependent antigen, the main site of B cell clonal 
expansion is the GC in the B cell follicles. Since the size and number of the GC is 
reduced in ICOS' mice, it implies that ICOS, although not essential for GC formation, 
is critical for B cell expansion in GC [93,94,96]. No GCs were formed in ICOS' mice in 
secondary response [96]. Interestingly, signalling via CD28 is required for the 
development of the GC response, but the established GCs can be maintained without 
CD28 signalling [271,272]. The organisation of B and I lymphocytes is normal in 
spleen of ICOS' mice, and surprisingly, these mice even have normal number of CD2 1 + 
FDCs [93,96]. Possibly, in the absence of ICOS-ICOSL interaction, the B cells are 
poorly stimulated in the I cell areas and fail to migrate into FDC network to form GC. 
As the immune response progresses T cells migrate into the follicles to provide help to B 
cells to class switch and form GC. Using carrier-hapten based in vitro help assay, I 
observed that ICOS T cells were unable to help wildtype B cells to class switch to 
either IgG i or IgG2a. The importance of ICOS in T-B cell interaction is evident from a 
study on transgenic mice expressing soluble and secreted B7RP-l-Fc. Such mice had 
lymphoid hyperplasia in T as well as B cell areas, high circulating IgG and 
plasmacytosis [89]. 
As the capacity of T cells to help B cells for activation and antibody production is 
generally correlated to their ability to migrate into B cell follicles, the number of T cells 
in the follicles would quantitatively reflect the T cell help for B cells. A pilot study done 
in the lab suggested reduced number of T cells in the splenic B cell follicles of the ICOS 
" mice 6-9 days after immunisation (A. Cervera, unpublished data). I intended to study 
the T cell migration in ICOS" mice over a period of time, but this was not possible due 
to shortage of time. Contrary to this, Smith et al. found that disruption of ICOS-ICOSL 
interaction does not affect the migration of T cells in B cell follicles, although the T cell 
help to B cells was markedly reduced [97]. They blocked the ICOS-ICOSL interaction 
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by injecting anti-ICOS mAb in mice transferred with DO 11.10 T cells and MD4 B cells 
and found reduced 1gM serum responses in these mice. 
ICOS expressing T cells interact with ICOSL during two different phases of a response 
to a T cell dependent antigen: first, during the T cell priming and differentiation phase, 
in which professional or semi-professional APCs promote T cell acquisition of helper 
function; and second, during the delivery of T cell help to B cells. Mak et al. dissected 
the role of this interaction in both situations using adoptive transfer system of T and B 
cells from either ICOSL' or wildtype mice into irradiated recipients. Abrogation of 
ICOS-ICOSL engagement during either APC-T interaction or secondary T-B interaction 
resulted in substantial defects in the antibody production in the recipient mice [106]. 
Long-lived plasma cells are responsible for the continuous maintenance of serum 
antibody levels [192]. Our ELISPOT data to enumerate ASCs confirms that ICOS is a 
critical costimulatory molecule for the B cells to become class switched antibody 
producing cells, especially in the secondary response. Presumably, this is partly due to 
the reduced B cell expansion following the primary immunisation. Given that ICOS is 
predominantly expressed on GC T cells located in the apical part of the light zone where 
the T cells are known to induce terminal differentiation of the B cells into plasma cells 
or memory cells, these results are not surprising [104].' Hutloff et al. while studying 
human SLE patients, found clusters of B cells and plasma cells in close contact with 
ICOS T cells in the kidneys. They suggested ICOS to be one of the forces driving the 
formation of memory B cells and plasma cells in SLE [273]. Since ICOS has been 
implicated in maintenance of immune responses, it will be interesting to enumerate the 
ASCs in ICOS' and wildtype mice over a period of time in the absence of boosting. 
Reduced B cell recall responses in terms of clonal expansion and number of ASC along 
with reduced T cell primary clonal expansion and T cell helper function in ICOS' mice 
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suggest a crucial role of this interaction in the generatiOn and/or reactivation of 
functional antigen-specific memory cells. 
4.4. Conclusion 
The experiments carried out in this chapter show that in the absence of ICOS-ICOSL 
interactions, CD4 T cells were unable to provide help for B cells to undergo clonal 
expansion as well as class switching to IgGi and IgG2 a. Thus, ICOS mice have 
markedly reduced levels of class switched immunoglobulins in their serum and 
significantly less antibody secreting cells in spleen and bone marrow. Using adoptive 
transfer studies with ICOS-deficient transgenic T cells, I have shown that ICOS is 
important for the comprehensive activation, clonal expansion and differentiation of 
CD4 T cells. 
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5. Role of B cells in the development of T cell helper 
function 
Background 
Initial activation of naïve CD4 T cells depends upon prolonged signalling through TCR 
engagement of peptidefMHC complexes as well as ligation of costimulatory molecules 
on APCs. Following peptide/MHC-TCR and CD28-CD80/CD86 interactions [274], 
additional receptors that promote costimulation are induced onT cells, including CD40L 
(CD154) (371), 0X40 (CD134) [10] and ICOS [94], which engage with counter-
receptors on APC to promote optimal T cell stimulation. Productive interaction can be 
achieved by sustained as well as serial encounters of T cells with APC [275]. The 
duration of stimulation can detennine the commitment of CD4 cells to division, which 
typically correlates with the development of the effector functions [151]. Although cell 
division per se does not appear requisite for epigenetic remodelling of cytokine gene 
transcription sites [276], several in vitro studies reveal a strong correlation between CD4 
cell expansion and the frequency of cells that produce such cytokine [151,277]. Other 
studies have shown that secretion of cytokines IFNy and IL-2 and expression of markers 
of T cell differentiation, such as CD44, CD45RB and CD62L, all depend primarily on 
cell division rather than receipt of costimulatory signals [278]. 
Once division commences, effector cells can expand and differentiate independently of 
antigen [200,279]. Optimal induction of costimulation and cytokine production are two 
major mechanisms that contribute to growth, differentiation and survival of CD4 T cells. 
So, APCs are integral not only for initiating a CD4 response but also for determining the 
magnitude of expansion and development of effector cells with Thi and Th2 
phenotypes. 
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Although initial priming of the naïve T cells occurs on DCs and various DC subsets can 
promote development of Thi and Tb2 CD4 I cells [280], recruitment of DCs diminishes 
after the initial phase of a response [275]. DCs can affect T cell differentiation via 
antigen presentation and cytokine production for only a limited duration before further 
maturation and exit from lymphoid organ [281]. 
The role of B cells in T cell priming and differentiation has been strongly debated for a 
number of years. Literature is available supporting the critical role of B cells as APCs in 
deciding the fate of CD4 T cell response [82,200,203,205,218,282], though there are 
reports showing normal CD4 I cell expansion and differentiation in the absence of B 
cells as well [205,222,283,284]. B cells have been found to be necessary as APC for 
protein antigens [202] but not for peptide antigens [285]. Peptide antigens do not require 
antigen processing and can bind directly to surface MIHC-II molecules and therefore are 
much more efficient antigens, which makes them less dependent on antigen-specific B 
cells as APC [286,287]. 
Early work done in vitro has shown that B cells can present peptide-MIHC-II complexes 
and stimulate naïve T cells [288]. The stimulatory capacity is greatly enhanced if B cells 
possess a BCR that crosslinks an antigen. For example, TNP-specific B cells have been 
shown to present TNP-conjugated antigen at 1000-10,000-fold lower concentration than 
non-TNP coupled proteins [193]. B cells have been implicated in CD8 T cell responses 
as well. Christensen et al. have shown that CD8 T cell response to LCMV initially is 
qualitatively similar in wildtype and B cell-deficient mice but CD8 T cells loose 
functional capacity in the absence of B cells [198]. They also observed markedly 
impaired priming of virus-specific CD4 T cells in B cell-deficient mice. Furthermore, 
in relB mice, that are deficient in myeloid and functional lymphoid DCs, CD4 T cells 
can be primed in response to soluble protein antigen, suggesting that B cells play a role 
in T cell priming in the absence of DC functions [206]. 
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B cells require T cell help to clonally expand, class switch and undergo GC reaction in 
response to a protein antigen. Although it has long been realised that delivery of help by 
T cells require cognate recognition of antigen presented by B cells, the mechanisms by 
which this is achieved are unclear. However, it seems unlikely that T cells primed by 
DCs should immediately express all the functions of a competent helper cell, as this 
would allow help to be given to all the B cells, regardless of the antigen specificity. 
Instead, there may be further signals which are required in order for T cells to mature as 
helper cells, or which trigger delivery of help. This could be delivered during secondary 
interactions between recently primed T cells and other APCs such as B cells. 
Earlier work in the lab, in an in vivo model, has shown that T cells primed in CD40 
deficient mice are unable to help normal B cells to class switch [289]. Taking this as the 
baseline, I studied further the molecular basis of this observation in a less laborious in 
vitro model. The aim of this study was to investigate the role of B cells in the 
differentiation of helper T cells for antibody class switching. 
Results 
5.1. C1340-deficient T cells do not help B cells to produce class switched 
antibodies 
Initial experiments were done to repeat the previous experiments [289] using in vitro 
system. The experimental model involved hapten-carrier system (fig 5.1). B cells were 
purified from the spleens of C57B1/6 mice primed with alum-precipitated DNP-KLH 
along with killed Bordetella pertussis as adjuvant. CD4 4 T cells were purified by 
positive selection from spleens of CD40-deficient mice or wildtype C57B1/6 mice 
immunised with ovalbumin-alum and killed B. pertussis. A minimum of three mice 
constituted a group and T cells were purified from the pooled splenocyte population. 
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Figure 5.1 Experimental protocol of help assay. B cells were purified from C57BI/6 mice imniunised with 
alum-precipitated DNP-KLH. Mice, either knockout or chimeric with defective B cell compartment, immunised 
with alum-precipitated oval bumin, were the source of T cells. Purified B and T cells were cultured in vitro in the 
presence of DNP-ovalbumin. The medium containing antigen was removed 48h later and replaced with fresh 
medium. The culture supernatant was harvested 5 days later. DNP-specific inimunoglobulins in the supematant 
were measured by ELISA. DNP-specific immunoglobulins were not detectable when B cells were cultured in the 
absence ofT cells. 
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After 2 days, the medium containing the antigen was removed and replaced with fresh 
medium. The culture supernatant was harvested after 5 days and DNP-specific 
immunoglobulin isotypes measured by ELISA. The reciprocal dilution required for half-
maximal OD was measured and plotted. 
In this experimental system, naïve B cells did not make measurable quantities of DNP -
specific IgG, so in all the experiments DNP-primed B cells were cultured with 
ovalbumin-primed T cells. The DNP-specific IgG synthesis observed in help assays 
using normal control T cells was dependent upon cognate T-B interactions, and only 
occurred when T cells, B cells and specific antigen were all present. 
Figure 5.2 shows that there is no significant difference in the amount of DNP-specific 
1gM produced in CD40' and C5713116 cultures. However, the amount of IgG was 
significantly reduced in the presence of CD40' T cells in comparison to the wildtype T 
cells. One very obvious question arising from this finding was whether the reduced help 
to B cells was due to smaller clonal expansion of the CD4 T cells in CD40' mice as 
compared to C5713116 mice, and hence less antigen-specific T cells interacting with B 
cells. To address this question, lymph node cells from OVA-specific TCR transgenic 
OT-Il mice ôrossed onto CD40' background, were adoptively transferred into C5713116 
and CD40' mice. These mice were immunised 24h later with alum-precipitated 
ovalbumin intraperitoneally. The expansion of transgenic T cells was measured 7 days 
after the immunisation by staining the splenocytes with antibodies against CD4, Va2 and 
V35 , and analysed by flow cytometry. Figure 5.3 depicts that the transgenic T cell 
expansion was 2-fold higher in C57131/6 mice as compared to the CD40 4 hosts 
(C5713116, 7.73%; CD40 1 , 3.26%). As shown in chapter 3, the initial T cell priming at 
day 3 is equivalent in the presence or absence of CD40-CD40L interactions, though it is 
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Figure 5.2 CD40-deficient T celLs do not help B cells to class switch. Purified CD4 T cells 
from C57B1/6 and CD40' mice immunised with ovalbumin were cultured with DNP-KLH 
primed C57B1/6 B cells in the presence of DNP-ovalbumin. The medium containing antigen 
was removed 48h later and replaced with fresh medium. The culture supemalant was harvested 
5 days later and DNP-specific immunoglobulins in the superrntant measured by ELISA. Both 
groups consisted of 3 mice each and cells purified from pooled splenocytes. The reciprocal 
dilution required for half-maximal OD was measured and plotted. Data shown is the mean of 
triplicate wells ± SEM and represents four independent experiments. Both groups were 
compared statistically by unpaired Student's t-test. 
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To compensate for the reduced number of antigen specific T cells in CD40' mice, the 
protocol for help assay was modified slightly. CD4 T cells were purified from the 
spleens of ovalbumin-immunised C5713116 and CD40 recipient mice and the proportion 
of double positive cells (V(X2Vi35) assessed by FACS. The number of T cells from 
CD40' and C5713116 mice cultured with the DNP-KLH-specific B cells in the help assay 
were equalised on the basis of proportion of Va2V5 positive cells. Similar amount of 
DNP-specific 1gM was observed in both cultures, while IgG and IgG1 were below the 
detection limits in CD40 culture supernatants (fig 5.3). Thus, T cells from CD40' mice 
do not provide help to the normal B cells to class switch to IgG in vitro. 
5.2. T cells differentiated in the absence of OX40L are unable to help B 
cells for antibody production 
Given the findings of Linton et al. [82] that reconstitution with wildtype B cells but not 
OX40U' B cells could restore CD4 I cell responses in .tMT mice, I next studied the 
role of OX40L for T cell helper function development. 
When OX40L ovalbumin-primed T cells were cultured with DNP-KLH-specific 
C57B1/6 B cells in the presence of DNP-ovalbumin, the amount of DNP-specific 
antibodies in the supernatants was significantly lower as compared to C5713116 cultures. 
Significantly lower 1gM and undetectable levels of IgG, IgG1 and IgG2 a in culture 
supernatants from OX40L' T cells highlight the critical role of this costimulatory 
molecule in the development of T cell helper function (fig 5.4). 
It has been reported recently that inbred mouse strains with the Igh 1-b allele do not have 
the gene for IgG2a but instead express the isotype IgG2 c and due to inadequate cross- 
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DNP-specific B cells in the presence of soluble DNP-ovalbumin 
Day 7 	Measuring of DNP-specific Ig in culture supematant by ELISA 
Figure 5.3 CD40-deficient T cells do not help B cells to class switch. 5x106 OT-il CD40' lymph node cells 
were adoptively transferred to C57Bl/6 and CD40 -'-  recipient mice followed by i.p. immunisation with 
ovaibumin-alum 24h later. The expansion of OT-il cells in both groups was assessed by flow cytometry and 
equal number of Va2V( 5  C134 T cells from both groups were cultured with DNP-KLH primed C57B1/6 B 
cells in the presence of DNP-ovalbumin. The antigen was removed 48h later and culture supematant harvested 
5 days later. DNP-specific immunoglobulins in the supematant were measured by ELISA. The reciprocal 
dilution required for half-maximal OD was measured and plotted. Both groups consisted of 3 mice each. Data 
shown is the mean of triplicate wells ± SEM and represents two independent experiments. Since the amount of 
lgG and lgG 1  were below the detection limits in CD40' cultures, their dilution required to achieve half-










IgG 1 IgG2a! 
C57B1/6 	OX40L' 	 C57B1/6 
	
OX4OL 4 
Figure 5.4 T cells differentiated in the absence of OX40L are unabk to help B cells for 
antibody production. Purified CIYt T cells from C57B1/6 and OX40L' mice immunised 
with ovalbumin were cultured with DNP-KLH primed C57B116 B cells in the presence of 
DNP-ovalbumin. The medium containing antigen was removed 48h later and replaced with 
fresh medium. The culture supernatant was harvested 5 days later and DNP-specific 
immunoglobulins in the supernatant measured by ELISA. Both groups consisted of 3 mice 
each. The reciprocal dilution required for half-maximal OD was measured and plotted. Data 
shown is the mean of triplicate wells ± SEM and represents two independent experiments. 
Both groups were compared statistically by unpaired Student's t-test. Since the amount of 
class switched Ig were below the detection limits in OX40L' cultures, their dilution required 
to achieve half-maximal OD was assumed to be I. 
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mice [290]. In our study however, we did not observe any difference in absorbance 
values of culture supernatants when measured for either IgG2 a or IgG2 (not shown). 
5.3. B cells are critical for T cells to acquire helper function 
This study aimed at the role of B. cells in helper T cell differentiation. Since there have 
been conflicting reports as to whether T cells primed in B-cell deficient mice can 
provide help to B cells [202,205,242], I first addressed this issue in in vitro system. 
Ovalbumin-primed T cells from B cell-deficient .tMT and C57131/6 mice were cultured 
with DNP-KLH-primed B cells in the presence of soluble DNP-ovalbumin. 7 days later, 
the supernatant was harvested and the amount of DNP-specific 1gM, IgG, IgGi and 
IgG2a measured by ELISA. Figure 5.5 shows that C57131/6 T cells provided help for 
DNP-specific antibody production, while pMT T cells induced little IgG secretion. 
When assessed for IgGi and IgG2a levels in the supernatants, the levels of both isotypes 
were below the detection limits in pMT culture supernatants. In all the three experiments 
done, the levels of 1gM in jtMT cultures were significantly and consistently lower in 
comparison to wildtype cultures. 
The priming of CD4 T cell in B cell-deficient mice has been a contentious issue. 
Available literature from experiments done with different types of B cell deficient mice 
(.tMT-H21', p.MT-H2', JHD) and using B cell-depleting antibodies, reach conflicting 
conclusions [199,200,204,205,218,291]. 
Experiments were done as per the modified protocol of help assay to compcnsate for any 
defect in T cell clonal expansion. Thus, equal numbers of antigen-specific T cells from 
both groups were placed in wells. 3.5x10 6 purified CD4 T cells from OT-Il Ly5.1 
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Figure 5.5 B cells are critical for T cells to acquire helper function. Purified CD4 T cells 
from C57131/6 and 1iMl' mice immunised with ovalbumin were cultured with DNP-KLH 
primed C5713I/6 B cells in the presence of DNP-ovalbumin. The medium containing antigen 
was removed 48h later and replaced with fresh medium. The culture supernatant was 
harvested 5 days later and DNP-specific immunoglobulins in the supematant measured by 
EUSA. Both groups consisted of 3 mice each. The reciprocal dilution required for half-
maximal OD was measured and plotted. Data shown is the mean of triplicate wells ± SEM 
and represents three independent experiments. Both groups were compared statistically by 
unpaired Student's t-test. 
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Adoptive transfer of 3.5x10 6 purified T cells from 01-I1 Ly5.1* 1- mice 
Day -8 
C5713116 	 tMT 
Day -7 	Intraperitoneal immunisation with alum-precipitated ovalbumin 
Day 0 	Expansion of OT-lI Ly5.V'T cells in the spleen measured by FACS 
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Ly5.1 cells as % of OT-Il cells. Cells initially gated on CD4 1 T cells. 
Equal number of Ly5. I + CD4 T cells from C57B116 and MT groups cultured with 
DNP-specific B cells in the presence of soluble DNP-ovalbumin 
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Figure 5.6 T cells differentiated in B cell-deficient mice are unable to help normal B cells for antibody 
production. 3.5x 106 OT-lI Ly5.l' lymph node cells were adoplively transferred to C57Bl16 and 1iMT recipient 
mice followed by i.p. immunisation with ovalbumin-alum 24h later. Expansion of OT-lI cells in both groups was 
measured by FACS and equal number of Ly5. V T cells were cultured with DNP-KLH primed B cells in the 
presence of DNP-ovalbumin. The culture sçernatant was harvested at d7 and DNP-specific immunoglobulins 
measured by ELISA. The reciprocal dilution required for half-maximal OD was measured and ploued. Both groups 
consisted of 3-4 mice each. Data shown is the mean of tiiplicate wells ± SEM and represents two independent 
experiments. Since the amount of class switched lg were below the detection limits in p.tMT cultures, their dilution 
required to achieve half-maximal OD was assumed to be 1. Both groups were compared statistically by unpaired 
Student's t-test. 
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C57B1/6 mice, followed by i.p. immunisation with alum-precipitated ovalbumin 24h 
later. Seven days later, the expansion of OT-II-Ly5.1 CD4 T cells in the spleens of the 
recipients was measured by staining with antibodies against CD4 and Ly5.1, and 
analysed on FACS. The number of Ly5.1 UT-Il T cells in .tMT mice was half the 
number in wildtype mice (fig 5.6). For example, in one out of the two experiments done, 
transgenic cells were 4.14% of the CD4 T cells in .tMT mice while in wildtype mice, it 
was 9.48%. These transgenic T cells were purified using biotinylated anti-Ly5. 1 mAb, 
followed by streptavidin microbeads, and magnetic separation on QuadroMACS 
(Miltenyi). 
DNP-KLH-primed B cells were then cultured with purified Ly5.1 cells from C57B1/6 
and iMT mice in the presence of DNP-ovalbumin. The B:T ratio in these experiments 
was 4:1 and not 2:1 as in earlier experiments due to lower yield of Ly5.1 cells. Figure 
5.6 shows that, despite compensating for the reduced priming of I cells in j.iMT mice, T 
cells differentiated in gMT mice did not provide help to the B cells for antibody 
production. Levels of DNP-specific 1gM were significantly lower in tMT culture 
supernatants; IgG and IgGi were below the detection limits (fig 5.6). 
Since the full helper activity does not develop over the 7 days in the presence of normal 
B cells in the in vitro culture, it seems that presence of B cells is crucial during the initial 
T cell priming event. Thus, B cells are important for T cell acquisition of helper 
function. 
5.4. Bone marrow chimeras 
Having confirmed that B cells are important for T cell acquisition of the helper function, 
I next wanted to dissect out its molecular basis. I first investigated whether cognate 
interaction between B and T cells is necessary for the helper T cell differentiation. This 
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Figure 5.7 Bone marrow chimeras: Generati)n and reconstitution. (A) Lethally irradiated (I lSOcGy) 
C57BI/6 mice were reconstituted with 3 .5x 106 T-depleted bone marrow cells the following day. MHC-ll' 
chimeras received 80% tMT and 20% A' bone-marrow, control chimeras 80% pMF + 20% C57B1/6 and the 
CD40-1-  chimeras got 80% t&MT + 20% C[)40 bone marrow. The mice were left 8 weeks to allow 
reconstitution of the immune system. (B) The reconstitution of the mice was confirmed by flow cytometry before 
use. Splenocytes from few mice sacrificed per group were stained with antibodies against B220, CD40 and 
MHC-I1 (M5 114) and analysed on FACS. 156 
was studied by making bone marrow chimeras (fig 5.7A) with the result that MHC class-
II was lacking on B cells but expressed on DCs and other APCs. 
Irradiated (1 150cGy) C57B116 mice were reconstituted with 80% bone marrow from 
jtMT (gene for .t heavy chain deleted causing a block in B cell differentiation [196] and 
20% A13' (MHC class-Il knockout) [172]. Thus, 80% of the hematopoietic cells (except 
B cells) in the chimeric mice will be wildtype in gene expression whereas the B cells can 
only be derived from A13'  precursors (fig 5.7A). Over an 8-week period, the 20% 
knockout bone marrow completely repopulated the peripheral lymphoid system with B 
cells while contributing only 20% to other lineages. In this way, the function of other 
APCs including DCs is minimally impaired whereas antigen presentation via MHC 
class-TI by B cells was abolished. As controls, bone marrow chimeras with normal B cell 
compartment were made by combining 80% tMT and 20% C57B1/6 bone marrow. 
Proper reconstitution of the bone marrow chimeras was confirmed before they were 
immunised (fig 5.713). 
5.5. Differentiation of helper T cells is defective in the absence of 
cognate interaction with B cells 
Ovalbumin-specific CD4 T cells from MHC class-TI deficient B cell chimeras and 
control chimeras were cultured with DNP-specific C57131/6 B cells in the presence of 
DNP-ovalbumin. ELISA for DNP-specific antibodies in the supernatant harvested a 
week later revealed that amount of IgG was significantly lower in the cultures with T 
cells from MHC class-IT deficient B cell chimeras as compared to control chimeras. 
Level of IgGi was below the detection limits in MHC-ff chimera cultures (fig 5.8). 
These results were consistent over four experiments. In two out of four experiments, 
levels of IgG2a were low even in control chimera group. Thus, in the absence of antigen 
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Figure 5.8 Cognate interaction between B and T cells is critical for T cells to acquire helper 
function. Oval bumi n-specific T cells from MHC-11' or control chimeras were cultured with DNP-KLH 
primed C57BI/6 B cells in the presence of DNP-ovalbumin. The culture supernatant was harvested at d7 
and DNP-specitic immunoglobulins in the supematant measured by ELISA. Both groups consisted of 3 
mice each. The reciprocal dilution required for half-maximal OD was measured and ploued. Data shown 
is the mean of triplicate wells ± SEM and represents four independent experiments. Both groups were 
compared statistically by unpaired Student's t-test. Wherever the amount of lg was below the detection 
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Figure 5.9 Costimulation by B cells is important for T cell acquisition of helper function. 
Oval bumi n-specific T cells from CD40' or control chimeras were cultured with DNP-KLH primed 
C57BlI6 B cells in the presence of DNP-ovalbumin. The culture supernatant was harvested at d7 and 
DNP-specific immunoglobulins in the supematant measured by ELISA. Both groups consisted of 3 mice 
each. The recipmeal dilution required for half-maximal OD was measured and plotted. Data shown is the 
mean of triplicate wells ± SEM and represents four independent experiments. Both groups were 
compared statistically by unpaired Student's t-tesL Wherever the amount of Ig was below the detection 
limits, the dilution required to achieve half-maximal OD was assumed to be I. 
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5.6. Costimulation by B cells is important for T cell acquisition of helper 
function 
Bone marrow chimeras were generated in which only B cells lacked CD40, all other 
APCs being CD40 positive (fig 5.7B). The bone marrow inoculate in these chimeras 
constituted of 80% tMT and 20% CD40' [71]. 
When assessed for providing help to B cells, the I cells from these chimeras were found 
deficient. Figure 5.9 depicts that IgG as well as IgG1 were markedly reduced in cultures 
which had T cells primed in the absence of CD40 on B cells. These results were 
consistent over four experiments, two of which had significant difference in IgG levels 
between CD404  B cell chimeras and control chimeras. Thus, CD40-CD40L interaction 
between B and T cell is important for T cells to acquire the ability to help B cells for 
class switching. 
5.7. The defect in T cell help in chimeras is not due to reduced clonal 
expansion of T cells 
One of the possible reasons for the deficient T cell help in MHC class-IF' and CD40' B 
cell chimeras could be reduced clonal expansion of T cells and hence fewer antigen-
specific T cells in the cultures as compared to wildtype cultures. To compensate for this 
defect, the number of antigen-specific T cells cultured with the DNP-KLH-specific B 
cells were equalised among various chimeras. OT-Il CD40' T cells, 3x10 6 per mouse, 
were transferred i.v. to MHC c1ass-I1 - B cell chimeras, CD40' B cell chimeras and 
control chimeras. Mice were immunised i.p. with ovalbumin-alum 24h later. CD4 I 
cells were purified from the spleens of these mice 7 days later and equal number of 
Va2V135 double positive cells from all three groups cultured with DNP-specific C57B1/6 
B cells. Despite equalising the number of antigen-specific T cells in the cultures, the T 
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Figure 5.10 Defect in the help provided by T cdis from either MHC-H or CD40 1 B cell 
chimeras is not due to reduced number of antigen-specific T cells in these mice. 3x106 OT-
II CD40' lymph node cells were adoptively transferred to MHC-ll', CD40' and control 
chimeras followed by i.p. immunisation with ovalbumin-alum 24h later. The expansion of OT-il 
cells in both groups was assessed by flow cytometry and equal number of Va 2V 5 CD4 T cells 
were cultured with DNP-KLH primed C57BI/6 B cells in the presence of DNP-ovalbumin. The 
medium containing antigen was removed 48h later and replaced with fresh medium. The culture 
supematant was harvested 5 days later. DNP-specific immunoglobulins in the supernatant were 
measured by ELISA. The reciprocal dilution required for half-maximal OD was measured and 
plotted. Both groups consisted of 3 mice each. Data shown is the mean of triplicate wells ± SEM 
and represents two independent experiments. Wherever the amount of Ig was below the 
detection limits, the dilution required to achieve half-maximal OD was assumed to be 1. 
Statistical comparison between groups was done by unpaired Student's t-test. 
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efficiently help the B cells to produce DNP-specific IgG and IgGi compared to control 
chimeras (fig 5.10). 
Hence, it can be inferred from above studies that in the absence of T cell-interaction 
with B cells, in terms of antigen-presentation and CD40 costimulation, the T cells fail to 
acquire the ability to help B cells for class switching in vitro. 
5.8. Class switching in bone marrow chimeric mice 
Cognate interaction between B cells and I cells is required to form GCs and undergo 
isotype class switching in response to protein antigens. Also, CD40-CD40L interaction 
between B and T cells is critical for the production of class switched antibodies. The B 
cells in MHC-If' B cell chimeras do not present the antigen to T cells, while in CD40' 
B cell chimeras, the B cells cannot provide costimulation to T cells via CD40. In both 
the situations, mice should not make IgG responses to protein antigcns. To confirm this, 
mice were immunised with alum-precipitated DNP-ovalbumin and their sera examined 
for DNP-specific antibodies a week later by ELISA. The IgM.response was comparable 
between all mice while only control chimeras could mount DNP-specific IgG response 
(fig 5.11A). 
5.9. Expression of CD40L and ICOS on T cells in chimeras 
An important signal required by B cells to isotype switch is CD40 cross-linking, which 
coincidently also provides a costimulatory signal to T cells via CD40L and enhances IL-
4 synthesis [292]. I compared the CD40L upregulation on CD4 T cells from MHC-ll' B 
cell chimeras, CD40' B cell chimeras and control chimeras immunised a week before 
with ovalbumin-alum. The surface staining of splenocytes for CD40L was done either 
directly ex vivo or 20min after in vitro stimulation with PMA and ionomycin at 3 7°C, a 
process known to translocate preformed CD40L to the cell surface [165]. Intracellular 
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Figure 5.11 Characterisation of the bone man-ow chimeras. The chimeras were immunised i.p. with alum-
precipitated ovalbumin, 15Oi.gImouse. and their responses assessed at V. (A) B cells in MHC-ll and CD40 ,1 B 
cell chimeras do not produce class switched antibodies. Mice were bled before imminisation and at d7 after 
immunisation and serum separated. DNP-specific 1gM and lgG levels were measured by ELISA. The graphs 
show the OD at 405nm of d7 serum samples. (B) The splenocytes were stained with antibodies against CD4 
and ICOS and analysed by now cytometry for double positive cells. The graph shows lCOS cells as % of CD4 
T cells. (C) CD40L surface expression on C134 T cells was assessed either directly ex vivo or 20min after in 
vitro PMA+ionomycin activation by staining with antibodies against CDI and CD401- and analysing on FACS. 
Intracellular staining for CD40L was done after Sh incubation with PMA+ionomycin and GolgiStop. (D) Cells 
were stimulated with PMA+ionomycin+GolgiStOp and their cytokine expression measured by intracellular 
cytokine staining and flow cytometry (section 2.7.2). The graph shows the IL-2 and IFNy positive cells as % of 
CD4 T cells. All the groups had 2-3 mice each. Data shown in A, B and D is representative of two independent 
experiments while C shows data from one experiment. Unpaired Student's t-test was used to compare the 
groups statistically. 
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staining for CD40L was done after 5h of incubation with PMA; ionomycin and 
GolgiStop to measure the proportion of T cells capable of upregulating CD40L. 
No significant difference was noticed in the proportion of T cells that upregulated 
CD40L among different chimeras at all times apart from slightly reduced expression by 
T cells from MHC-If' chimera 20min after PMA and ionomycin stimulation (fig 
5.1 1C). This study indicates that B cell antigen presentation and costimulation via 
CD40 does not affect the upregulation of CD40L on T cells. 
ICOS has been implicated in the T-B interactions and the mice lacking ICOS have few 
small GCs and no class switched antibodies [94]. When the chimeras were compared for 
the expression of ICOS on CD4 T cells,.both MHC-11 4 B cell chimeras as well as CD40 
" B cell chimeras were found to have significantly fewer CD4 T cells expressing ICOS 
as compared to the control chimeras (fig 5.11B). 
5.10. T cell effector function: cytokine profile in chimeras 
The CD4 I cells from spleens of the chimeras immunised with ovalbumin-alum a week 
before were examined for the cytokines by intracellular cytokine staining. No apparent 
difference was noted in the number of CD4 T cells secreting IL-2. IFNy secreting CD4 T 
cells were fewer in MHC-IF chimeras and CD40' chimeras in comparison to control 
chimeras (fig 5.11D). Although by intracellular cytokine staining, number of T cells that 
were positive for IL-4 was always found to be low making it difficult to draw a 
conclusion, there was an indication towards lower number of IL-4 T cells in MHC-IF' 
chimeras (not shown). Attempts were made to measure the cytokines such as IL-4 in in 
vitro cultures of splenocytes from various chimeras by cell based ELISAs, but those 
experiments did not yield conclusive data due to the low amount of IL-4 produced. 
Perhaps, more sensitive assay such as ELISPOT to measure cytokines can give 
conclusive data. 
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5.11. Can wildtype B cells revert the defect in differentiation of helper T 
cells in chimeras? 
Apart from antigen presentation and costimulation, B cells can affect T cell responses by 
cytokines or some other B cell-derived factor. Transfer of naïve B cells [199] or antigen-
pulsed activated B cells [82] have been reported to restore the T cell responses in B cell-
deficient mice and 0X40L' mice, respectively. From this study so far, it could be 
concluded that B cells affect the T cell differentiation via M1HC class-I! and CD40. We 
attempted to compensate for this defect in chimeras by transferring C57B116 B cells. 
Between 10-20 million naïve B cells were injected into MHC-IF' B cell chimeras and 
control chimeras on the day of immunisation, and help assay carried out as before. 
ELISA for DNP-specific antibodies in the supematants indicated that wildtype B cells 
could compensate for the defect in T helper cell differentiation in chimeras (fig 5.12), 
but these results await confirmation. 
In one experiment, ovalbumin-primed B cells from C57B1/6 mice were injected in 
CD40' B cell chimeras and control chimeras 24h before immunisation. The level of 
DNP-specific IgG was highest in the group with transferred B cells, but due to 
inconsistency of the results especially in control chimeras, it was difficult to ascertain 
whether or not these B cells were instrumental in the T cell differentiation (fig 5.13). 
Given more time, I would like to try transferring naïve and primed wildtype B cells in 
the chimeras on two consecutive occasions. 
5.12. Role of chémokine receptor CXCR5 in the development of T cell 
helper function 
The chemokine receptor CXCR5 is critical for the migration of lymphocytes to the B 
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Figure 5.12 C57131/6 B cells may revert the T cell differentiation defect in MHC-I1 B cell 
chimeras. 10-2(Kl(P C57131/6 B cells were injected into MHC-Il' chimeras on the same day 
when they were immunised with ovalbumin. A week later, T cells were purified and cultured 
with DNP-KLH specific-B cells in the presence of DNP-ovalbumin. The antigen was removed 
after 2 days and the culture supernatant harvested 5 days later. DNP-specific Ig were measured 
by ELISA. 'Be reciprocal dilution required for half-maximal OD was measured and plotted. 
Each group comprised of 3 mice. Data shown is the mean of triplicate wells ± SEM and 
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Figure 5.13 Primed C57131/6 B cells may revert the defect in T cell differentiation in CD40' 
B cell chimeras. B cells were purified from C57131I6 mice primed with oval bumin 2 weeks earlier 
and transferred to CD40' chimeras a day before immunisation with alum-precipiated ovalbumin. 
A week later, T cells were purified from spleens of the recipient mice and cultured with DNP-
KLH specific-B cells in the presence of DNP-ovalbumin. The antigen was removed after 2 days 
and the culture supematant harvested 5 days later. DNP-specific Ig were measured by ELISA. 
Each grotç comprised of 3 mice. The graphs show the raw data from ELISA done on triplicate 
wells from one experiment 
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migrate into the follicles to provide help to B cells to class switch and form GC. From 
the results discussed so far, the interaction between T and B cells in the follicles is 
possibly bi-directional. I intended to investigate whether the signals that induce T cells 
with the specialisation to help B cells are delivered prior to (by DC) or after (B cells) T 
cell migration to the B cell follicles. This study can be undertaken by making bone 
marrow chimeric mice in which T cells lack CXCR5, and thus are not able to migrate to 
B cell follicles. Since TCR06' mice do not have T cells, a combination of bone marrow 
inoculum from TCRI38-' mice ('-80%) and CXCR5' mice (-20%) would give rise to 
chimeric mice that do not express CXCR5 on the T cells. Due to difficulties in acquiring 
TCRI38' mice however, this study could not be done. As a prelude, I tested the B cell 
helping ability of CXCR5' T cells. Ovalbumin-primed CXCR5' T cells were cultured 
with DNP-KLH-specific wildtype B cells in the presence of DNP-ovalbumin. As shown 
in figure 5.14, CXCR5' T cells were as efficient as wildtype T cells to help B cells to 
class switch. Interestingly, the levels of 1gM in CXCR5' cultures were significantly 
higher than C57B1/6 cultures. I had expected a defect in help by CXCR5' T cells, 
considering that the lymphoid architecture in CXCR5' mice is aberrant without proper 
segregation of B and I cells. However, it is possible that CXCR5 is required only for 
migration of lymphocytes since class switching and affinity maturation do occur in 
CXCR5' mice in spite of disturbed organisation of the secondary lymphoid organs 
[166,167]. 
5.13. Discussion 
It is a rare event for a naïve I cell to interact with a naïve B cell, and it is likely that T 
cells first divide to increase their number before interacting with B cells. The initial 
priming of the naïve T cells occurs on DCs. Besides higher expression of MHC-II, 
adhesion and costimulatory molecules, DCs process and preent limited 
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Figure 5.14 CXCR54  T cells are efficient helpers for B cell antibody production. Purified 
CD4 T cells from C57B1/6 and CXCR5' mice primed with oval bumin were cultured with DNP-
KLH-primed C57B1/6 B cells in the presence of DNP-ovalbumin. The medium containing the 
antigen was removed 48h later and replaced with fresh medium. The culture supematant was 
harvested 5 days later and DNP-specific immunoglobulins in the supernatant measured by 
ELISA. The reciprocal dilution required for half-maximal OD was measured and plotted Data 
shown is the mean of triplicate wells ± SEM and represents two independent experiments. Both 
groups were compared statistically by unpaired Student's t-test. 
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B cells, the complexity of antigenic epitopes made available to the T cell pool by a 
particular B cell increases significantly. This happens despite the frequency of a B 
lymphocyte of any one specificity being only in the order of 2.5-4x10 4 for murine 
lymphoid organs [293-295]. B cells can also increase chances of T cell survival by 
providing costimulatory molecules to T cells e.g. OX40L, which interacts with 0X40 on 
T cells and suppresses apoptosis by promoting the expression of Bcl-xL and Bcl-2 [55]. 
B cells are also known to act as decoys by expressing Fas and regulating their own 
destruction instead of T cells [136]. 
B cells have been shown to be important for the differentiation of helper T cells on the 
basis of various studies done using B cell-deficient mice of various strains. Also, 
costimulatory molecules like CD40 and OX40L have also been proved to be critical for 
the T cell acquisition of helper function [209,289]. However, using more classical 
cellular assays, it has been difficult to determine the precise nature of the observed 
defects in either B cell deficient mice or mice lacking these costimulatory molecules. In 
particular it is unclear to what extent the defects are quantitative, qualitative or both. 
Therefore, to better characterise the defect in the T cell differentiation in mice with 
defective B cell compartment, we took advantage of a unique technology involving bone 
marrow chimeras. By transferring a combination of bone marrow precursor cells from 
tMT and A1E'  or CD40' into lethally irradiated mice, I could create chimeric mice that 
lacked the molecule of interest on B cells only. These mice provided me with 
opportunity to study the role of MHC-II and CD40 on B cells in differentiation of T 
helper cells. 
Because I used purified populations of CD4 T cells and B cells, and because T and B 
cells were primed with different antigens, it is unlikely that DNP-speci'fic IgG was 
produced by contaminating B cells in the T cell (ovalbumin-primed) population or that 
contaminating I cells in the B cell population induced immunoglobulin synthesis. 
I found j.tMT T cells to lack the capability to help B cells for antibody production. This 
was evident by significantly lower levels of IgG, IgGi and IgG2 a in i.LMT culture 
supernatants. This. study corroborates earlier findings [202,204]. Macaulay et al. 
attributed the lack of help by JHD T cells only partly to a failure to upregulate IL-4 
synthesis, since addition of IL-4 to the JI{D cultures did not increase IgG production to 
the level in wildtype cultures without exogenous IL-4. I observed low 1gM levels in 
.tMT culture supernatants. This finding differs from the earlier reports [204], though, not 
unexpected given that T cell help is important, if not critical, for 1gM responses. 
On the contrary, Rivera and colleagues reported that systemically primed T cells from 
.tMT.BALB/c or i.tMT.B6 B cell-deficient mice were equally capable of providing B 
cell help as T cells primed in normal control mice [199]. This contrasting result may be 
because of differences in experimental protocols. This report had both T as well as B 
cells primed with SRBC before adoptive transfer into lethally irradiated recipients. The 
possibility of contaminating SRBC-specific T cells in the B cell population providing 
the help required for class switching cannot be excluded. 
Given that same number of OVA-specific OT-Il T cells from C57BI/6 and CD40' mice 
in the culture could not compensate for the reduced help by CD40' T cells, it is likely 
that the defect in helper function is qualitative. Gray and co-workers observed similar 
findings in an in vivo model where KLH-primed T cells from CD40' and wildtype 
littermates were injected into lightly irradiated CD40' mice along with CD40 
expressing B cells [289]. Only those mice that received T cells primed in CD40 
environment produced class switched antibodies of the donor origin. The outcome was 
the same despite giving 15-fold excess of antigen-specific C040' T cells compared to 
wildtype T cells. 
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Oxenius et al. however showed that neither CD40 expression nor the presence of B cells 
was necessary for the development of T cell helper function [242]. T cells from either 
.tMT or CD40' mice infected with LCMV could facilitate isotype switching when 
transferred into normal naïve mice. These conflicting results may reflect a difference in 
the predominant cytokine and isotypes present during LCMV infection (Thi) versus 
priming with alum-precipitated antigen (Th2). It is also possible that viral infection 
activates APCs in such a way as to give different signals to responding I cells than 
adjuvant activation does. 
Having shown that MHC-II and CD40 on B cells are required for T cells to differentiate 
into efficient helpers for B cells, it is important to consider why these molecules could 
be important. It is possible that some T cells that undergo only a short interaction with 
DC have not been primed enough to undergo cell division and differentiation, and the 
second interaction with a B cell is necessary for differentiation. It has been shown that T 
cells require several hours of stimulation before they can undergo proliferation. 
Furthermore, MHC-signalling in B cells may enhance their proliferation, upregulate 
costimulatory molecules and cytokine production, making them efficient APC [296-
298]. Another possibility is that B cells provide cytokines or some other factor during a 
stable interaction with T cells as a result of peptidefMHC-TCR and CD40-CD40L 
interactions. 
The defects I have observed in the interaction of primed T cells (from .tMT mice and 
chimeras) with B cells in vitro indicate an absence of a signal normally provided by B 
cells during in vivo priming. Given the findings of van Essen et al. [289] that I cells 
primed in CD40' mice are unable to provide B cell help and that CD40L signalling can 
stimulate I cell IL-4 synthesis [292], CD40-CD40L interaction seems like a critical 
signal in the development of helper T cells. Although other APCs express CD40, B cells 
express this molecule at higher levels [207,299], which may be necessary for these 
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responses. Signalling via CD40 on B cells has a number of effects, including class 
switching, proliferation [300] and upregulation of costimulatory molecules like CD80 
and CD86 [301,302]. Since B cell activation and proliferation seem to depend critically 
on presence of cognate T-help [183,303], it may be possible that in MHC-If' and CD40 
B cell chimeras, there are fewer activated B cells as APC and reduced costimulatory 
molecules, which affects the T cell differentiation. 
It has also been suggested that limited expansion and differentiation of T cells in pMT 
mice is probably due to APC deficiency since either B cell or splenic DC transfers in 
iMT mice could reconstitute the expansion and Th2 cytokine response [203]. This could 
be one of the reasons for defective helper T cell differentiation in the MHC-IP' B cell 
chimeras where B cells are not able to present antigen to T cells. 
Interestingly, uptake of antigen in vivo via Ig receptor upregulates B7-2 and MHC-II 
expression on B cells within 4h and allows successful priming of naive T cells [285]. 
However, by 24h of antigen introduction, B cells downregulate B7-2 and loose their 
antigen-presenting capacity over time unless they interact with an antigen-specific T 
cell. Between 24-48h, B cells expressing antigen complexes in the absence of 
costimulatory molecules are most likely to induce T cell anergy. 
5.13.1. 0X40-OX40L interactions in T cell differentiation 
T cells differentiated in the absence 0X40-OX40L interaction fail to acquire the ability 
to help B cells to class switch. A possible function of 0X40-OX40L interaction in 
regulating the T cell-dependent B cell responses was proposed based on the finding that 
injection of rabbit anti-mouse 0X40 antiserum inhibits antigen-specific B cell responses 
in mice [85]. Treated mice developed GCs in response to TNP-KLH but were impaired 
in the production of TNP-specific IgG. However, Pippig et al. did not fmd 0X40 to be 
essential for B cell differentiation and antibody secretion in their studies done with 
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OX40 mice. 0X40' and wildtype mice exhibited equivalent levels of serum antibody 
in response to various antigens [304]. Probably the use of parasitic infections like 
Leishmania major and Nippostrongylus brasiliensis, involving powerful antigenic 
stimulation, might have masked the effects due to lack of 0X40. Costimulation of CD4 
T cells through 0X40-OX40L interaction has also been implicated in the upregulation of 
chemokine receptor CXCR5 in vitro [209]. Since CXCR5 is required for the migration 
of B and T cells into the follicles, 0X40-OX40L interaction could be important for 
recruiting antigen-specific T cells into the GCs and thereby influencing antibody 
responses. Additional support for the involvement of OX40L on T cell responses comes 
from the studies done by Linton and co-workers. They showed restoration of CD4 T cell 
responses in pMT mice reconstituted with wildtype B cells but not OX40U' B cells 
[82]. Jacquot et al., in a human study showed that CD27-CD70 interactions induced 
plasma cell differentiation once CD40-dependent clonal expansion of the B cells had 
taken place [214]. Morimoto et al., in a similar study suggested that this is followed by 
0X40-OX40L mediated enhanced antibody production on per cell basis in the presence 
ofIL-4 and IL-b [134]. 
To answer whether OX40L on B cells is important for T cells to acquire the ability to 
help B cells, I have generated OX40L' B cell chimeras. It was not feasible to do the 
experiments with these mice yet due to time lost in re-derivation of 0X40L' mice and 
the reconstitution of the bone marrow chimeras. 
5.13.2. Lymphoid architecture in T cell responses 
Although studies with B cell deficient mice have increased our understanding of the 
involvement of B cells in regulation of T cell responses, the fact that these mice have 
disrupted architecture of the major lymphoid organs (e.g. spleen and lymph nodes), 
cannot be ignored. Making chimeras was an elegant way to look at the role of B cells in 
particular in context of antigen presentation or costimulation, without disruption of the 
splenic architecture. Unlike pMT mice, these BM chimeras possess both FDCs and 
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marginal zone macrophages. Interestingly, it is the environment of B cell zone that is 
more critical than the B cells themselves as impaired CD4 cell responses to LCMV have 
been reported in 11 FR' 2 mice that have normal B cells but resemble B cell-deficient 
mice in that they lack splenic B cell follicles, follicular dendritic networks 'and germinal 
centres [198]. Normal lymphoid architecture hence seems critical for the optimal T cell 
priming. 
5.13.3. Regulation of T cell help by cytokines 
B cells can regulate cytokine secretion by CD4 T cells. Linton and colleagues observed 
that OT-Il cells produced similar quantities of IFNy, IL-2 and IL-lO irrespective of 
whether they were primed in normal or j.tMT mice. However, I cells from .tMT mice 
produced markedly lower levels of IL-4, IL-5 and IL-13, which could be restored by 
provision of activated, antigen pulsed OX40L B cells [82]. Reconstitution with B cells 
did not affect the frequency of IFNy producing effector cells in pMT mice suggesting 
that IFNy response, which can develop before that of IL-4 [151,305] can be optimally 
primed without a contribution from B cells. Link between B cell antigen presentation 
and induction of IL-4 secretion by CD4 T cells has been suggested earlier [207,208]. 
Literature is available on reduced IFNy production by I cells in B cell deficient j.iMT 
mice [203] and in vitro in JHD cultures [204]. In contrast, Moulin et al. have reported 
that CD4 effectors primed in .tMT mice are skewed towards Thi response with 
secretion of high levels of IFNy that appeared to correlate with DC synthesis of IL-12 
[306]. It is possible that without B cells to either downregulate IL-12 synthesis or DC 
maturation via IL-lO, or assume a role as APC that do not produce IL-12, only Thi cells 
would arise [307-3 09]. Moreover, after stimulation of naïve CD4 cells, the capacity to 
produce IFNy develops early, whereas IL-4 secretion develops more slowly, and can be 
associated with progression through several cycles of division [151]. Thus, reduced CD4 
expansion in the absence of B cells may result in aborted CD4 cell differentiation, and as 
a consequence, a Thl dominated response [200]. 
173 
5.13.4. Importance of B cells 
Significantly less CD4 T cells in the MHC-Ir chimera as well as CD40' chimera 
expressed ICOS as compared to control chimeras. The fact that ICOS is critical for B 
cell help by T cells, this finding strongly indicates the suboptimal differentiation of 
helper T cells in mice with defective B cell compartment. Hence, it suggests that B cells 
are an important regulator of T cell responses. 
I did not observe any major defect in CD4OL upregulation on T cells in chimeras. 
CD40L has been reported to be upregulated to the same extent in JHD and wildtype T 
cells when stimulated with anti-CD3, though it is not known if the same would be true 
with B cells as APC [204]. In support, CD40L induction is largely independent of 
costimulatory signals [96,268,269]. 
The absence of IgG antibodies in MHC class-Il and CD40-deficient B cell chimeras can 
likely affect the T cell responses in these chimeras. One possible way this can happen is 
by reduced IgG mediated opsonization and therefore reduced activation of macrophages 
through FcyRI (CD64). Macrophages when activated are potent APCs and can 
contribute to enhanced T cell responses [75]. On the other hand, antibodies can 
neutralise the antigen and thereby reduce lymphocyte priming. 
TFH subset of T cells, characterised by expression of CXCR5, is considered to be 
involved in B cell help [33,164,165]. I could not characterise this subset of T cells in the 
chimeras in this study in want of CXCR5-specific antibody that could be used to 
visualise these cells on FACS. Alternatively, induction of CXCR5 mRNA in CD4 T 
cells can be tried [209]. 
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Although the involvement of marginal zone (MZ) B cells in T-independent immune 
responses is well established, a recent report by Attanavanich and Keamey suggested 
that MZ B cells can present protein antigens to CD4 I cells inducing their proliferation 
both in vivo and in vitro [310]. Moreover, the authOrs observed that MZ B cells 
upregulate costimulatory molecules such as CD80 and CD86, and regulate effector I 
cell generation by stimulating CD4 T cells to produce high levels of Th 1 cytokines upon 
in vitro stimulation. Since Follicular (FO) B cells have always been considered more 
important for the T-B interactions, it would be interesting to investigate whether MIHC-II 
and CD40 on FO or MZ B cells are important for the T cell differentiation into helper 
cells for B cells. Bone marrow chimeric mice specifically lacking these molecules on 
MZ B cells can be created using Dedicator of cytokinesis 2 (Dock2) deficient mice or 
Protein kinase 2 (Pyk2) deficient mice that lack MZ B cells [17,311,312]. 
Jordan et al. have recently shown that intraperitoneal injection of alum resulted in more 
than 50% of the splenic B cells being primed in the context of intracellular Ca 2 levels 
[313]. IL-4 secreted by a subset of Gr1 cells was ascertained for this priming. How the 
use of alum as adjuvant in my study affect the B cells in chimeras, would be interesting 
to investigate. 
5.14. Conclusions 
In summary, B cells are crucial for the T cells to acquire helper function. The data 
presented in this chapter suggest that T cells that have been activated in vivo in the 
absence of B cells are impaired as they are unable to help B cells to class switch in vitro. 
Furthermore, T cells primed in the absence of CD40 and OX40L are unable to help 
normal B cells to class switch. By creating bone marrow chimeric mice,iI have shown 
that in the absence of B cells that express MHC class-IT or CD40, antigen induced 
differentiation of effector T cells that help B cells to class switch, is impaired. 
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6. Discussion 
6.1. Role of CD40 and ICOS in CD4 I cell responses 
Costimulation is more complex than it was originally thought. The immune system has 
lots of back up mechanisms in terms of the redundant and overlapping functions of 
various costimulatory molecules. In addition, costimulatory signals may not be 
completely distinct from ICR signals. Many studies now show that CD28, ICOS and 
members of TNFR family can engage signalling intermediates that are common to the 
TCR and to each other [314]. So, the effects of co-signalling can be quantitative, leading 
to the accumulation of common signalling intermediates, or qualitative, involving 
distinct signals that do not overlap between various costimulatory molecules, and are not 
engaged by the TCR. 
As there are many costimulatory receptors, a reasonable hypothesis is that several 
costimulatory signals are required for the development of effective T cell immunity in 
any given situation. Acknowledging that some redundancy exists, the requirement for 
many or all of these molecular interactions probably reflects two things: first, that 
several signals are required simultaneously at any one time in the life of the responding 
T cell; and second, that different signals are required at different times and/or stages of 
the T cell response. 
I have addressed the requirement of costimulation via CD40 and ICOS in T cell 
responses. Chapter 3 describes attempts to investigate the importance of cD4O on DCs 
for T cell proliferation in an in vitro model. I found that activation and survival of 
DOl 1.10 T cells in vitro was not curtailed in the absence of CD40 on DCs, since the 
proliferation of T cells in terms of thymidine incorporation as well as loss of CFSE was 
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similar in the presence or absence of CD40 on DCs. However, when OT-Il transgenic T 
cells were tested for their ability to proliferate and survive in the absence of CD40-
CD40L interactions, contrasting results were observed. OT-Il T cells proliferated less 
and underwent apoptosis when cultured with CD40' DCs in comparison to wildtype 
DCs. We hypothesised that owing to the low affinity of the OT-Il cells for the MHC-
peptide compared to DO 11.10 T cells, their requirement for costimulation is greater. 
Using APLs, I tried to study if dependence of DO 11.10 T cells on CD40 costimulation 
increases in the presence of peptide for which their TCR has lower affinity. However, I 
did not observe any difference in the proliferation of DO 11.10 T cells whether or not the 
DCs expressed CD40. Although, this study did not shed any light on why DO! 1.10 T 
cells are independent of CD40 costimulation, it does suggest that the requirement for 
CD40 is much more stringent for low affinity TCR-peptide-MHC interactions of 01-I1 
T cells than for high affinity DO 11.10 T cells. Studies done in the lab using MHC class-
II tetramers have shown that CD4 T cells do not get primed in CD40' mice. However, 
due to small number of antigen-specific T cells, they could not be detected until 7 days 
after immunisation in this system. 
Although the in vitro requirements for I cell activation have been studied extensively, 
the initiation of the immune response in vivo takes place within a complex 
microenvironment, in which the interplay between DC and T cells is restricted by 
anatomical constraints. The findings of in vitro experiments may give an indication of 
the requirements for T cell activation in vivo, but their validation in in vivo settings is 
essential. The in vivo experiments involving the adoptive transfer of 01-Il T cells into 
wildtype and CD40' mice revealed that OT-Il T cells need CD40-CD40L interactions to 
sustain proliferation in vivo, thus confirmed my in vitro findings. Experiments are 
underway to confirm whether the DO 11.10 T cells have similar requirements in vivo. 
In the CD28-CD80/CD86 and CD40-CD40L costimulatory pathways for the initial 
activation of the lymphocytes, the signalling molecule (CD28 and CD40) is 
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constitutively expressed and the ligand is inducible. In contrast, in the ICOS/ICOSL 
pathway, the putative signalling molecule ICOS is induced after activation. Therefore 
stimulation of T cells via ICOS will depend primarily on induction of ICOS, which can 
then interact with constitutively expressed ligand on the APCs. It is important to 
determine the role of ICOS in T cell responses and the factors that regulate ICOS 
induction. I addressed the former by studying the T cell responses in ICOS' mice. 
I took advantage of two techniques to study whether ICOS is required for T cell 
activation: adoptive transfer and MHC-II tetramers. The use of TCR transgenic T cells 
for adoptive transfer has several advantages - first, the majority of the T cells are naïve; 
second, T cells are of known antigenic specificity, so they can be stimulated with 
physiologic signals i.e. peptide and MHC on APC. The disadvantage is that this system 
is far from physiological. In this study, the number of ICOS-deficient 01-I1 cells was 
significantly lower compared to wildtype OT-Il cells, during  both clonal expansion as 
well as clonal deletion phases. However, when strong adjuvant CFA was used, both 
types of cells expanded to similar levels, but again were significantly reduced in the 
deletion phase when ICOS was lacking. Using CFSE labelled cells we have shown that 
cells can enter proliferation in the absence of ICOS-ICOSL interactions but they 
undergo less division. These findings are in line with the fact that ICOS is induced after 
activation and hence crucial for sustained T cell expansion once they are activated. 
With MHC-tetramer binding studies following immunisation with Hi 9env peptide 
emulsified in CFA, I did not find much defect in I cell proliferation in IC0S' mice. 
Although more physiological, this technique is inherently different from the adoptive 
transfer system as it can detect the antigen-specific T cells only after they have 
expanded. The comparison of both the techniques using alum was not possible, since 
tetramer staining, following immunisation with H19env-alum was fried by other 
members of the lab without much success. Thus, it is difficult to rule out the possible 
role played by the different ãdjuvants in both models. 
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Costimulation can augment cell proliferation, survival and production of cytokines. 
Following antigen recognition, IL-2 is required for I cell clonal expansion. Once the T 
cell is activated by antigen and costimulation, it stimulates transcription of IL-2 gene 
followed by the synthesis and secretion of IL-2. It is possible that in the absence of one 
costimulatory molecule, T cells can still proliferate as the required amount of IL-2 is 
achieved by other costimulatory molecules. Generation of ICOS' IL-2" mice by 
crossing ICOS' mice to IL-2 mice may be an approach to determine if ICOS plays a 
critical role in the initial I cell proliferation, since these mice will make less IL-2 to 
begin with. 
Activated B cells do not attract T cells to lymphoid follicles, rather it is the DCs that 
control the I cell migration into the follicles [9]. Considering that DCs are the APC for 
the majority of the T cells, it is possible that the interactions that occur in the follicle 
may optimise clonal expansion of T cells. There is evidence that the follicle is a major 
site of CD4 T cell proliferation [315,316]. Although this study has not addressed the 
migration of T cells to the follicles in ICOS' mice due to time constraints, this can give 
further insight into the role of ICOS in T cell clonal expansion. However, Smith et al. 
blocked these interactions by anti-ICOS mAb and found that T cells were able to 
migrate to the follicles after immunisation although the T cell clonal expansion was 
reduced by 50 percent [97]. 
That ICOS is critical in the contact-mediated I cell help to B cells was suggested by our 
in vitro help assay in which ICOS 4 T cells failed to help primed wildtype B cells to 
produce class switched antibodies. The ligation of ICOSL on B cells is critical for them 
to undergo clonal expansion and Ig isotype switching, since the ICOS mice had 
reduced number of antigen-specific (PE) B cells and reduced serum Ig and ASC in 
comparison to wildtype mice. Furthermore, the induction of ICOS on T cells in M}IC-II 
as well as CD40-deficient B cells chimeras was significantly lower in comparison to 
wildtype chimeras. Collectively these findings implicate the interaction between ICOS 
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and ICOSL in the development of T cell helper function. In our quest, to dissect the 
molecular basis of B cell dependence of differentiation of T cells, we intended to make 
ICOSL' B cell chimeras. Whether T cells from such chimeric mice are able to help the 
B cells, would be interesting to investigate. Once ICOSL' mice are available, these 
studies would be undertaken. 
6.2. B cells can regulate T cell differentiation 
There is growing interest in the fundamental roles that B cells may play in regulating 
immune responses. Interactions between T and B cells involve a complex network of 
signals mediated by communication through multiple receptors expressed by both 
populations of cells. One aspect of this complexity that is not well understood is the 
directionality, and possible bi-directionality, of signalling through specific "receptor -
ligand" interactions. While the importance of these interactions for the B cell and GC 
response is clear, the importance of the signals that T cells gain is less apparent. 
B cells require T cell help to clonally expand, class switch and undergo GC reaction in 
response to a protein antigen. Although it has long been realised that delivery of help by 
T cells require cognate recognition of antigen presented by B cells, the mechanisms by 
which this is achieved are unclear. Initial activation of naïve T cells occurs on DCs. 
However, it seems unlikely that T cells primed by DCs should immediately express all 
the functions of a competent helper cell, as this would allow help to be given to all the B 
cells, regardless of the antigen specificity. Instead, there may be further signals which 
are required in order for T cells to mature as helper cells, or which trigger delivery of 
help. This could be delivered during secondary interactions between recently primed T 
/ ôells and B cells. It is also possible that some T cells that undergo only a short 
interaction with DC have not been primed enough to undergo cell division and 
differentiation, and the second interaction with a B cell enables this to occur. 
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van Essen et al. studied the helper T cell development in the absence of CD40 
costimulation [289]. They found that although I cells primed in the absence of CD40 
undergo normal clonal expansion, they are unable to provide help for B cells to either 
produce class-switched antibodies or generate GCs. The CD40-CD40L interaction 
cannot take place during the initial priming event on DCs, as resting T cells do not 
express CD40L. However, CD4 T cells rapidly induce expression of CD40L after 
activation, allowing subsequently encountered APCs to costimulate them via this 
molecule. Signalling via CD40L enables differentiation of helper T cells, and perhaps 
the type of APC on whose surface it is seen directs this differentiation. Hence I cells 
engaging CD40 on a DC or macrophage causes them to secrete IL-12, .favouring 
differentiation to Thi phenotype [67]. Conversely, T cells meeting CD40-expressing B 
cells are pushed towards the Th2 pathway. This is exemplified by the findings of 
Stockinger et al. [208]. They demonstrated that B cell presentation could override an 
intrinsic propensity for Thi development and results in generation of C5 specific 
antibodies in self-antigen C5-specific TCR transgenic mice. The T cells from these mice 
otherwise induce biased Thi response and do not generate antibody response to CS. 
T cell differentiation is dependent on the number of divisions they undergo, and this also 
correlates with whether a T cell migrates into B cell follicle, these two functions may be 
related. As suggested by Garside and colleagues, T cells require passage through a B cell 
follicle and the cellular interactions they undergo there are necessary for maximal clonal 
expansion, terminal differentiation and to acquire effector and memory function [317]. 
The blockade of any of the molecules or interactions essential for either migration of T 
cells into B cell follicles, or for their interaction with B cells in the follicles, would limit 
the number of divisions they undergo and alter their differentiation. My experiments 
with MHC-If' and CD40' B cell chimeras identify two molecular interactions between 
B and T cells that seem to be critical for the development of helper function. From 
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Fillatreau and Gray's findings, T cells migrate normally to the follicles in both these 
chimeras [9]. This also confirms that the migration of T cells to the follicles is not solely 
for the purpose of helping B cells, but related to normal T cell differentiation pathways. 
In support, the markers that distinguish various memory T cell subsets, e.g. the 
chemokine receptors CCR7 and CXCR5, are important for the positioning of I cells in 
or out of the lymphoid follicles, sUggest a link between passage through the follicle and 
differentiation into these subsets [33,164,165,318,319]. 
Given my findings, it appears that incomplete interaction of T cells with B cells in 
follicles due to the absence of MHC-II and CD40 on B cells, affects their differentiation 
into T cells that can help B cells. In MHC-ff' chimeras, since the B cells are not even 
able to present the antigen to the T cells, both cell types are affected. In these chimeras, 
B cells do not make class switched antibodies and T èells do not evolve as helpers for 
the B cells. Thus, T cells presented with antigen by B cells have an advantage over their 
DC-presented counterparts in terms of acquisition of helper function. These findings 
provide an insight into earlier reports that I cells from B cell deficient mice do not 
acquire the ability to help B cells to class switch [202,204]. I found that T cells 
differentiated in the absence of 0X40-OX40L interactions are also not able to help B 
cells to class switch. Costimulation by 0X40 upregulates CXCR5 on I cells thereby 
facilitating their migration into B cell follicles where they can then provide the necessary 
help to B cells [209]. To answer whether B cell expression of OX40L plays any role in T 
cell acquisition of helper function, studies are currently underway with 0X40L' B cell 
chimeras. 
The importance of migration through follicles for T cell differentiation has been 
controversial, particularly for Th 1, as Randolph et al. suggested that this subset neither 
upregulates CXCR5 nor migrates into follicles [160]. When CXCR5 was retrovirally 
transduced into Thi cells, they remained primarily in the central PALS, suggesting that 
action of CCR7 is dominant over CXCR5. In contrast, Smith et al. observed similar 
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number of in vivo generated Thi and Th2 I cells in the B cell follicles [163]. Moreover, 
they found both subsets were equally able to support B cell clonal expansion and 
antibody production. This finding is supported by other reports [97,320,321]. Indeed, 
high affinity IgG2a antibodies are generated, itself an indication of Th 1 cells migration to 
follicles, since B cell clonal expansion in extrafollicular foci is not associated with 
somatic hypermutation [39]. Alternatively, some studies have suggested that B cell help 
is a function of an entirely separate Th cell subset, IFH, which may not be Thi or Th2 
[165,322,323], or may become polarised only after passage through the follicle [324]. 
This remains a controversial though crucial area for understanding of T cell 
differentiation. 
What signals do B cells provide to T cells that no other APC can replicate? As the 
immune response progresses, a switch in APC usage from DC to B cells is favoured, this 
is due to various reasons: first, the recruitment of DCs is diminished after the initial 
phase of response unless the source of antigen is chronic; second, DCs have relatively 
shorter life span; and third, due to clonal expansion of antigen-specific B cells, the 
number of B cells that can act as APC increases as the response matures. Thus, the B 
cells have a quantitative advantage over DCs and this property appears to be exclusive to 
B cells. 
In addition to antigen presentation, B cells can affect T cell response by cytokines and 
costimulatory molecules. DCs control T cell differentiation by secretion of IL-12. B 
cells have been shown to be able to secrete cytokines such as IL-b, IL-6, TGF, TNIFa 
and IFNy [11] and there are some reports that B cells can make IL-12 [325]. Skok etal. 
reported that DC-derived IL- 12 was required for the induction of Th2 response by a 
negative feedback loop involving IL- 10 secreted by B cells [11]. B cell-derived IL-6 can 
direct the differentiation of Th2 cells by inducing IL-4 transcription [11,212]. Moreover, 
Macaulay et al. reported impaired IL-4 production by I cells in B cell deficient mice to 
be at least partly responsible for the failure to develop effective T cell help for B cells 
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[204]. These findings indicate that B cells can influence T cell differentiation either 
directly (IL-6) or by modulating DC function (IL-b). 
There do not seemto be any B cell-specific costimulatory molecules. Initially ICOSL 
was reported to be expressed by B cells and not DCs, however, there are many reports 
now suggesting its expression on DCs [92,101]. Despite this, the differences in the 
timing of expression of costimulatory molecules may possibly be one of the reasons for 
the unique ability of B cells to affect T cell differentiation. Considering the many 
possible differences between DCs and B cells in terms of cytokines, chemokines, 
adhesion molecules, costimuli and signalling molecules, a cDNA microarray analysis 
would yield a global picture of qualitative, quantitative and kinetic differences in 
expression of these molecules in DC and B cells. 
In summary, the experiments reported in this thesis shed light on some of the 
mechanisms involved in I cell activation and differentiation as helper T cells. At the 
same time, a number of new questions have arisen. Their resolution promises to be an 
exciting area of future research. 
SIM 
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